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Abstract
Characterisation and understanding of genetic components is a key part of both synthetic bi-
ology and systems biology. Quantitative knowledge of how DNA parts encode function allows
parts to be predictably constructed into synthetic gene circuits. Less understood is how the
expression of a synthetic gene circuit can have a detrimental effect on its host cell (the chassis)
and how these effects can feed back to the behaviour of the circuit. In this thesis, we inves-
tigate how synthetic circuits use cellular resources (e.g. DNA polymerase, RNA polymerase,
ribosomes, tRNA, etc.) to replicate and express and we quantify these effects and model gene
expression in a way that accounts for this. This is done by considering this shared ’resource
pool’ as an interface between the host cell and the synthetic circuit. Through genetic engineer-
ing and synthetic biology, we have created a system that monitors the availability of shared
resources in E. coli, thus enabling the quantification of the burden a synthetic circuit places on
the cell’s resources. We then measure the burden of a combinatorial library of different de-
signs to examine how different genetic components influence the magnitude of burden. This is
accompanied by a mathematical model. Through this method we work towards a system that
will enable the prediction of how to optimise the design of a synthetic circuit with regards to its
output and the levels of burden it places on a cell.
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Synthetic biology is a newly emerging field within the scientific community which lies at the junc-
tions of many disciplines. One of the key aims of synthetic biologists is to apply an engineering
approach to the design and construction of biological systems. This approach has the potential
to create a new wave of applications and technologies which “will influence many other scien-
tific and engineering disciplines, as well as affect various aspects of daily life and society” [9].
However, as with the development of any other new scientific discipline or engineering field,
there are numerous challenges which must be overcome before this potential can be reached.
The literature offers myriad definitions of synthetic biology, though a widely accepted one is
that synthetic biology is A) “the design and construction of new biological parts, devices,
and systems,” and B) “the re-design of existing, natural biological systems for useful pur-
poses” [1]. Analogies between synthetic biology and electrical or computer engineering have
been made [9]. Although there exist clear departures from this analogy, such as the lack of insu-
lation in biological systems and the fact that in biology pools of resources are important as well
as fluxes of these resources through systems, many parallels can be drawn between the two
and it can be useful for people trying to understand what synthetic biology is, and the approach
to its development, to keep this in mind. Figure 1.1 is taken from Andrianantoandro et al. [9]
and shows a comparison between the hierarchical structure of synthetic biology and a similar
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hierarchy in computer engineering.
Figure 1.1: An analogy between synthetic biology and computer engineering. Taken from
Andrianantoandro et al. [9]
The expression of the genes from a synthetic circuit can impart extra functionality on a cell.
These functionalities are wide ranging and include the ability to perform logic operations [67,105,7],
pattern formation [16], tuneable oscillators [96], counting abilities [36], light sensing for bacterial
photography [56] and chemical sensors [48]. There is a diverse range of applications that affect a
broad range of fields such as health, such as biofilm detection [84] to energy where next genera-
tion biofuels and commodity chemicals are being developed [35,39,54,29,86]. The synthetic biology
solutions to the problems within this wide range of fields of potential applications are currently
limited by a number of technical and scientific factors [80]. As a field that is now currently emerg-
ing from its infancy, there are a number of ‘growing pains’. When the first synthetic biology
research started to emerge almost a decade and a half ago, the circuits being reported were
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relatively simple and used a small range of biological parts [78,38,33]. However, as the field has
progressed there is an increased demand for better tools and understanding of the underlying
biology to facilitate more advanced applications.
Synthetic biology research can be split into two main sub-fields: fundamentals and applications.
The fundamentals side of synthetic biology concentrates on answering fundamental questions
about the nature of life and the underlying processes which occur in biology [95] whilst the ap-
plications side uses this knowledge to either reengineer existing systems or to construct new
systems in a way which allows for the development of novel functions and applications [50].
These two sides are intrinsically linked by the need for greater understanding to facilitate im-
proved methods and techniques for the generation of applications. In this project we aim to gain
a greater understanding of some of the most important fundamentals of implementing synthetic
biology - the link between the chassis cell and a synthetic genetic circuit - with results which
will directly impact upon the ability of researchers to create future applications.
Definitions
At this point it is important to introduce some definitions that are crucial for understanding
synthetic biology and especially this study.
Synthetic Genetic Circuit A synthetic genetic circuit (or synthetic circuit in the context of
synthetic biology) is a section of DNA which is inserted into the cell and contains sequence
for the expression of certain mRNA or proteins. For E. coli this is usually inserted in the
form of a plasmid, a circular strand of DNA which is ‘separate from, and can replicate
independently of, the chromosomal DNA’ or inserted directly into the genome of the cell [70].
Chassis/Host Cell The cell which contains this synthetic circuit is known in synthetic
biology as the chassis, or host, cell. The synthetic circuit uses machinery from this cell in
order to replicate itself and to express the genes it contains. Returning to the computer
engineering analogy, one can imagine the chassis cell as a computer and its operating
system, while the synthetic circuit is the code for a programme on that computer.
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Shared Resources The term shared resources refers to the machinery and building
blocks (such as amino acids and nucleotides) required by both the host cell and synthetic
circuit for the replication of DNA, transcription of RNA and translation of protein. Examples
of these resources are ribosomes, RNA and DNA polymerases etc.
Burden The burden placed on a chassis cell’s shared resources by a synthetic circuit
refers to the resources that are used by the synthetic circuit and therefore not available for
the cell to use for its own native processes. This burden on shared resources is one of
many types of stress such as nutrient starvation, nitrogen starvation, physiological stresses
etc. and in the same way that cells respond to these stresses, cells will respond in different
ways to burden (such as the stringent response in some strains - see Section 1.1.5).
Capacity The capacity in a cell is the amount of free resources that are not being used
by either a synthetic circuit or the chassis cell. An increased burden from a synthetic ge-
netic circuit will, dependent on any cellular feedback in response to the burden, reduce the
capacity in a cell. Certain strains of E. coli cell may have a larger ‘unburdened’ capacity
than others.
Although synthetic biology promises much, there still remain many challenges to overcome [78,80].
One of these challenges regards standardisation and the manner in which it can be imple-
mented within the field. Within biology there are many examples of standards, ranging from
microarray data [18] to restriction endonuclease activities [83]. An attempt has been made to
standardise the manner in which genetic parts are characterised in Canton et al. [21], where an
example data-sheet akin to those seen in other engineering disciplines is shown [21] (see Figure
1.2). Although data about individual parts can be collected and displayed [2], this is not sufficient
for making predictions. As Jay Keasling, one of the foremost experts in the field of synthetic
biology, admits “even if the function of each part is known, the parts may not work as expected
when put together” [80]. This principle is not only true for part-part combinations, but it has also
been seen that a circuit may not act as predicted due to interactions with the host cell. This can
be seen in numerous examples such as Tan et al. [99].
Tan et al. [99] explore the interactions between a host cell and a synthetic circuit. It was ob-
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served that these interactions can change the behaviour of a circuit and cause it to perform
with characteristics that would not be possible when predicting circuit behaviour from a model
of the circuit in isolation. This was done by introducing a simple 2 gene non-cooperative feed-
back loop into E. coli. This control structure on its own does not allow for bistability, however
the circuit is observed to have this behaviour. This is due to an additional negative feedback
loop that is introduced through interactions between the cell and the circuit due to changes
in growth rate brought about by the burden of gene expression. This study shows that these
interactions are not always negative, and indeed can be used for positive effects by enabling
otherwise unachievable circuit behaviours.
Figure 1.2: An example data sheet display-
ing characterisation data on a BioBrick part
BBa F2620 from Canton et al [21]
An understanding of how a circuit interacts
with other circuits and its host chassis cell
may allow us to design circuits that have spe-
cific behaviours (such as introducing bistabil-
ity through cell-circuit interactions [99]). This
understanding may also allow circuits to be
optimised so that the level of interactions with
the cell is minimised for a given output. Alter-
natively, for a given ‘budget’ of burden the out-
put of a desirable product may be optimised
(such as the production of a valuable protein).
A key tenet of any engineering discipline is
predictability, where the behaviour of a sys-
tem can be reliably predicted from an under-
standing of its component parts. This equally
applies to synthetic biology, though the large
levels of complexity often means making re-
liable predictions can be difficult, if not impossible in some cases. Moving synthetic biology
towards being a discipline where designs with predicable functionalities can be made requires
an increased understanding of the underlying biology and a modelling framework to be in place.
The creation of models allows predictions to be made about biological systems and the func-
tions of parts. This was shown in Ellis et al. [32] where a model-based approach was used in
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conjunction with the creation of a library of promoters of varying strength. This approach al-
lowed a single test design to be used to inform a model which was able to accurately predict
how a range of circuit versions would behave. A reliable genetic timer switch was created where
‘tweaks’ in behaviour were able to be rationally designed rather than performed by retrofitting
networks. It is important that we are able to expand and extend this model-based approach
to the design of full large-scale genetic circuits and cell-circuit combinations. The reason we
are currently unable to make accurate predictions about circuits with expression levels where
the cellular context is important is due to the fact that there is no explanation for how the data
presented in data-sheets [21] or databases [2] can be used together to make these predictions.
These ‘rules of composition’ are vital and, as claimed in Andrianantoandro et al., will “help de-
termine which device combinations yield the desired logic functions and, more importantly, how
to match cellular or physical functions of devices” [9].
There have been attempts to develop basic frameworks for predicting the behaviour of genetic
parts when combined. Marchisio et al. [62] demonstrate a novel approach to this by modelling
systems based on fluxes of cellular machinery such as polymerases, ribosomes, transcription
factors and environmental signals [62]. This modelling framework was implemented within the
ProMoT systems modelling and design tool and allows for individual parts to be composed
into larger networks, something that is key in making synthetic biology design predictable and
modular. The models used in this study are very simple and lack some key considerations (such
as codon usage etc, which we discuss later in this introduction). There is also no provision of
a methodology for characterising the individual parts to obtain the information required by the
model to make predictions. However, an expansion of this approach may lead to an improved
framework whereby predictions can be made about cell-circuit interactions.
Any part can be characterised in a number of different ways, and it is standardisation which will
ensure this is done in a consistent manner for all parts. A number of approaches can be taken
to part characterisation in terms of what data to collect, however it is vital that before a standard
is implemented we understand what datasets will be required in order to use a model to make
predictions. Figure 1.3 shows the different variables that can impact upon levels of commercial
protein production, the simplest example of a gene expression application for bacterial synthetic
biology.
Therefore, in order for standardisation to enable accurate and portable predictions it is nec-
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Figure 1.3: The factors impacting protein production levels can be split into different categories.
We are interested in both gene and vector variables. Figure adapted from Gustafsson et al. [44]
essary that standards are developed for both the collection and displaying of data as well as
how this data from individual parts can be combined (and additionally how this data can be
combined with species or strain characterisation to make predictions about how a circuit will
act within different cellular contexts). These two types of standard must clearly be developed
together as one loses much of its worth when not used with the other. This project aims to
develop both a standard for characterising cells and circuits as well as a methodology for using
this characterisation data to make accurate predictions about how a circuit and cell will behave
when combined.
1.1.2 Cell-circuit and circuit-circuit interactions
As discussed above, the nature of biological systems is such that it is often not possible to
insulate the activities of two or more biological processes. We use the term isolate in this
context to mean that two circuits are isolated if each of their behaviour is independent of the
presence of the other circuit. Hajimorad et al. [45] expressed three proteins and investigated
their interdependence through shared usage of transcriptional resources. This study shows
that it is very difficult to isolate the behaviour of the devices.
It is often the case that the behaviour of one process is dependent on the behaviour of oth-
ers [28]. The impact of cell-circuit interactions is neatly summed up by Cardinale et al. when
they say that “the last decade has shown that predictable engineering of cell functions is ham-
pered by ignorance of the host factors that affect and are affected by the engineered pathway
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and that lead to non-optimal or undesirable behavior” (where a pathway is a type of circuit) [23].
These undesirable interactions are often unavoidable, and as such it is important that they
are understood, able to be predicted and, if possible, their effects able to be minimised. In
synthetic biology, the context of the cellular environment for a synthetic circuit and their inter-
actions are very important and there are numerous ways in which the circuit can interact with
its host cell. The effects of these interactions can be wide-ranging in their scale, from a linear
relationship between gene copy-number where the interactions can be ignored whilst maintain-
ing predictability in terms of cell and circuit activity [103], all the way to a situation where the
presence of the synthetic circuit causes non-viability of the host cell [103].
Interactions between the cell and the circuit can be divided into two general types. Firstly there
are the generic interactions that impact upon the behaviour of both the synthetic circuit and the
host cell and are due to variations in global dynamics and shared resources. Secondly, there
are the specific interactions that occur because of the choice of specific strains of host cells
or parts within the synthetic circuit. These specific interactions are often avoidable through the
choice of suitable combinations of host cells and synthetic circuits. Moser et al. show that the
selection of both host strain and growth medium can impact upon the behaviour of a synthetic
circuit [68]. This is due to the cell having different characteristics such as proteome (the entire
set of proteins expressed by a cell at a certain point in time) and transcriptome (the set of all
RNA molecules, including mRNA, rRNA, tRNA, and other non-coding RNA produced in a cell)
when growing in different growth medium.
In addition to cell-circuit interactions there is also the issue of circuit-circuit interactions whereby
the combination of multiple parts within a single circuit, or alternatively the inclusion of a num-
ber of separate circuits, causes these parts or circuits to act differently to how they would in
isolation, for example the addition of an extra gene within a circuit may cause the expression
levels from the original circuit to drop compared to the original alone [45,28,27]. It is therefore
important when attempting to make predictions about the behaviour of a system to understand
how its components interact with each other.
Interactions that occur when introducing a synthetic genetic circuit into a chassis cell can occur
in numerous ways such as: toxicity, where the proteins produced by the circuit are toxic to
the host cell [64]; cross-talk, where the circuit expresses mRNAs or protein which interfere with
the native regulatory mechanisms of the host, or there may be molecules in the cell, such as
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transcription factors, which affect the behaviour of the circuit [11];and shared resource pools,
where expression from the circuit requires the use of the same resources and machinery as
native cellular processes [90]. Since toxicity and cross-talk are both types of specific, avoidable
interactions (toxicity is only an issue when expressing toxic proteins and cross-talk is avoidable
through the use of regulatory mechanisms orthogonal to those of the host cell) we will ignore
these aspects of cell-circuit interaction from now on and concentrate on shared resource pools.
In 2000 two papers were published which are widely considered to be the first true synthetic
biology papers, these were the repressilator circuit by Elowitz et al. (a three gene genetic os-
cillator) [33] and the toggle switch circuit by Gardner et al. [38]. In Gardner et al. the synthetic
circuit constructed is referred to as an ‘applet’, a circuit designed to be a self-contained genetic
circuit which ran with minimal impact on the native cellular processes [38]. Research in syn-
thetic biology has since increasingly moved from looking at ‘toy’ circuits, such as logic gates [8]
towards increasingly application driven projects where higher expression from circuits is often
required, such as projects with metabolic pathways [82], or with large and complex signalling
circuits [59]. Increased expression as well as an increase in the number of genes and parts cor-
relates to increased ‘burden’ and the interactions between the circuit and its host cell become
more significant.
This requirement for increased output from the genetic circuit, whilst maintaining the important
characteristics of its behaviour, is not always trivial due to, amongst other things, the non-
linearity of changes in the behaviour of both the cell and circuit due to their interactions at high
levels of circuit expression [45]. A result of this limit is the relatively low maximum number of pro-
moters observed (and thus genes) in circuits reported in synthetic biology publications before
2009 [78] (see Figure 1.4). In order to effectively and predictably increase gene expression lev-
els it becomes important to understand the mechanisms by which the cell and circuit interact,
and to use this understanding to build up models of cell-circuit interactions which can reliably
predict the behaviour of both.
Cells can react in a number of way to the introduction of a synthetic circuit. Different circuits will
induce different reactions ranging from almost no change in the cell physiology to cell death [37].
Often the growth rate of the cell will decrease in response to heterologous protein production
due to the generic effects mentioned above. Evolution of the synthetic circuit may also occur,
where cells have either evolved to grow without the circuit, or had recombination events occur
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Figure 1.4: Purnick & Weiss [78] “sampled publications that describe the construction and char-
acterization of complete synthetic biological circuits from 2000 to 2008. Each publication can
contain more than one circuit (each circuit is referenced here as a system). a — The number
of synthetic systems in publication. The number of new synthetic biological systems increased
moderately from 2000 to 2008. b — The complexity of synthetic systems in publication. For the
purposes of this analysis, we define complexity as the number of regulatory regions (promot-
ers) comprising any given synthetic system. Shown are 18-month moving window averages
and maximum values. Although the overall number of synthetic systems has increased over a
9 year span (as shown in part a), the complexity of published systems seems to have reached
a plateau (at least for now).”
where parts that are disadvantageous to cell growth have been mutated or deleted in response
to burden [94,93]. While these events are relatively rare, a beneficial impact on growth rate occurs
and they quickly outcompete other cells and become dominant within a population, leading to
a population mostly lacking the desired circuit [94,93].
1.1.3 E. coli
As mentioned previously, the organism we are using in this study is E. coli, specifically the
K-12 line of strains. E. coli is a widely used model organism that is a gram-negative bacterium.
It is widely used in synthetic biology [38,33,98,67,105,7,96,36,56] and has been extensively charac-
terised [17]. It is the dominant prokaryote model organism used for biological research. There
are a large number of strains of E. coli that have been developed for different purposes, includ-
ing research and industry [13]. E. coli are typically rod-shaped, and are about 2.0 microns (µm)
long and 0.5 µm in diameter, with a cell volume of 0.60.7 µm3. The E. coli genome consists of
approximately 4300 genes.
The wild-type K-12 strain is MG1655 [47], however, the strain used through most of this study is
DH10B. This is a commonly used strain designed for the propagation of large insert DNA library
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clones. It is widely used in research, where its properties such as high DNA transformation effi-
ciency and the ability to maintain of large plasmids are taken advantage of [31]. DH10B has the
relA1 and spoT1 alleles which inactivates the protein responsible for ppGpp production, during
a stringent response [31]. This means that the stringent response phenotype is not present in
DH10B. The construction path of DH10B can be seen in Figure 1.5.
Figure 1.5: Construction of DH10B. The steps leading to the creation of DH10B from HfrC+ are
outlined. From Durfee et al. [31].
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1.1.4 Shared resource pools
The cellular genetics of individual species have been optimised through evolution to maximise
fitness [55]. This means that the mechanisms for cell growth and maintenance are balanced
such that there are enough resources available to the cell for maximal growth rate in desired
environments whilst maintaining cellular robustness so that it can deal with environmental per-
turbations such as change in carbon source which leads to new enzymes needing to be made
and thus a change in transcriptome and proteome [55].
Once again we return to the computing analogy. In computing there exist a wide range of
programmes, ranging from small ones with very little impact upon the computer’s resources
such as RAM or processor availability, all the way to much larger ones which require a huge
amount of the computers resources to run and can even cause the computer to crash or stall.
In much the same way a synthetic circuit can have a whole range of impacts upon the host
cell ranging from small background circuits which have no significant impact upon the host cell,
to circuits which cause huge amounts of burden upon the cell’s resources, sometimes even
causing cell death [37].
Upon the introduction of a synthetic genetic circuit into a chassis cell, the replication of and ex-
pression from the synthetic circuit requires the usage of native cellular resources and machin-
ery. Replication of the synthetic DNA (DNAx) within the cell requires the same machinery used
to replicate native cellular DNA (DNAc) such as DNA polymerase and deoxyribonucleotides.
Depending on the system used to maintain the DNAx in the cell, there may also be competition
for factors involved in the initiation of DNA replication [75]. There will also be competition be-
tween DNAx and DNAc for proteins which bind DNA, such a RNA polymerase (RNAP) which
is central to transcription. RNA polymerase binds both specifically and non-specifically to DNA,
both types of binding lead to the redistribution of RNAP between DNAx and DNAc on the basis
of number of bases and promoter strength and number respectively. In the process of tran-
scription RNA is produced by RNAP as well as a cohort of other enzymes and factors (such as
ribonucleotides) associated with transcription, all of which are competed for in the production
of RNA from DNAx and DNAc. Translation is also subject to the same types of competition
for resources as transcription and replication. mRNA produced from the synthetic circuit (mR-
NAx) and mRNA derived from the native cell (mRNAc) are templates for protein production a
process which uses ribosomes and amino acids, along with a number of other factors. The
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balance of protein derived from the DNAx and DNAc will be a function of the balances of mR-
NAx and mRNAc as well as the affinities of the ribosome binding sites on these mRNAs for
ribosomes [75].
This study focuses on cell-circuit interactions arising solely from the competitive interactions
between the cell and circuit for shared resources. In order to correctly predict and simulate the
response of the host cell to the insertion of a synthetic circuit it is important initially to under-
stand and evaluate the kinetics of the processes common to expression from both DNAc and
DNAx [75]. There are two key steps in this process; firstly to understand how the interactions
occur which enables the creation of a mechanistic model followed by implementation and anal-
ysis of this model. Studies have been done to build up models of the link between a synthetic
circuit and the host cell through shared resource pools [90,74,75,57,62,51].
These differ in the approaches taken to the modelling process both in terms of the way cellular
processes are described, as well as the depth to which these processes are described. It is im-
portant to understand the crucial interactions that cause changes in the behaviour of cells and
circuits, as well as the important variables affecting these interactions. Klumpp et al. [51] model
a direct link between gene expression levels and cell growth rates, however they do not include
the mechanisms which link these two processes. Scott and Hwa argue that gene expression is
‘intimately coupled to the growth state of the cell’ [91] in the sense that knowing growth rate, the
rate of gene expression can be readily predicted. However, they acknowledge that the study
was only performed by medium-based limits on growth rates and that ‘relationships between ri-
bosomal content, protein expression and growth rate must be characterised under other modes
of growth inhibition’ [91].
Klumpp et al. [51] explore the relationship between growth rate and a range of cellular metrics
that influence gene expression such as cellular RNA levels and protein production rates. They
alter growth rates using a range of 5 different growth medium and show that there is a pro-
portional relationship between the growth rate and levels of RNA in the cell. In addition they
show that there is no growth rate dependence for the translation rate in cells (defined as total
cellular protein divided by total cellular RNA). They argue that cells use feedback mechanisms
involving growth rate to auto regulate certain key processes and also suggest the possibility for
designing circuits which utilise growth feedback in their behaviour (as seen in Tan et al. [99]).
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1.1.5 Translation and ribosomal usage
It has been indicated in previous research that ribosomes are the key factor in the limitation
of growth rates due to over expression of proteins [90,24,104]. This suggests that an intelligent
approach to understanding cell-circuit interactions would be to investigate, in depth, the process
of translation. This would involve understanding how ribosomes are used by a synthetic circuit
(including identifying the key variables which affect this usage) as well as how a change in
the number of available ribosomes can affect native cellular processes and how these effects
manifest themselves in terms of the cellular phenotype. An understanding of these processes
may allow us to design circuits that make more efficient use of shared resources to produce
proteins.
As mentioned before, the ribosome is the molecular machine which converts information en-
coded in the sequence of an mRNA into a chain of amino acids which forms a protein. It is
composed of ribosomal RNA (rRNA, which is also involved in the regulation of ribosomal pro-
tein production) and ribosomal protein and is formed from a large and a small subunit (bacterial
50S and 30S respectively). As well as being sequestered by synthetic circuits, levels of avail-
able ribosomes in the cell can also change due to environmental variation and different nutrient
availability [90]. Ribosomes form a very large portion of both the RNA and protein found in a cell
and much of their activity involves generating new ribosomes [90].
Stringent Response
One of the key mechanisms through which ribosome numbers are regulated in E. coli is the
stringent response [101] which recognises that there has been a drop in charged transfer RNA
(these are type of RNA which are bound to an amino acid, or ‘charged’, and take part in the
elongation stage of translation - see below) through an increase in the concentration of un-
charged tRNA (transfer RNA that are not bound to an amino acid and need to be bound before
they can take part in translation), and signals to a protein RelA to synthesise the alarmone
ppGpp [61]. ppGpp [77] then causes a decrease in the amount of time most promoters are avail-
able for transcription to initiate, causing a down-regulation in synthesis of stable RNA, including
rRNA, which in turn down-regulates the synthesis of the entire translation apparatus [101]. Thus
we can see how over-expression of genes within a cell could lead to a systematic change
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Figure 1.6: Diagram of the stringent response in bacterial cells, adapted from Magnusson et
al. [61]
in global translation rates through decreased ribosome levels, heavily impacting upon the cell.
However, many E. coli strains used in modern biotechnology have the stringent response mech-
anisms disabled by deletion of the relA gene. One such commonly used strain is DH10B [31]
which we will be using in this project. These experiments will be complemented by also using
MG1655 (the K-12 wild type), which has the stringent response intact. Figure 1.6 shows a
diagram of the stringent response, including which pathways are up-regulated and which are
down-regulated.
Translation
Translation occurs in 4 phases: initiation, elongation, termination and ribosome turnover [53].
Initiation involves the assembling of the ribosomal subunits on the 5’ end of the mRNA at the
ribosome binding site (RBS). Elongation occurs as the ribosome moves along the mRNA and
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Figure 1.7: a) Translation is a multi-step process: the assembly of the 30S complex (box),
initiation, elongation, termination, and the turnover of ribosomal subunits and other factors. b)
mRNA folding, Shine-Dalgarno sequence and spacing distance all play important roles in the
binding of the 30S subunit to the RBS. Figure adapted from Salis et al. [85].
a peptide chain is synthesised as transfer RNA (tRNA) that have been ‘charged’ with an amino
acid read base triplets (codons) corresponding to certain amino acids. This process occurs
until the ribosome reaches a stop codon and termination occurs, whereby the synthesis of the
protein finishes and the unfolded protein is released from the ribosome. Ribosome turnover
is the next stage as the ribosome breaks up off the mRNA and returns to the free ribosome
pool [53]. Figure 1.7a shows an overview of the translation process.
Initiation is a complex process and the rate at which it occurs determines how quickly ribo-
somes will bind to an mRNA with an empty RBS (an RBS which does not have a ribosome
bound to it). This rate depends on the sequence of the RBS and is affected by the binding
affinity between the 16S rRNA and the RBS as well as secondary structures formed by the
RBS and surrounding mRNA [85]. Salis et al. developed a statistical thermodynamic model
of initiation to develop a calculator which can be used to predict the initiation rate of a given
RBS sequence as well as design RBS sequences which will have a desired initiation rate [85].
Translational initiation is a highly complex process that involves multiple agents and factors.
The 5’ sequence of a CDS interacts with the RBS site and can encourage or discourage sec-
ondary mRNA structures that might affect ribosomal binding and the sequence of the RNA at
this point governs the free energy of secondary structures where higher energies correspond
to reduced time during which the the Shine-Dalgarno sequence is exposed. When the Shine-
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Dalgarno sequence is unblocked, it interacts with the anti-SD sequence of the 16S rRNA [107].
The ejection of initiation factors then causes binding by the 50S subunit to form the 70S ini-
tiation complex which concludes the initiation phase. Initiation is governed by a number of
factors including mRNA secondary structure, Shine-Dalgarno sequence and spacing distance
between the Shine-Dalgarno sequence and start codon.
Each step in elongation (the βis in figure 1.8) does not occur at the same rate and the dynamics
of this process are dependent on a cohort of factors such as “gene sequences, the tRNA
pool of the organism and the thermodynamic stability of the mRNA transcripts” [41]. These
varying rates can have large effects on how efficiently ribosomes translate a protein and certain
configurations of codons can cause ribosomal traffic jams where a section of codons can cause
ribosomes to translate more slowly and cause other ribosomes to bunch up behind it [26,65]. The
speed of codons is related to the availability of corresponding charged tRNAs [71] and it has
been shown that under nutrient starvation the relative speeds of codons can change [97].
Initiation and elongation rates affect both the protein production rate as well as the number of
ribosomes sequestered on the transcripts at any given point in time [26,65]. It is clear these vari-
ables will affect ribosome availability within the host cell and therefore impact on its behaviour.
Different genes place different levels of burden on the cell and have different production rates
due to a range of factors such as promoter and RBS strengths. However, Welch et al. [106] have
shown that even with the same promoter and RBS strengths, changing the coding sequence,
even whilst conserving the amino acid sequence and only switching synonymous codons , can
vastly change the amount of protein produced (from undetectable to 30% of total protein) and
thus the impact on the host [106].
It has been shown in Tuller et al. that a certain profile of translational efficiency along mRNAs
is conserved universally [34,102] in nature. In this profile codons which are translated with low
efficiency are found with higher frequency among the first 30-50 codons. Tuller et al. ‘suggest
that the slow ‘ramp’ at the beginning of mRNAs serves as a late stage of translation initiation,
forming an optimal and robust means to reduce ribosomal traffic jams, thus minimising the cost
of protein production’ in terms of ribosomes sequestered [102]. Although this profile may cause
protein to be produced at a lower rate, it may require less ribosomes to be sequestered per
protein produced as they will not be stuck in large ‘traffic jams’ along the middle of the transcript.
This lower output per transcript may be compensated for by a higher number of transcripts,
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which the cell can do at little cost if RNAP is not limiting. These universally conserved motifs
seen in nature can be used as inspiration for the analysis of mathematical models and may
assist in discovering rules which can be applied to the optimisation of gene sequences.
An alternative theory for why certain codons are more prevalent at the start of a transcript
has been suggested, where the codons used mean the mRNA is less likely to form strong
secondary structures. This in turn means that the RBS sequence is unblocked and free for a
ribosome to bind to it, thus increasing the likelihood of translational initiation [42].
There are many factors which influence the speed and efficiency of the translational process,
and a number of competing theories about the reasons certain genetic motifs are observed
(such as ‘slow’ or ‘rare’ codons vs anti Shine-Dalgarno sequences). The slow codon hypothesis
is that there is a lower abundance of the loaded tRNAs for certain ‘slow’ codons, meaning there
is a lower likelihood that an elongation event for these codons occurs within any time interval. Li
et al. show that part of the reduced codon speeds that occur around ‘slow codons’ is due to the
increased likelihood of anti Shine-Dalgarno sequences which causes hybridisation between the
16S ribosomal RNA of the translating ribosome and the mRNA [58]. The energetic interaction
between the 16S ribosomal RNA of the translating ribosome and the mRNA means that an
elongation event becomes less energetically favourable and is therefore less likely to occur. It
is likely that all of these factors play some role but their importance is a function of multiple
other variables.
Mitarai et al. model the translational process and treat it as a traffic problem and perform
stochastic simulations [66]. They observe ‘traffic jams’ of ribosomes on the mRNA where there
are codons which are translated at a slower rate. They also report that codon usage impacts
the total number of ribosomes on a transcript. The effect of traffic jams and slow codons can
be minimised using an ‘on ramp’ of slower codons at the start of the transcript, as well as using
a weaker RBS (though there is a threshold of RBS strength below which no additional benefit
is gained). A ribosomal ‘cost’ of protein production per transcript is also discussed, and is a
concept we are particularly interested in this project.
Several models have been constructed to try and link synthetic circuits with their host cell
through ribosome usage. Scott et al. [90] show a model where there is a detailed description of
how ribosomes and protein levels are linked through growth rates. In this study they posit that
cellular protein is posit into different fractions where a fixed fraction of protein is allocated for
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Figure 1.8: A representation of the flow of ribosomes in translation (green arrows). The blue
scaffold represents the mRNA with Eis being codons along it, the green arrows represent the
direction of movement of the ribosome with αis and βis being the rates and the orange arrow
represents the production of a protein.
core cellular maintenance functions and the remaining fraction is split between unnecessary,
or heterologous, protein, ribosomal protein and ‘other’ protein. Capacity is a concept in this
study and they attempt to draw analogies to physical laws such as with Ohm’s Law. However,
a key assumption in their model is that the cell is in ‘balanced growth’ which means that total
protein grows at the population growth rate and proportions of different types of protein (such
as ribosomal protein and protein from the synthetic circuit) remain constant. This is not true in
a large number of cases where the circuit has a dynamic output and therefore protein levels
are not constant.
Carrera et al. [24] attempt to build a model which can predict the growth rate of cells based upon
a number of parameters associated with the inserted synthetic circuit. This model was built
using existing data from the literature. They then built two constructs with fluorescent proteins
and inducible copy number. By predicting the amount of ribosomes being used by the circuit
they were able to estimate the number of ribosomes available to the cell and from that predict
the growth rate. However, in this model they assume universal elongation rates for translation
for any circuit, which we have seen above is certainly not true. In addition, as we will see in this
thesis, in different medium a single synthetic circuit can place different levels of burden upon
the cell. In order to improve this model it is necessary to look in more detail at the inserted
synthetic circuit and make prediction about the elongation rates in the specific cellular context
as well as understanding the link between the burden imposed and the environment in which
the cell is growing.
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1.2 Aims and Objectives
This project aims to gain a greater understanding of the interactions between a synthetic ge-
netic circuit and its host chassis. We are interested in the concept of the ‘burden’ that synthetic
circuits can place on a chassis cell through shared resources. We aim to develop a quantitative
system that can interrogate the shared resource pool and inform us about the availability of
shared resources within the cell. Through development of such a system we aim to be able
to test how different circuits place different burdens on the cell and attempt to uncover a rela-
tionship between circuit design choices and the implications of these choices in terms of circuit
output and the burden imposed. Complementing the experimental work we also aim to build a
model of translation that can be used to make predictions about the implications of changing
various control points in gene expression (e.g. promoter strength, RBS strength, codon usage).
This project has a number of milestones it will attempt to achieve, which are split between
modelling and wet-lab. The project will develop and make use of two core experimental modules
and a modelling module. The modules are as follows:
Module 1: Capacity Monitor We will build a synthetic device that is able to infer the availabil-
ity of shared resources (capacity) within the cell. This circuit will run as a small ‘background’
process within the cell and have minimal impact on the shared resource pool. The shared re-
source pools will be inferred by monitoring levels of protein and OD from this circuit and then
using these measurements to calculate rates of protein production. Using quantitative PCR
techniques to quantify the levels of specific mRNA per cell we will also be able to infer the avail-
ability of shared resources associated with both transcription and translation. This system will
also require robust testing to ensure that its behaviour is due to changes in shared resources
from the production of heterologous proteins.
This system will be able to be used by synthetic biologists to investigate how any circuit (within
the constraints our design will impose) impacts upon the cell in terms of shared resources.
We will provide a standardised way of investigating the capacity available within a cell that
can be used to characterise both cell strains and circuits. This will allow synthetic biology to
move beyond the contextless characterisation of cell strains and circuits to characterising them
in terms of the interface of shared resources. As mentioned above, this is a very important
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consideration as circuits become larger and more complex and as greater accuracy in the
predictability of behaviour is required.
Module 2: Investigating the Impact of Various Control Points We know that the expres-
sion of heterologous protein within cells can be controlled at a number of points by changing
the DNA parts involved (copy number, promoter strength, RBS strength and codon usage). The
current literature is full of investigations into how these control points impact upon the amount of
protein produced [85,44,25]. We consider an equally important consideration to be the amount of
resources that a circuit uses. This module will consist of building a library of circuits that differ in
these control points. This library will then be used to elucidate the impact of changing different
control points and potentially allow us to uncover design principles that should be employed for
optimal circuit behaviour, not just in terms of output but also in terms of resource usage.
The findings of this module have the potential to be high impact as they will have implications
across all of genetic design, which in turn cascades down to applications in synthetic biology
and biotechnology. Optimising resource usage by synthetic circuits will allow researchers to
minimise deleterious effects on the chassis cell whilst maintaining desired circuit performance.
This is of great importance as larger and more complex circuits are built as well as for industry
where efficiencies and waste are of huge importance.
Module 3: Modelling the Interactions To complement the experimental data we will build a
model of translation (identified within the literature to be the key bottleneck in protein production
and cell-circuit interactions [90,24,104]). This model will capture the impact of changing all of the
control points mentioned above and will be able to simulate phenomena such as ribosomal
stalling and ‘traffic-jams’. Ideally this model should be able to reproduce the behaviours seen in
our experimental data. Whilst all of the parameters required for such a model are not currently
obtainable, we will be able to perform qualitative comparisons to understand why we see the
behaviours from the experimental data.
This model will be able to be used by researchers to predict the impact of potential genetic
designs on both protein production rates and resource usage. It will also be implemented in
a programming language (Python) so that it can easily be used by researchers who want to




2.1 Polymerase Chain Reactions (PCR)
2.1.1 Reaction Protocol
Unless otherwise specified, all polymerase chain reactions (PCRs) were performed using the
protocol detailed below.
Each reaction had a total volume of 50µl with the following amounts of reagents:
Buffer 10µl
dNTPs (10mM each dNTP) 1µl
Phusion enzyme 0.5µl
Primer 1 @ 10mM conc. 1µl
Primer 2 @ 10mM conc. 1µl
Template DNA @ 30ng/µl conc. 1µl
H2O 35.5µl
TOTAL 50 µl
Table 2.1: PCR reaction recipe
The reactions were performed in an GS482 Dual 48 Well Thermal Cycler using the following
protocol:
1. 1:20 @ 98°C
2. 10 cycles of:
(a) 0:15 @ 98°C
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(b) 0:45 @ 67°C dropping by 1°C each cycle until reaching 58°C
(c) 2:00 @ 72°C
3. 20 cycles of:
(a) 0:15 @ 95°C
(b) 0:45 @ 58°C
(c) 2:00 @ 72°C
4. 5:00 @ 72°C
5. left to store @ 4°C
2.1.2 Primers
All primers were synthesised by Integrated DNA Techologies (IDT) and diluted to a working
stock concentration of 10mM ready to be used directly in a reaction without further dilution.
Both master stocks and working stocks of these primers were stored in a freezer at -20°C and
were thawed on ice when required in a reaction.
2.2 Digestions and Ligations
2.2.1 Digestions
All digestions were performed using New England BioLabs (NEB) enzymes according to the
protocols detailed for the corresponding enzyme at the NEB website.
Unless otherwise specified, all digestion reactions had a total volume of 20µl. If the reaction
was a single restriction digest, the following recipe was used:
Buffer as determined by NEB protocol @10x conc. 2µl
BSA @10x conc. (if required, else H2O) 2µl
Enzyme 1 0.25µl
Template DNA diluted in H2O to appropriate conc. 15.75µl
TOTAL 20 µl
Table 2.2: Single restriction digest recipe
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If the reaction was a double restriction digest, the following amount of reagents were used:
Buffer as determined by NEB protocol @10x conc. 2 µl
BSA @10x conc. (if required, else H2O) 2 µl
Enzyme 1 0.25 µl
Enzyme 2 0.25 µl
Template DNA diluted in H2O to appropriate conc. 15.5 µl
TOTAL 20 µl
Table 2.3: Double restriction digest recipe
Digestions were done in 1.5 ml volume tubes at the specified temperature. If the protocol re-
quired the reaction to take place at 37°C then the reaction was placed in a static incubator
at 37°C, otherwise it was placed in a heating block at the appropriate temperature. Digestion
reactions took place for a minimum of 1 hour and maximum of 3 hours. Once complete, sam-
ples were denatured if required by the protocol and then placed on ice or put straight to ice if
denaturation was not required.
2.2.2 Ligations
All ligation reactions were performed using the following protocol, unless otherwise stated.
Ligation reactions were done at a volume of 10µl with the following recipe:
NEB T4 Ligase buffer 1µl
NEB T4 Ligase 0.25µl
Input DNA diluted in H2O to appropriate conc. 8.75µl
TOTAL 10 µl
Table 2.4: Ligation recipe
For ligations that contained separate backbone and insert DNA fragments, the molar concen-
trations were 1:3 respectively with backbone DNA concentration of 40-80ng/µl.
For ligations with a single linear DNA fragment to be circularised the DNA was at a concentra-
tion of 50-100ng/µl.
The following protocol was followed:
1. 1.5 hours @ room temperature (18-22°C)
2. 15 minutes @ 65°C
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3. 5 minutes on ice
2.3 DNA Plasmid Extraction
All plasmid extractions from cells were performed using QIAGEN QIAprep Spin Miniprep Kit ,
eluted into 50µl of ddH2O according to the manufacturers instructions.
2.4 DNA Purification
All DNA purification was performed using QIAGEN QIAquick PCR Purification Kit , eluted into
50µl of ddH2O according to the manufacturers instructions.
2.5 RNA Extraction
All RNA extraction was performed using Qiagen RNeasy Protect Bacteria Mini Kit , eluted into
50µl of ddH2O according to the manufacturers instructions.
2.6 Quantitative Polymerase Chain Reaction (qPCR)
1. Take 1 µg of total RNA and perform second DNase treatment with NEB DNase I (RNase-
free) following the corresponding protocol.
2. Using Tetro cDNA Synthesis Kit perform reverse transcription to obtain cDNA for circuit
protein (VioB-mCherry fusion), monitor protein (codon optimised sfGFP) and housekeep-
ing gene (GapA) using corresponding reverse primers shown in Table 2.6.
3. Treat cDNA with NEB RNase H following the corresponding protocol.
4. Make 1:100 dilution of cDNA to prepare for qPCR.
5. Prepare reaction mix as shown in Table 2.5. Repeat in triplicate.
6. Run qPCR protocol in Eppendorf Mastercycler ep realplex:
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(a) 10 mins at 95 °C
(b) 40 cycles of:
i. 30 seconds at 95 °C
ii. 30 seconds at 63.4 °C
(c) 2 minutes at 72 °C
7. Analyse data using comparative C(T) method [88].
Forward primer 0.2 µl
Reverse primer 0.2 µl
2x SYBR Green Jumpstart Taq ReadyMix 5 µl
DEPC water 1.6 µl
cDNA 3 µl
TOTAL 10 µl
Table 2.5: qPCR reaction recipe
Decription Sequence
sfGFP Forward Primer TTCTGGGCCATAAACTGGAG
sfGFP Reverse Primer CCATGTGATCACGTTTTTCG
VioB-mCherry Forward Primer GAACCGTTTAGCGAAAGCAC
VioB-mCherry Reverse Primer GAGTCGCGATCGAAAACTTC
GapA Forward Primer GGAACGCCATACCAGTCAGT
GapA Reverse Primer GGCATCATCGAAGGTCTGAT
Table 2.6: Oligonucleotides for cDNA synthesis and qPCR reaction
2.7 Capacity Monitor Assays
2.7.1 3 Hour Exponential Phase Assay
These assays tested the growth rate, circuit output and monitor output over 3 hours of growth
in defined medium. The protocol for this was as follows:
1. Day 1
(a) Inoculate defined medium plus appropriate antibiotics with corresponding cells.
(b) Grow up overnight at 37°C.
2. Day 2
42
(a) Dilute overnight cultures into fresh medium at a dilution of 100:1
(b) Grow up for 3 hours to move cells into exponential phase at 37°C.
(c) Dilute into fresh medium in 96 well plate. Each well contains 180µl of medium
with appropriate antibiotics and induction chemicals as detailed below. 20µl of cells
grown into exponential phase were added to each well as detailed below
i. 6 wells of medium with no antibiotic or induction chemical to which was added
chassis cell without capacity monitor or synthetic circuit.
ii. 6 wells of medium with no antibiotic or induction chemical to which was added
chassis cell with capacity monitor and without synthetic circuit.
iii. For each circuit being tested:
A. 6 wells of medium with antibiotic and no induction chemical to which was
added chassis cell with capacity monitor and synthetic circuit.
B. 6 wells of medium with antibiotic and induction chemical to which was added
chassis cell with capacity monitor and synthetic circuit.
(d) Measure OD, green fluorescence and red fluorescence using Omega Fluorometer:
i. Measurements taken every 10 minutes of OD, GFP fluorescence and RFP fluo-
rescence.
ii. Shake plate between readings at 200rpm.
2.8 Cell Strains
Three strains of E. coli were used in this project:
DH10B were obtained from the Ellis Lab Culture Collection.
MG1655 were obtained from the Ellis Lab Culture Collection.
TransforMax™EC100D™pir-116 Electrocompetent E. coli cells were purchased from Cam-




All cells were made electrocompetent through the following protocol:
Day One
1. Inoculate a 5 ml LB culture with a single colony of the E. coli strain and incubate O/N at
37°C.
2. Incubate a conical flask (1 litre volume) containing 500 ml of LB at 37°C overnight.
3. Store 500 ml sterile water in the fridge overnight.
Day Two
1. Use the O/N culture to inoculate the 37°C LB broth 1:100 and incubate shaking at 37°C.
2. Get plenty of ice and pre-chill a sterile 20% (w/v) glycerol stock and the sterile H2O. Label
microtubes and store in the -80°C freezer. Pre-chill a rotor to 4°C.
3. When the OD600 of the culture reaches 0.5, transfer to 50 ml Falcon tubes (ensure that
there is no more than 40 ml/tube) and chill on ice for 30 minutes.
4. Centrifuge the tubes in the rotor pre-chilled to 4°C at 4000 g for 15 minutes.
5. Discard the supernatant and, on ice, re-suspend the cells in the equivalent volume of
pre-chilled water.
6. Centrifuge as before.
7. Discard the supernatant, on ice re-suspend cells in pre-chilled 20% glycerol (volume is
not important but ideally just enough to re-suspend the cells e.g. 2ml/tube) and pool all of
the cells into one of the 50 ml Falcon tubes.
8. Centrifuge as before.
9. Discard the supernatant and, on ice, re-suspend the cells in 3 ml pre-chilled 20% glycerol.




All transformations were done by electroporation into cells prepared by the above electrocom-
petency protocol as follows:
1. Add 0.5µl of prepared plasmid into a cold BioRad E.Coli Pulse Cuvette™ from freezer.
2. Add 40µl electrocompetent cells into same cuvette.
3. Pulse using BioRad MicroPulser™ on ‘Bacteria’ setting.
4. Immediately add 300µl of LB medium to cuvette and mix with cells.
5. Remove mix of cells and medium from cuvette and place into 1.5µl tube and shake for
45mins at 37°C.
6. Spread 40µl on plate with appropriate antibiotic and leave to grow overnight at 37°C.
7. Pick colonies the next day and grow overnight at 37°C.
2.10 Antibiotics
All antibiotics used in this project were used at standard concentrations for E. coli :
Chloramphenicol was used at a concentration of 34 µg/ml in all media and agar plates.
Kanamycin was used at a concentration of 100 µg/ml in all media and agar plates.
Ampicillin was used at a concentration of 100 µg/ml in all media and agar plates.
2.11 Growth Media
Two types of growth medium were used in this project:
LB Medium
LB medium was made using standard LB broth granules from Sigma-Aldrich diluted into the
appropriate amount of water (as directed by manufacturer’s instructions) and autoclaved
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M9 Medium
M9 medium was made to the following recipe and supplemented with the appropriate carbon
source:
• 200 ml Sterilised 5X M9 minimal salts containing:




• 34 ml Sterilised 10 mg/ml Thiamine
• 10 ml Sterilised 40% Carbon source (to 0.4% final concentration)
• 20 ml Sterilised 10% Casamino acids
• 2 ml Sterilised 1M MgSO4
• 100 µl Sterilised 1M CaCl2
• 733.9 ml Sterilised deionized water
Since all ingredients used are pre-sterilised, sterile technique was used when mixing the ingre-
dients in a pre-sterilised container.
2.12 CRIM Genomic Insertion
All genomic insertions were done using the CRIM system [46] into the E. coli λ site using CRIM
plasmid pAH63 and helper plasmid pINT-ts.
2.13 Oligonucleotides
All oligonucleotides were ordered from IDT (www.idtdna.com) and diluted to a master stock of




The sfGFP sequence was codon optimised by DNA2.0 using their proprietary algorithm. The
sequence was ordered preceded by the J23100 promoter and the designed RBS with the fol-












2.14.2 Slow Codons gBlock






Data was analysed using Microsoft Excel and variables were calculated as follows:
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1. OD: obtained by taking raw OD600 data for relevant cells and subtracting the average raw
OD600 readings for wells containing only the medium the cells were being grown in.
2. GFP: obtained by taking raw GFP data for relevant cells and subtracting the average
raw GFP readings for wells containing cells without any fluorescent protein production at
equivalent OD.
3. GFP/OD: obtained by dividing the GFP value by the OD value for a well.
4. mCherry: obtained by taking raw mCherry data for relevant cells and subtracting the
average raw mCherry readings for wells containing cells without any fluorescent protein
production at equivalent OD.
5. mCherry/OD: obtained by dividing the mCherry value by the OD value for a well.
6. Specific Growth Rate: obtained as an estimate of average growth rate over time interval









where ODt is the OD value at time t.
7. GFP Production Rate: obtained as an estimate of average GFP production rate over the
time interval of length τ hours using the following equation:
GFP production rate =
(lnODt+τ − lnODt)(GFPt+τ ·ODt+τ −GFPt ·ODt)
τ(ODt+τ −ODt)
whereGFPt is the GFP per cell value at time t.
8. mCherry Production Rate: obtained as an estimate of average mCherry production rate
over the time interval of length τ hours using the following equation:
mCherry production rate =
(lnODt+τ − lnODt)(mCherryt+τ ·ODt+τ −mCherryt ·ODt)
τ(ODt+τ −ODt)
where mCherryt is the mCherry per cell value at time t.
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2.16 Monitor device construction
Section 3.4 outlines the design of the monitor variants. Constructing these variants required a
multi-stage approach. Initially all versions of the monitor were created in a pSB1AK3 backbone
with each of the degradation tags. Once these variants were created, they were moved into
different plasmid backbones for insertion into the cell (either directly on plasmid-based systems
or into a CRIM plasmid ready for genomic integration.
2.16.1 Initial Device Construction
We designed an initial construct which we would then be able to create variants of (different
degradation tags) and place into different insertion systems (plasmid systems or genomic in-
sertion). In order to obtain a version of sfGFP that had been codon optimised for E. coli we
used the DNA2.0 codon optimisation software and subsequently ordered synthesised DNA
from them. The physical DNA we received consisted of promoter J23100 driving the transcrip-
tion of codon optimised sfGFP with LVA degradation tag, driven by a strong RBS (as predicted
by the Salis RBS calculator [85]) but without terminator (see Figure 2.1).
This was delivered in a DNA2.0 proprietary backbone. By ordering this synthesised DNA from
DNA2.0 we were able to obtain a complete version of one of our test circuits (excluding ter-
minator). In order to obtain the rest of the variants we first moved the insert into pSB1AK3
containing terminator B1002 to prepare it for being placed into other plasmids for either being
inserted into the cell in the plasmid-based system or as a genomic insertion using the following
steps:
1. Digested DNA2.0 plasmid containing monitor with EcoRI and SpeI.
2. Gel purification of insert fragment (849 bp fragment).
3. Digest pSB1AK3 containing terminator B1002 with EcoRI and XbaI.
4. Gel purification of pSB1AK3 containing B1002.
5. Ligate monitor with pSB1AK3 containing B1002.
6. Transform into DH10B onto kanamycin agar plates.
7. Grow up overnight in 5ml LB medium (select colonies by green fluorescence).
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8. Miniprep and sequence insert.
Once this ‘master construct’ was in pSB1AK3, PCR was used with 1) BioBrick VF primer and
2) the corresponding primer from Table 2.7) to change the degradation tag (or remove any
degradation tag) and add an SpeI restriction site for simple insertion back into pSB1AK3.
Oligo Description Sequence
RS002 BioBrick VF primer TGCCACCTGACGTCTAAGAA
RS003 No Tag ATATACTAGTATCATTACTTATACAGCTCGTCCATACCG
RS004 AAV Tag ATATACTAGTATCATTAAACCGCCGCCGCGTAATTCTCATCATTTGCAGC
RS005 DAS Tag ATATACTAGTATCATTAGCTCGCGTCCGCGTAATTCTCATCATTTGCAGC
RS006 LAA Tag ATATACTAGTATCATTACGCCGCCAGCGCGTAATTCTCATCATTTGCAGC
Table 2.7: Primers for changing monitor degradation tags
We used PCR to amplify the fragments in standard conditions and followed the following steps
to obtain each variant of the monitor, in terms of degradation tag, in pSB1AK3:
1. PCR pSB1AK3 containing monitor with RS002 and one of RS003 (No tag), RS004 (AAV
Tag), RS005 (DAS Tag) or RS006 (LAA Tag).
2. PCR purification of PCR products.
3. Digestion of purified PCR product with EcoRI and SpeI.
4. PCR purification of digestion product.
5. Digest pSB1AK3 containing terminator B1002 with EcoRI and XbaI.
6. Gel purification of pSB1AK3 containing B1002.
7. Ligate monitor variants with pSB1AK3 containing B1002.
8. Transform into DH10B onto kanamycin agar plates.
9. Grow up overnight in 5ml LB medium (select colonies by green fluorescence).
10. Miniprep and confirm insert sequence by sequencing.
The next step was to move the monitors into different different plasmids ready to be inserted
into the cell. As mentioned above three different plasmid-based systems and one genomic
integration were being tested. For the plasmid-based systems all that was required was to
perform a digestion and ligation followed by a transformation. For the genomic integration it
was necessary to introduce the monitor into a CRIM plasmid [46] which would subsequently be
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integrated into the genome of the cell at the λ-site with the aid of a ‘helper plasmid’. Therefore
for each insertion type it was necessary to insert the monitor into a plasmid backbone. This
was done as follows:
1. Digest monitor variants in pSB1AK3 with EcoRI and PstI.
2. Gel purification of insert fragment (849 bp fragment).
3. Digest plasmids in Table 2.8 with EcoRI and PstI.
4. Gel purification of plasmids.
5. Ligate each monitor variant (5x) with each plasmid backbones (see Table 2.8) (4x).
6. Transform into DH10B onto kanamycin agar plates (20 transformations).
7. Grow up overnight in 5ml LB medium (select colonies by green fluorescence).
8. Miniprep and sequence inserts.
DNA2.0 Plasmid pSB1AK3
Digest with EcoRI and SpeI 
and gel purify
Digest with EcoRI and SpeI 
and gel purify
Ligate and transform
Monitor (LVA version) in pSB1AK3
PCR to change tags and digest 
with EcoRI and SpeI 
Ligate with digested pSB1AK3
All monitor versions in pSB1AK3 pSBxKy
Digest with EcoRI and PstI 
and gel purify
Digest with EcoRI and PstI 
and gel purify
All monitor versions in all plasmids
Ligate and transform
Figure 2.1: The final monitor design consists of promoter J23100 driving the transcription of a
strong RBS (as predicted by the Salis RBS calculator [85]) and coding region for a fully codon
optimised sfGFP without any degradation tag, followed by a fully synthetic B1002 terminator
(not to scale).
After the above steps had been completed we had all the plasmids prepared necessary for
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Backbone Description
pSB1K3 High copy number BioBrick plasmid with kanamycin resistance marker
pSB3K3 Medium copy number BioBrick plasmid with kanamycin resistance marker
pSB4K5 Low copy number BioBrick plasmid with kanamycin resistance marker
pAH63 CRIM plasmid for integrating into λ-site in E. coli genome with kanamycin resistance marker
Table 2.8: Backbone plasmids for inserting monitor into
inserting all of our monitors variants into the host cell.
2.16.2 Inserting into host cell
Plasmid-based insertion
Inserting the plasmid-based systems (monitor in pSB1K3, pSB3K3 or pSB4K5) into cells and
verifying that we have the correct constructs is a relatively simple process and proceeds as
follows:
1. Transform ligation product into DH10B using protocol outlined in section 2.9 (Transfor-
mations in Materials and Methods) and plate each transformation onto a separate plate
containing kanamycin at a concentration of 100 µg/ml.
2. Grow up 2 colonies from each plate overnight.
3. Miniprep overnight growth.
4. Test digest to confirm correct backbone.
After the above steps were completed we have all versions of our monitor in all plasmid-based
systems inserted into our host cell (DH10B).
Genomic insertion
To insert the monitor into the genome we used the CRIM system [46]. This system involves two
separate plasmids, one of which contains the monitor and will be inserted into the genome, the
other being a ‘helper plasmid’ that facilitates the genomic integration.
The CRIM system works by placing the circuit you wish to insert into the genome into the CRIM
plasmid corresponding to the integration site. CRIM plasmids have the γ replication origin of
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R6K, which requires the trans-acting Π protein (encoded by pir) for replication. This means that
these plasmids can only be maintained in cells which have a pir+ genotype. In order that we
can maintain our CRIM plasmid with monitor inserted we needed to transform into pir+ cells.
For this we used TransforMax™EC100D™pir-116 Electrocompetent E. coli cells.
1. Transform pAH63 plasmids containing monitors into TransforMax™EC100D™pir-116 Elec-
trocompetent E. coli cells.
2. Prep and test digest.
3. Transform pINT-ts helper plasmids into DH10B at 30°C.
4. Make DH10B containing pINT-ts electrocompetent using protocol outlined in Section 2.9.
5. Integrate CRIM plasmids containing monitors into genome using protocol outlined in Sec-
tion 2.12.
2.17 Test Circuit Library Construction
The library of test constructs was constructed in a number of steps and is represented graphi-
cally in Figure 2.2. Initially the three core pieces were created as linear DNA fragments using
PCR as follows:
1. Two pSB1C3 and AraBAD fragments were created, one for the weak promoter version
and one for the strong promoter version, using PCR with no overhangs. The template
was AraBAD in pSB1C3 from the Parts Registry [2].
2. Three RBS, vioB and H-linker fragments were created, one for each RBS strength, using
PCR. The template was the vio operon from the Parts Registry [2]. Forward primers were
designed so that they had an overhang that corresponded to the end of the PBAD promoter
(same overhang required for both strong and weak variants) followed by the appropriate
RBS sequence and then a sequence to anneal to the start of vioB. The reverse primer
were designed to anneal to vioB and add the H-linker peptide linker sequence.
3. One version of mCherry was created using PCR from mCherry as found in the Parts Reg-
istry [2]. The forward primer was designed to anneal to the initial sequence of mCherry and
prepend it with the H-linker peptide linker sequence. The reverse primer was designed to
53
anneal to the end of the mCherry sequence (with stop codon) and append a sequence
corresponding to the start of the pSB1C3 backbone sequence (including BioBrick restric-
tion sites for easy transfer into alternative backbones).
These fragments all contained overlaps that were used to construct the initial test circuits with
high copy number and fast codons. There were a total of 6 circuits with 2 promoter strengths
and 3 RBS strengths. These fragments were combined to create a small library of 6 construct
versions using a Gibson Reaction [40].
The next stage was to create the circuit versions with the slow codons:
1. A gBlock fragment was ordered from IDT (www.idtdna.com) that contained the slow codon
region of vioB that we required.
2. PCR was used to create linear fragments of the constructs that excluded the fast codon
segment (with the exception of small 20 bp overhangs.
3. These fragments were used in CPEC reactions [79] with linear gBlock fragments to give
an additional 6 test construct versions with slow codons.
4. Constructs were transformed into DH10G cells.
The final step was to use standard restriction and ligation technique to move all 12 construct
versions into the pSB3C5 medium-copy backbone.
1. Digest both pSB3C5 backbone and construct versions with EcoRI and PstI using standard
method.
2. Gel purify fragments.
3. Ligate using standard method.
4. Transform into DH10G
Once this step was complete we had all 24 versions of our library transformed into DH10G
cells. In order to place some constructs into MG1655G cells we simply took mini-preps of the
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Step 3) Change Codons at end of VioB Using CPEC 
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Figure 2.2: Overview of the construction process used to build library of test constructs. Step
1) Create linear DNA fragments with appropriate extensions to create pSB1C3 and AraBAD
fragments (2 promoter strengths), RBS, vioB and peptide linker fragments (3 RBS strengths)
and a single peptide linker and mCherry fragment. Step 2) These fragments were combined
in Gibson reactions to create 6 constructs for the library. Step 3) CPEC was used to replace
the fast codons at the end of the vioB coding sequence with slow codons from a gBlock giving
a total of 12 constructs. Step 4) Restriction and ligation was used to place the constructs into
pSB3C5 backbone (medium copy) to give a total of 24 constructs.
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Chapter 3
Results: Constructing a Capacity
Monitor
3.1 Motivation
As mentioned above, a key aim of the project was to gain an insight into the way in which a
synthetic circuit interacts with its host cell through shared resources. Using currently available
techniques, it is not currently possible to get a direct quantification of the amounts of these
resources being used in native cellular processes, processes associated with the synthetic
circuit and those being used by neither (i.e. free resources). Therefore, we require a proxy for
these values.
3.1.1 Impact on Cell
There are a number of ways to infer the impact of a synthetic circuit on its host cell. 1) Growth
rate is a commonly used indicator of the state of a cell whereby a decreased growth rate indi-
cates a larger ’burden’ being placed on the cell. 2) We can investigate how the transcriptome,
proteome or metabolome change in cells that contain synthetic DNA. The complex nature of
biological systems means that the reactions of a cell to the presence of synthetic DNA will be
multi-faceted and all of these techniques are useful and informative. However, none of them
give a decent insight into the impact on the core means by which the cell and circuit interact
- i.e. through shared resources. Changes in the availability of these resources have global
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effects on the cell in terms of growth rate, shifts in the transcriptome, proteome, etc. We can
envisage these impacts being a network of global physiological effects on the cell that are all
interlinked with the availability of shared resources being the central node that interacts with
the synthetic circuit (see Figure 3.1).
By creating a means of investigating the availability of these resources we will be able to gain












Figure 3.1: A synthetic gene circuit and its host cell interact in a number of ways. The key
interface being investigated in this project is the shared resource pool. This is the set of com-
mon resources that are used by both the cell and circuit for cell maintenance and growth as
well as for gene expression from the circuit. Key examples of shared resources are ribosomes,
polymerases etc.
3.1.2 Impact on Additional Heterologous Gene Expression
Expression of a heterologous protein within a cell affects both the cell itself as well as the
expression of other heterologous proteins within the cell. For example, we consider two ex-
pression units A and B that when placed alone into a chassis cell, these express protein at
rates x and y respectively. When these units are placed simultaneously into the same chassis
cell they will be competing for the same resources and expression machinery. Therefore the
level of expression of units A and B would be reduced to < x and < y respectively (see Figure
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3.2).
It is therefore important to understand how the output of two genes changes when they are
co-expressed as compared to in isolation. A greater understanding of how these interactions
occur may lead to improvements in the design of multi-gene synthetic systems and will be











Figure 3.2: Expression of a synthetic gene circuit will also have interaction with other synthetic
genes within the cell through the same shared resource pool. The two genes may be on differ-
ent plasmids in the same cell, or may simply be different genes in the same circuit. Expression
of gene A will be competing for the same shared resources as gene B.
3.1.3 Capacity Monitor
In order to gain an insight into the interactions detailed above it would make sense to investigate
the interfaces between cell and circuit. As mentioned, the core interface is through the shared
resource pool. We wanted to know whether we could measure changes in this shared resource
pool by placing a small synthetic circuit into the cell that would allow us to quantify the amount
of ‘capacity’ available in this pool. While we did not envisage this monitor being able to give
direct quantifications of the number of individual resources, we wanted to get an insight into
the availability of resources required for gene expression. We can look at gene expression
58
as a single step (and therefore as a function of all machinery and building blocks), and once
we have confirmation that we are able to observe changes in this machinery we will aim to
separate the processes that constitute gene expression - i.e. transcription and translation (see
Figure 3.3). While it may be desirable to gain a greater insight into the availability of individual
resources that affect the transcriptional and translational rates we believe quantifying the rates
of these steps is sufficient for the scope of this project. Obtaining quantification of resources at
a resolution where each individual resource is quantified separately would require a significant
amount of work beyond what is achievable within the timeframe of this project, and we believe
the insight into shared resources just from looking at transcriptional and translational resources
will be enough to gain a better understanding of cell-circuit interactions. This will allow us to
understand which processes are most important and, if necessary, try to identify individual
resource availabilities in further work.
This capacity monitor can be considered analogous to the system monitor found on many
computers, which informs the user of the availability of certain resources available to programs
(such as RAM or CPU).
3.2 Requirements
Once the core functionality of the capacity monitor had been defined, it was necessary to create
some specifications for its design. By creating a list of specifications it was possible to clearly
delineate the features we required from a capacity monitor. These were as follows:
3.2.1 Allow quantification of capacity in E. coli cells
This is clearly a key feature of the capacity monitor. By being able to quantify the resource ca-
pacity within a cell it is possible make comparisons between different circuits or circuit variants.
It was also necessary to ensure that the capacity monitor did not interact with the cell via any














Figure 3.3: Capacity monitor acts as a proxy for the availability of shared resources. An in-
crease (or decrease) in the output of the monitor translates as an increase (or decrease) in
availability of shared resources.
3.2.2 Interact with Shared Resources
It was necessary to ensure that any non-resource-derived interactions between the cell and
the circuit were avoided or minimised to a level where their effect was negligible. An important
consideration was the choice of proteins used so that they were not toxic when expressed in
E. coli. In order to do this, it was useful to choose proteins that are widely used and well
understood in the literature not to cause a toxic affect on a host cell.
In addition, we wanted to minimise any cross-talk where by the regulatory mechanisms of the
cell and circuit overlap. This was done, where possible, by using synthetic elements that do
not occur naturally in E. coli or, ideally, in any natural organism. This was achieved through
different approaches:
1. Designing sequences de novo such that they are entirely synthetic and not derived from
any naturally occurring sequence.
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2. Creating mutations of sequences that exist in nature such that they maintain their func-
tionality while having different sequences from the natural origin. This can be done either
through random mutant library creation or by using techniques such as codon optimisa-
tion to rationally redesign sequences.
3.2.3 Easily quantifiable output
As mentioned above, the monitor requires a quantifiable output. This output should be quantifi-
able at a population and single-cell level and be measurable at regular intervals over a period
of time. Using a fluorescent protein would enable the easy and rapid quantification of protein
levels within cells [92].
Use of fluorescent proteins as reporter proteins is a very well established technique and many
variants of these proteins have been made with a range of excitation and emission wavelengths
as well as folding speeds and stabilities [92]. Therefore we were able to select our reporter
protein from a large set of potentials with a range of characteristics to ensure the specifications
for our capacity monitor are able to be met.
Many synthetic biology labs have the ability to measure green fluorescence and green fluores-
cent protein (GFP) is commonly used as a reporter protein in synthetic systems. While using
GFP as the reporter protein in our capacity monitor poses some issues in terms of compatibility
(see below), is it highly beneficial in a number of ways.
GFP is highly characterised and there exist a number of variants with desirable characteristics.
Super folder GFP (sfGFP) is a rapidly folding protein [73] and therefore allows us to minimise the
delay between the protein being translated and becoming measurable via fluorescence read-
ings. In addition it is highly stable with a degradation rate in excess of 24 hours [73,52], which
means that in combination with the 5 degradation tags we have a wide range of degradation
rates (< 30 mins to > 24 hours). These are key benefits that we consider outweigh the nega-
tives associated with using GFP as the output of our monitor.
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3.2.4 Maximal interoperability with other synthetic circuits
By maximising the number of synthetic circuits we are able to use in conjunction with our
capacity monitor we will clearly increase its effectiveness and utility.
Synthetic circuits are introduced into cells either on a plasmid-based system or are integrated
into the genome [46]. Plasmid-based systems can have compatibility issues whereby different
plasmids cannot co-exist in the same cell if they have the same mechanism for replication [12].
Therefore, if the capacity monitor was plasmid-based, we would experience issues when trying
to monitor the burden imposed by synthetic circuits that use the same replication mechanism
as that of the capacity monitor. If we were able to place the capacity monitor on the genome
we would remove compatibility issues with both plasmid- and genome-based synthetic circuits.
Compatibility between selection markers also presents an issue when trying to maximise in-
teroperability. If the capacity monitor and synthetic circuit use the same selection system then
it will not be possible for them to reliably co-exist in the same cell. Since maintaining a plas-
mid within a cell requires a selection marker and most systems for genomic integration also
require a selection marker, avoiding the use of a selection marker in our capacity monitor was
not necessarily feasible.
In order to measure the output of our monitor we need a quantifiable reporter protein. This
reporter would not be able to be used in any synthetic circuit we are testing as we would not
be able to differentiate between protein produced by the capacity monitor and that produced
by the synthetic circuit . In selecting our reporter we had a number of considerations such as
how well characterised is the protein and how easily we could quantify it on a population and
single-cell level.
3.2.5 Minimal burden on cell
We wanted our capacity monitor to place a minimal burden on the cell by using minimal re-
sources. Much of this thesis concentrates on understanding the ways in which different control
points in a circuit affect the burden it places on a cell and therefore it is unlikely that the system
we design to be a capacity monitor will place the minimal possible burden on the cell. However,
there are some strategies we can use to decrease it such as minimising the amount of protein
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that needs to be produced. In order to minimise the amount of protein produced we can attempt
to maintain the capacity monitor at as low a copy number as possible. It will be important to
balance this requirement with the need to produce enough protein to be measurable for most
levels of burden placed on the cell. We also used DNA2.0 codon-optimisation algorithms to
optimise the DNA sequence for efficient expression in E. coli and remove any slow codons that
may cause ribosomal traffic jams and unnecessary burden.
3.3 Implementation
After taking into consideration the above specifications for our monitor we decided upon the
following implementation of our monitor. We would have a constitutively expressed GFP variant
driven by a relatively strong RBS. In order to optimise our monitor we required a number of
variants that had both different copy numbers and degradation rates. To do this we placed the
circuit on three different plasmid backbones as well as a genomic integration, and used a range
of 4 degradation tags as well as a version with no tag. See Figure 3.4 for an outline of the
combinations. The degradation tags used are discussed in further detail in Section 3.4.6 and


















Figure 3.4: This array shows all of the constructs we built, where each box is a separate
construct. An X in a box denotes that we tested this combination. Overall we constructed 20
variants of potential capacity monitor systems and tested 12. Copy number and degradation
rate characterisations are all from Parts Registry [2].
3.4 Device Design
3.4.1 Copy Number
From the requirements outlined above, it was noted that a genomic insertion would provide
the highest level of compatibility with other synthetic gene circuits as there would have been
no issues with cross-compatibility of plasmid origins. In addition, a genomic insertion was
predicted to produce the lowest amount of protein and use up the least of the cell’s resources
thereby impacting on the cell the least amount.
It was decided that implementations of both plasmid-based systems and genome insertion-
based systems should be tested in order to compare how they behaved with regards to a
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number of factors including:
1. Signal strength - Are the GFP fluorescence levels sufficiently high to detect?
2. Signal to noise ratio - How do different copy number implementations affect not only the
signal but the ratio of variance/noise in the signal outputs?
3. Growth Rate - Does the implementation of the monitor system impact the cell in terms of
its ability to grow?
In order to vary the copy number of our monitor we placed the circuit onto 3 different plasmid
backbones (see Table 3.1 for more details) and used the CRIM system for genomic integra-
tion [46]. The CRIM system allows a circuit to be placed into a number of different phage sites
in the E. coli genome. Attempts were made to insert monitor systems into both λ and φ80
sites (see Figure 3.5 for a guide to the locations of the different sites in the genome) in order
to maximise chance of successful integration. Monitor variants were successfully integraded
into the λ-site before the φ80-site and therefore the λ was subsequently used throughout the
project.
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Figure 3.5: Locations on E. coli genome where CRIM system inserts constructs into. λ-site
used in this project is highlighted in yellow. Figure adapted from [46].
The CRIM system integrates a kanamycin resistance marker into the genome along with the de-
sired circuit, and in order to ensure consistency we used 3 plasmid backbones with kanamycin
resistance for testing the circuit on plasmids. The plasmids we used are widely-used backbones
from the Registry of Standard Biological Parts (see Table 3.1).
Plasmid Backbone Origin Estimated Copy Number
pSB1K3 pMB1 100-300 [2]
pSB3K3 p15A 10-12 [2]
pSB4K5 pSC101 5 [2]
Table 3.1: Plasmid backbones used for capacity monitor candidates. These are all from the
Registry of Standard Biological Parts.
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3.4.2 Promoter - J23100
It was decided that a constitutive promoter would be the optimal choice for this project. By avoid-
ing the requirement for regulation at the promoter, the rate of transcription is be decoupled from
the activity of any specific regulatory proteins. Instead the rate is a function of the availability of
the global resources associated with transcription, such as polymerases and sigma factors.
The promoter selected was J23100, and was chosen from a library of combinatorial variants
of a promoter sequence that is a fully synthetic design based on consensus sequences for -35
and -10 promoter regions and has no homologs in bacteria. This library was created by the
Berkeley 2006 iGEM team [3] and consists of a single consensus sequence (J23119) as well
as 19 additional synthetic sequences. From this library J23100 is reported to have the highest
level of expression, apart from the consensus version [3]. Since it is a synthetic sequence, it
would be expected that cross-talk interactions with the host E. coli cells are highly unlikely. The
comparison of J23100 with the wild type is shown in Figure 3.6
Figure 3.6: Sequence alignment of J23100 against the wild-type J23119 sequence. Figure
adapted from Registry of Standard Biological Parts page for J23100. The two main resources
this promoter interacts with are the σ70 (sigma factor) which binds to the -35 sequence, and
RNA polymerase which binds to the -10 sequence.
3.4.3 RBS - Synthetic Design
The RBS sequence for the monitor was designed using the Salis RBS Calculator [85]. The
forward design program was used with no upstream sequence (since the J23100 promoter
ends at its -1 base) and with a downstream sequence consisting of the initial 40 bases of our
codon optimised sfGFP sequence (see below). The calculator was set to ‘maximise’ the RBS
strength and gave a predicted strength of 244950.7 au. Since this sequence was generated by
the RBS calculator, it is a fully synthetic sequence and is not known to occur naturally.
TACTAGAGAAATCAAATTAAGGAGGTAAGATA
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3.4.4 CDS - optimised sfGFP
We decided to use GFP and specifically the Superfolder GFP variant (sfGFP) for the reasons
given before. Superfolder GFP is a protein that was designed by Pe`delacq et al. in 2006 [73].
This protein is not known to act as an enzyme for any reactions within E. coli and its functionality
is not known to be affected by any native cellular processes. It was codon optimised by DNA2.0
for efficient E. coli expression.
3.4.5 Terminator - B1002
This terminator is artificially designed and does not exist natively in the genome of any organ-
ism that we are aware of. It has been characterised as having a particularly high termination
efficiency (90% [20]) which ensures that there will be minimal ’run-through’ of polymerases as
the gene is transcribed.
3.4.6 Degradation Tags - SsrA
We used a set of degradation tags from the SsrA family. These tags are derived from the natural
LAA variant which is a sequence of 11 amino acids that are naturally added to the C-terminal of
an amino acids chain when translation is interrupted. This sequence of 11 amino acids targets
proteins for degradation by ClpXP and ClpAP [43]. The variants of this tag differ in their final
3 amino acids where the name of the tag is the abbreviated name of the final 3 amino acids.
These degradation tags are not fully orthogonal from the host E. coli cell since they use some
of the same machinery as the cell does naturally to degrade proteins. Cookson et al. show that
competition for this degradation machinery can have a number of adverse affects on the cell
such as growth retardation [27]. Tags were considered as part of the design because they may
have assisted in getting dynamic readings of protein expression.
3.5 Testing
Once all of the variants of our monitor had been constructed and inserted into the host DH10B
cells either via plasmid based systems or CRIM integration, we had to test them to see which
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best fitted the requirements mentioned above. The key factors we were interested in were:
• Whether we were able to detect GFP at sufficiently high levels and whether we would be
able to reliably and accurately measure changes in fluorescence levels.
• What the impact on growth rate was of all the versions of the monitor. We wanted to
make sure we were impacting the cell as little as possible and growth rate is a reasonable
indicator of this.
• What the strengths of the degradation rates were for each of the tags and whether they
would be constant enough to allow us to make accurate calculations about the production
rates of GFP given only fluorescence measurements.
We designed a simple protocol to answer these important questions. The constructs we de-
cided to test were the variants with either a) no degradation tag, b) AAV degradation tag or c)
LVA degradation tag across all expression systems (see Figure 3.4). This was initially testing
in LB media (results not shown) but was repeated in defined M9 medium (shown below) with
fructose since many of our later chapters utilise this carbon source due to compatibility issues
between the circuit and some commonly used carbon sources such as glucose.
3.6 Results
3.6.1 Growth Rates
Figure 3.7 shows how the cells containing different variants of the monitor grew in M9 medium
over a 5 hour timeframe. It is clear that generally as copy number is increased (from genomic,
to pSB4K5, to pSB3K3, to pSB1K3) the cells are growing at a decreasing optical density (OD).
In Figure 3.7c it can be seen that, with the exception of the LVA tagged variant, the growth
of cells containing low-copy number versions of the monitor have very similar growth profiles
to DH10B cells without any monitor device. Medium-copy plasmid based systems (3K3), and
4K5 with an LVA tag, grow at slightly lower OD compared to DH10B cells. High-copy plasmid
systems (1K3) grow at significantly lower OD compared to DH10B. This indicates that both
medium- and high-copy variants of the monitor are having significant retarding affects on the
cell behaviour, decreasing growth rate.
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(a) Growth Curves for High-copy candidates (pSB1K3) (b) Growth Curves for Medium-copy candidates
(pSB3K3)
(c) Growth Curves for Low-copy candidates (pSB4K5) (d) Growth Curves for genomic candidates
Figure 3.7: Growth curves for all monitor candidates grown for 5 hours in M9 medium sup-
plemented with 0.4% fructose with readings taken at 10 minute intervals. Measurements are
done on plate reader and averages over 6 repeats with error bars showing standard error of
the mean. DH10B cells are included in all graphs to indicate how growth curves compare to
cells without any monitor circuit. Normalisation is preformed by dividing each OD reading by
the initial reading for the corresponding curve at time = 0. DH10B are the untransformed cells
with no monitor candidate, ‘1K3’, ‘3K3’, ‘4K5’ and ‘Genomic’ represent pSB1K3 (high copy),
pSB3K3 (medium copy), pSB4K5 (low copy) and genomic insertion respectively. where ‘LVA’,
‘AAV’ and ‘-’ represent candidates with LVA degradation tag (high predicted degradation rate),
AAV degradation tag (medium predicted degradation rate) and no degradation tag respectively.
See Figure 3.4 for more details on constructs tested.
In addition to looking at basic OD levels, the normalised ODs were also calculated. These
values are obtained by normalising the OD values to the initial value at t = 0. Figure 3.8 shows
the curves for normalised OD. These show that the decrease in OD for pSB3K3 candidates
(medium-copy) and the pSB4K5 (low-copy) with LVA candidate are mainly due to the lower
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initial ODs for these candidate strains. In addition, the amount of decreased OD relative to
DH10B for pSB1K3 candidates (high-copy) is lower when ODs are normalised, again because
the cultures were initialised at slightly lower ODs. Whilst there are many ways to compare
the growth of different cultures that have different starting ODs (such as shifting the curves
along the x-axis so that they have the same starting ODs) this approach is sufficient for us to
be confident that there s very little difference in growth rate across all low-copy and genomic
candidates.
Growth rates for these different candidate strains were calculated over the course of the ex-
periment and their decreases relative to untransformed DH10B cells can be seen in Table 3.2.
This shows that high-copy candidates have a decreased growth rate of 5%-8%, medium-copy
candidates have a decreased growth rate of 0%-2% and low-copy and genomic integrations
have negligible decrease in growth rate.
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(a) Growth Curves for High-copy candidates (pSB1K3) (b) Growth Curves for Medium-copy candidates
(pSB3K3)
(c) Growth Curves for Low-copy candidates (pSB4K5) (d) Growth Curves for genomic candidates
Figure 3.8: Growth curves for all monitor candidates grown for 5 hours in M9 medium sup-
plemented with 0.4% fructose with readings taken at 10 minute intervals. Measurements are
done on plate reader and averages over 6 repeats with error bars showing standard error of
the mean. DH10B cells are included in all graphs to indicate how growth curves compare to
cells without any monitor circuit. Normalisation is performed by dividing each OD reading by
the initial reading for the corresponding curve at time = 0. DH10B are the untransformed cells
with no monitor candidate, ‘1K3’, ‘3K3’, ‘4K5’ and ‘Genomic’ represent pSB1K3 (high copy),
pSB3K3 (medium copy), pSB4K5 (low copy) and genomic insertion respectively. where ‘LVA’,
‘AAV’ and ‘-’ represent candidates with LVA degradation tag (high predicted degradation rate),
AAV degradation tag (medium predicted degradation rate) and no degradation tag respectively.
See Figure 3.4 for more details on constructs tested.
Growth rates were calculated using the formula for specific growth rate (µ) in Equation 3.1 over
a 40 minute period from 60 minutes to 100 minutes and are shown in Table 3.2. A 40 minute
interval was used as this was the shortest time period we considered that any errors from the
plate reading in OD levels would have a sufficiently low impact on calculated growth rates.
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This shows that high-copy candidates have a decreased growth rate of 5%-8%, medium-copy
candidates have a decreased growth rate of 0%-2% and low-copy and genomic integrations








where τ is the time interval between readings.
Candidate LVA AAV No Tag
pSB1K3 5.2% 7.8% 6.8%
pSB3K3 2.1% 0% 0.6%
pSB4K5 0% 0% 0.1%
Genomic 0% 0% 0%
Table 3.2: Decreases in growth rate relative to DH10B for all monitor candidates tested. Esti-
mates calculated as the growth rate between 60 minutes and 100 minutes of growth.
It is clear from these results that the high-copy and medium-copy candidates have retarding
effects in terms of the growth rate of cells. Low-copy and genomic candidates have minimal
effect on growth rate.
In summary, both high- and medium-copy candidates appear to have major drawbacks when
compared to the low-copy and genomic candidates. This is due to the negative impact on
growth rate and maximum OD. When considering one of the key requirements for a monitor is
that there should be minimal burden placed on the cell (see Section 3.2.5) the medium- and
high-copy candidates do not fulfil this.
3.6.2 GFP Production
A crucial factor in creating a suitable monitor is that GFP levels are able to be detected at
sufficient levels for accurate estimations of productions rates to be made. Figure 3.9 shows
the total GFP amounts for each monitor candidate. It can be clearly seen that for each copy-
number, the total amount of GFP decreases with the increase in predicted degradation rate:
LVA is predicted to degrade proteins faster than AAV, which is predicted to be faster than no tag
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(denoted by ‘-’). An interesting result is that the total GFP accumulation is higher for untagged
medium copy candidates than for untagged high-copy candidates.
(a) Total GFP for High-copy Candidates (pSB1K3) (b) Total GFP for Medium-copy Candidates (pSB3K3)
(c) Total GFP for Low-copy Candidates (pSB4K5) (d) Total GFP for Genomic Candidates
Figure 3.9: Total GFP for all monitor candidates grown for 5 hours in M9 medium supplemented
with 0.4% fructose with readings taken at 10 minute intervals. Measurements are done on
plate reader and averages over 6 repeats with error bars showing standard error of the mean.
DH10B cells are included in all graphs to indicate how growth curves compare to cells without
any monitor circuit. DH10B are the untransformed cells with no monitor candidate, ‘1K3’, ‘3K3’,
‘4K5’ and ‘Genomic’ represent pSB1K3 (high copy), pSB3K3 (medium copy), pSB4K5 (low
copy) and genomic insertion respectively. where ‘LVA’, ‘AAV’ and ‘-’ represent candidates with
LVA degradation tag (high predicted degradation rate), AAV degradation tag (medium predicted
degradation rate) and no degradation tag respectively. See Figure 3.4 for more details on
constructs tested.
We have seen above that the growth rates and ODs over time can be very different for these
different variants. Therefore it is important to look not only at the total GFP, but also to look at
the amount of GFP per cell (estimated by dividing GFP fluorescence by OD). We can see the
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results of this calculation for all candidates in Figure 3.10. By normalising the GFP fluorescence
reading we see that the GFP per cell decreases as copy number decreases. Similar to total
GFP, the GFP per cell decreases as the predicted strength of the degradation tag increases.
(a) GFP per Cell for High-copy Candidates (pSB1K3) (b) GFP per Cell for Medium-copy Candidates
(pSB3K3)
(c) GFP per Cell for Low-copy Candidates (pSB4K5) (d) GFP per Cell for Genomic Candidates
Figure 3.10: Per cell GFP for all monitor candidates grown for 5 hours in M9 medium sup-
plemented with 0.4% fructose with readings taken at 10 minute intervals. Measurements are
done on plate reader and averages over 6 repeats with error bars showing standard error of the
mean. DH10B cells are included in all graphs to indicate how growth curves compare to cells
without any monitor circuit. Calculated by dividing total GFP by OD. All graphs are shown to
the same logarithmic scale to allow ease of comparison. It can be clearly seen that the amount
of GFP per cell decreases for each degradation tag and that GFP per cell decreases as the
predicted strength of the degradation tag increases. DH10B are the untransformed cells with
no monitor candidate, ‘1K3’, ‘3K3’ and ‘4K5’ represent pSB1K3 (high copy), pSB3K3 (medium
copy) and pSB4K5 (low copy) respectively. where ‘LVA’, ‘AAV’ and ‘-’ represent candidates
with LVA degradation tag (high predicted degradation rate), AAV degradation tag (medium pre-
dicted degradation rate) and no degradation tag respectively. See Figure 3.4 for more details
on constructs tested.
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Using GFP and OD measurements it is possible to calculate GFP production rates for the
monitor candidates that do not have degradation tags. We use Equation 3.2 as a simple ODE
model for the rate of change of GFP.
dGFP
dt
= α− δGFP (3.2)
where GFP is the amount of GFP per cell, α is the production rate of GFP and δ is the decay
rate of GFP (degradation rate + dilution or growth rate). Since the half-life of sfGFP, the variant
of GFP we are using in this project, is so long (> 24 hours [73,52]) the rate of decay is approxi-
mated as being the rate of dilution (specific growth rate of cells µ), so we use the substitution
shown in Equation 3.3.






Using these approximations and by taking integrals of Equation 3.2 over a time period from t to









We can solve this algebraic equation to calculate the protein production rate α for GFP to obtain
Equation 3.5.
α =
(lnODt+τ − lnODt) (GFPt+τ ·ODt+τ −GFPt ·ODt)
τ (ODt+τ −ODt) (3.5)
whereGFPt is the calculated GFP per cell at time t andODt is the optical entity of the culture at
time t. Figure 3.11 shows the GFP production rate for monitor candidates without degradation
tags. The high-copy candidate clearly shows the highest production rate of GFP protein, and
the rate of protein production decreases alongside the copy number with the genomic insertion
having the lowest GFP production rate as would be expected. This is further revealed in Table
3.3.
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Figure 3.11: Estimated GFP production rates for all candidates with no degradation tag. Esti-
mates made over 10 minute intervals using GFP fluorescence and OD readings and Equation
3.5. All readings made on plate reader and are averages of 6 repeats where errors bars indicate
standard error of the mean.
Copy Number GFP Production rate (α)
High copy number (pSB1K3) 22900
Medium copy number (pSB3K3) 13800
Low copy number (pSB4K5) 8100
Genomic integration 4482
Table 3.3: Estimated GFP production rates for monitor at each copy number at 60 minutes from
initial reading (shown to nearest 100).
In order to accurately estimate production rates for tagged proteins it is important to have accu-
rate values for the degradation rates of the proteins as these values, added to the growth rate,
give the protein decay rate δ. Therefore it is crucial to verify the degradation rates of proteins
tagged with these degradation tags. These rates are reported in the literature for certain [6],
however it is necessary to also characterise them in the specific conditions being used in these
experiments.
It is possible to calculate the degradation rates of the proteins with different tags in our exper-
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iments by utilising the fact that protein production rates across all versions of the monitor at
the same copy number are expected to be highly similar. This assumption is made based on
the fact that the only differences in the tagged variants are the tags themselves and that fac-
tors influencing protein production rate such as copy number, promoter, RBS and codon usage
remain constant.
Equation 3.2 cannot be solved analytically to obtain the degradation rate. Therefore we solved
Equation 3.2 numerically to estimate the degradation rate for the different constructs. This was
done using Wolfram Alpha [4].
Figure 3.12: Estimated half lives of proteins with degradation tags from monitor candidate
devices at various copy numbers. Wolfram Alpha [4] was used to solve Equation 3.2 analytically
and obtain degradation rates.
The results of these calculations are shown graphically in Figure 3.12. The calculated half-lives
for the tags at different copy numbers show that there is very little constancy between different
copy numbers and from the reported figures [27]. This indicates that the degradation tags should
not be included in the final design since estimations of protein production rates for degradation
tagged proteins require accurate degradation rates. In addition, it can be seen that monitor
candidates at lower copy numbers with no degradation tag show lower amounts of variation
than medium- (pSB3K3) and high-copy (pSB1K3) candidates (see Table 3.3).
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3.7 Final Design
It can be clearly seen from the data that GFP fluorescence can be detected at all copy numbers,
including genomic integration. As mentioned above, there are a number of benefits to having a
monitor system that has been inserted into the genome including:
• No origin of replication incompatibility with any other plasmid-based circuits.
• Lower copy number means there will be a lower impact on the host cell in terms of growth
rate (see Figure 3.10d) and we would also expect a lower impact on shared resources in
the cell as there will be lower rates of DNA replication, transcription and translation.
• Maintaining a genetic circuit is known to be much easier when it is integrated into the
genome [93]. This means that the monitor will be maintained for a much larger number of
generations and will be much more likely to be maintained in cells that are experiencing
stress.
• No need for continuous selection with an antibiotic.
There did not appear to be any direct or indirect benefits from using a plasmid-based system
over a genomic integration that would mitigate these clear benefits in any way. Therefore it was
decided that the final monitor device would be integrated into the E. coli genome at the λ-site.
The data clearly show that there is a large inconsistency in degradation rates corresponding to
individual tags. This inability to reliably and consistently have an accurate estimate of protein
degradation rate means that it becomes very difficult to estimate protein production rates. By
using sfGFP without a tag it is possible to accurately approximate the decay rate of GFP per
cell as being growth rate, a variable we can accurately and reliably calculate directly and dy-
namically. The growth rates of E. coli mean that changes in GFP production can be measured
even when a degradation tag is not present.
Considering all factors there appeared to be no direct or indirect benefit to using a monitor
version with a degradation tag, and therefore it was decided that the final monitor version would
not use degradation tags.
Our final monitor design was therefore a genomic integration into the λ-site of DH10B. The
integrated construct was a linearised CRIM plasmid pAH63 [46] containing synthetic promoter
J23100 driving the transcription of a strong synthetic RBS (as predicted by the Salis RBS
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calculator [85]) and coding region for a DNA2.0 codon optimised sfGFP without any degradation
tag, followed by a fully synthetic B1002 terminator (Figures 3.13 & 3.14)
Figure 3.13: The final monitor design consists of promoter J23100 driving the transcription of
a strong RBS (as predicted by the Salis RBS calculator [85]) and coding region for a fully codon




Figure 3.14: Local context of capacity monitor within E. coli genome (not to scale). CRIM plas-
mid including kanamycin resistance marker and pstS site are integrated into the λ-site in the
genome between ybhB and ybhC at approximately 860000 bases into the genome of DH10B
(according to EcoCYC annotation). When integrated into MG1655, the location is approxi-
mately 806000 bases into genome (according to EcoCYC annotation). Figure modified from
EcoCYC [49]
It should be noted that whilst this design was able to fulfil most of the requirements outlined in
Section 3.2, the final design has some drawbacks that should be acknowledged.
3.7.1 Design Implications
Clearly the use of GFP as the output protein of the monitor means the monitor will be incom-
patible with synthetic circuits that use a fluorescent protein that has overlap in the emission
or excitation spectrum of GFP. Many synthetic circuits employ GFP (or a derivative of it) as a
reporter protein and the use of GFP in the project renders these incompatible. However, many
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of the benefits that cause GFP to be so widely used, such as extensive characterisation, rapid
folding and infrastructure compatibility, mean that the benefits of using it in the monitor design
outweigh the disadvantages.
In addition, when integrating the monitor plasmid into the genome using the CRIM system, the
entire CRIM plasmid is integrated. This means that features that are crucial for maintenance of
the plasmid such as origin of replication and an antibiotic resistance marker are also included
into the genome. The origin of replication in the CRIM plasmid is a pir conditional origin and
only functions in the presence of the pir protein. In the E. coli strains where the monitor is
implemented this protein is not present and the origin is non-functional. The kanamycin re-
sistance marker is still present and functional in the genome. This means that the monitor is
incompatible with synthetic circuits that use a kanamycin resistance marker. While kanamycin
is a popular antibiotic used in many circuits, many alternatives are available.
CRIM is not the only methodology for integrating into the genome of E. coli [15]. After a survey
of the alternative methods it was clear that CRIM offered the best set of advantages (such as




Results: Testing and Verifying
Function of the Capacity Monitor
4.1 Designing Test Circuits
In order to test whether the monitor was able to detect a decrease in the resources available in
the cell a test circuit was selected. This test circuit was chosen to produce mRNA and protein
under the presence of an inducer. In addition to the test circuit, suitable controls were designed
to confirm that protein production was causing the burden as opposed to the presence of the
inducer. In order to design a suitable test circuit a number of specifications were outlined.
4.1.1 Compatibility with Monitor
Clearly it is important to ensure that any test circuit is compatible with the monitor. As mentioned
in Section 3.7.1 there are a couple of constrains that the implementation of the monitor places
on circuits it can be used with. Circuits must:
1. Not contain GFP or a close derivative of the GFP protein.
2. Not use kanamycin as a selective marker.
These are relatively easy constraints to work with and are taken into consideration in the design
of the test circuit.
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4.1.2 Interact Through Shared Resources
This test circuit is designed to test whether the monitor is able to detect a decrease in shared
resources. In order to do this it is important to ensure that the interactions between the test
circuit, the monitor and the host cell occur solely through the shared resource pool. This means
other interactions such as cross-talk and toxicity must not be present between the systems. In
Chapter 3 we describe how they are avoided between the monitor and the host cell, and will
discuss in this chapter how they are avoided in the test circuit.
4.1.3 Inducible Circuit - The AraBAD Promoter Unit
Making the test circuit inducible meant that we could control whether or not protein was being
produced from it through the addition of a small inducer chemical. This is important as it was
necessary to make comparisons between cells containing the same DNA where one set was
producing protein from the circuit and the other was not. By making this comparison one can
be sure that any phenotypic differences between the two cases is due to the presence of the
inducer chemical.
It was necessary to confirm that the only impact the inducer chemical was having on the cells
was to cause additional protein production from the synthetic circuit, and not having any di-
rect interaction with any native cellular functions or behaviours. This could be confirmed by
growing similar strains without the inducible circuit, but including the plasmid backbone, and
untransformed cells with the capacity monitor and comparing their behaviour with and without
the induction chemical.
A widely used inducible promoter system in synthetic biology, and especially E. coli, is the
AraBAD promoter. This promoter unit consists of a constitutive promoter on the reverse strand
(with built-in RBS sequence) driving the expression of protein AraC, followed by a PBAD pro-
moter on the forward strand (see Figure 4.1) [87].
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Figure 4.1: The design of the AraBAD promoter unit consists of a constitutive promoter on the
reverse strand (with built-in RBS sequence) driving the expression of protein AraC, followed by
a PBAD promoter on the forward strand.
The AraC protein acts as both a repressor and activator of the PBAD promoter dependent on the
presence of arabinose. When arabinose is not present, AraC forms a dimer which binds to the
O2 and I1 sites in the PBAD promoter and causes it to fold over, preventing the binding of RNA
polymerase. When arabinose is present, it causes a conformal shift in the AraC dimer which
causes it to bind to the I1 and I2 sites and actively recruits RNA polymerase to the promoter [87].
Figure 4.2: When arabinose is not present, AraC forms a dimer which binds to the O2 and I1
sites in the PBAD promoter and causes it to fold over, preventing the binding of RNA polymerase.
When arabinose is present, it causes a conformal shift in the AraC dimer which causes it to bind
to the I1 and I2 sites and actively recruits RNA polymerase to the promoter. Figure adapted
from [87].
The cell strain being used as the main platform for this project is DH10B which has had the
ara operons deleted [31]. This means that any potential for cross-talk between the host cell or
monitor and the AraC gene and PBAD promoter has been removed. In addition, as a native E.
coli protein, AraC is not toxic to E. coli satisfying the key requirement that interactions between
the test circuit and the cell and monitor are exclusively through the shared resource pool.
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4.1.4 High Burden on Shared Resources
In order to increase the probability that our test circuit is going to place sufficient burden on
the shared resources we need to design a circuit that is likely to place high levels of burden
on these resources. Two separate circuits were tested in order to maximise the likelihood that
any decreases in monitor output observed are due to the usage of cellular resources in the
expression of protein rather than the proteins being expressed. The two circuits tested both
contained the PBAD mentioned above expressing operons within a pSB1C3 backbone and are
shown in Figure 4.3.
The first operon is the lux operon from Vibrio fischeri contains the luxCDABE genes. This
operon controlled by PBAD was designed by the Cambridge 2010 iGEM team and has a total
operon length of 6407 bp. The combination of a strong promoter (PBAD) and the fact it is
expressing 5 proteins means a lot of resources should be used in expressing it.
The second operon is the Red Firefly Luciferase from the Japanese Firely L. cruciata which
contains two genes that are 927 bp and 1644 bp long. This operon controlled by PBAD was also
designed by the Cambridge 2010 iGEM team.
Both of these operons are entirely heterologous to E. coli and therefore should not have cross-
talk with the native cellular metabolism. They have both also been codon optimised by DNA2.0
and are placed in a pSB1C3 backbone plasmid [44].
4.1.5 Suitable Controls
It was necessary to have a control that would show that changes in capacity monitor out-
put were due to protein expression. The control is the pSB1C3 backbone plasmid backbone
with no AraBAD promoter unit or operon, instead replaced by some non-functional DNA. The
non-functional DNA is an 81 bp sequence containing 7 zinc finger binding sites that has no
functionality within the contact of the chassis cell or plasmid backbone (BioBrick K323039).
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Figure 4.3: Three circuits used to initially test capacity monitor. All inserts transformed into cell
with pSB1C3 chloramphenicol resistant plasmid backbone. Lux is Lux operon under control of
AraBAD. Luciferase is Firefly Luciferase operon under control of AraBAD. NF is non-functional
DNA. AraBAD promoter is induced by arabinose (black arrows indicating activtion). Lengths of




We use the rate of protein production as a proxy for the availability of shared resources. We are
using a constitutively expressed fluorescent protein as our monitor and therefore the resource
availability will affect the rate of protein production and this metric will give us the best idea of
resource availability. Total protein per cell is not the correct metric as the accumulation will be
a function of production rate and dilution rate.
Figure 4.4 shows growth curves and estimates of capacity monitor activity (GFP production
rate) over time. Each plasmid was inserted in E. coli and grown in LB with and without arabi-
nose added at t=0 and we can clearly observe that when arabinose is added to cells with the
inducible promoter (Lux and Luciferase) there is a drop of approximately 50% in capacity mon-
itor activity after 2 hours while cells lacking this additional expression (NF) maintain a higher
level of capacity monitor activity in line with control (DH10G cells only containing the capacity
monitor). This is a proof of principle that the capacity monitor is able to detect the expression
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of a level of additional protein by GFP production per cell decreasing.
Once the fact that a decrease in output from the capacity monitor under protein production had
been confirmed attention was directed to what it was that the capacity monitor was actually
detecting. The drop in GFP production rate only occurs after 1-2 hours after induction. In
LB the shift in growth rate at approximately 2 hours occurs as a result of a change in carbon
source [14]. The initial carbon source used by the cell is maltose, which is a relatively favourable
carbon source for the cell and allows for higher growth rates. After approximately 2 hours this
carbon source runs out and the cell has to produce high levels of additional protein so it can
use a ‘large group of other carbon sources including D-mannose, melibiose... glycerol, and
lactate’ [14]. These carbon sources are less favourable for E. coli and limit its growth rate, which
is seen in figure 4.4a where the gradient of the graph falls at approximately 2 hours. In order
to utilise these alternative carbon sources the cell needs to reconfigure its proteome which
requires a large number of ribosomes due to the large number of proteins being translated.
Figure 4.4c shows clearly that the drop in output rate from the capacity monitor occurs after 1-2
hours and not at the time of induction.
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(a) OD 600 Growth Curves (b) GFP per Cell
(c) GFP Production Rate
Figure 4.4: Growth, GFP/OD and estimated GFP production rates in LB with arabinose in-
duction at t=0 for cells with no plasmid (DH10G) or plasmids with following inserts: Luciferase
(K325219) both without arabinose induction (Luciferase -) and induction at t=0 (Luciferase
(0)); Lux (K325909) both without arabinose induction (Lux -) and induction at t=0 (Lux (0));
and Non-functional DNA (K323039) both without arabinose induction (NF -) and induction at
t=0 (NF (0)). Readings of OD 600 and GFP taken every hour and estimations of production
rate made using standard equation between readings an hour apart (a) OD, (b) GFP divided
by OD, and (c) Estimated GFP production rate. Error bars show standard deviations over 3
repeats.
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4.2.2 Changing Induction Time
To identify if the drop in monitor output rate was due to a lag caused by transcription or due
to a shift in the growth rate, arabinose was added to the medium at different time points. If
the timing of the drop in GFP production was due to an expression delay we would expect the
timing of this drop to shift with induction time. If it was linked to a shift in growth rate we would
expect the decrease to occur consistently at the same time. More experiments were performed
(not shown) with different induction times and it was observed that there was no significant
difference in the behaviour between Lux and Luciferase device-containing cells and therefore
in further experiments only Lux device cells were used.
In the next investigation, arabinose was added to the cells in LB medium at 0, 2 and 4 hours
after the start of the experiment, meaning induction occurs before, approximately at the time
of and after the shift in growth rate. The results (Figure 4.5) show that Lux-expressing cells
induced at 0 and 2 hours drop in monitor GFP production at the same time, just after the shift
in growth rate. Cells induced at 4 hours maintain the same GFP production rate as uninduced
cells for approximately half an hour after induction after which GFP production drops in line
with cells that had been induced earlier. This means that before the shift in growth rate cells
do not see a significant burden due to expression of extra protein from the AraBAD promoter.
However, ‘at the shift’ cells producing extra protein see a decrease in GFP production from the
capacity monitor by 30-40% within 45 minutes, indicating that the change in carbon source is
causing the burden to manifest.
The hypothesis is that from 0-2 hours the carbon source primarily like to be used is maltose,
which inhibits AraBAD activity, but after this point all of the maltose is used up and the AraBAD
unit is not longer repressed. Any induction between 0-2 hours only causes an decrease in GFP
production after 2 hours because the induction is negated by the presence of maltose, but any
induction after 2 hours causes a decrease in GFP production right away.
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(a) Growth Curve - Lux Device (b) Growth Curve - NF Device
(c) GFP Production - Lux Device (d) GFP Production - NF Device
Figure 4.5: Growth and estimated GFP production rates in LB with arabinose induction at
t=0,2,4 for cells containing plasmids with AraBAD controlled Lux operon - graphs (a) and (c) -
and non-functional DNA - graphs (b) and (d). Readings of OD 600 and GFP taken every hour
and estimations of production rate made using standard equation between readings an hour
apart. (a), (b) OD readings shown with DH10B cells as a negative control for cells containing
Lux operon and non-functional (NF) DNA respectively, and (c), (d) estimated GFP production
rate for cells containing Lux operon and non-functional (NF) DNA respectively. ‘-’ suffix indicates
no induction and numbers in brackets indicated time of induction in hours after experiment
started. Red lines indicate times of arabinose induction. Error bars show standard errors over
3 repeats.
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4.2.3 Using Alternative Media and Carbon Sources
In order to understand fully the impact of different carbon sources used by the cell it is nec-
essary to use a defined medium where carbon sources are controlled. LB is an undefined
medium with a large, undefined mixture of carbon sources [14]. M9 is a widely used defined
medium which can be supplemented by various carbon sources and amino acids. The impact
of the induced circuit on the cell was first tested in supplemented M9 medium with 0.4% glu-
cose, a highly favourable carbon source for E. coli growth. In this medium we see no significant
drop in growth rate or GFP production for cells induced at any time point (see figure 4.6). Since
there is a single carbon source there is less likelihood of a shift in the proteome during a growth
curve and the culture will simply run out of carbon source and no longer be able to grow. Figure
4.6 shows that cells grown in M9 with glucose containing the Lux circuit show no drop in GFP
production, even after induction with arabinose. This is likely to be due to the fact that glucose
acts as a repressor of AraBAD and means that no protein is produced from the Lux circuit (i.e.
the induction fails).
(a) Lux Device (b) NF Device
Figure 4.6: Estimated GFP production rates in supplemented M9 + 0.4% glucose with arabi-
nose induction at t=0,2,4 for cells containing plasmids with AraBAD controlled Lux operon -
graph (a)) - and non-functional DNA - graph (b). ‘-’ suffix indicates no induction and numbers in
brackets indicated time of induction. Red lines indicate times of arabinose induction. DH10G
are DH10B cells containing capacity monitor.
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In order to separate 1) impact of carbon source shift and 2) extra protein production from the
circuit we design an additional experiment. In this experiment we observe the GFP production
rate of cells grown in M9 with glycerol for 6 hours as well as cells grown in M9 with glucose and
then shifted into M9 with glycerol after 2 hours.
For cells grown in M9 with glycerol a drop in GFP production rate is observed approximately
half an hour after induction for each of the induction times (see figure 4.7d). This drop is to 30-
40% of the GFP production rate of untransformed DH10G cells. Since there is no shift in carbon
source and the cells have been diluted into fresh medium the cells do not need to produce extra
protein to cope with alternative carbon sources and so we expect no burden effects due to this
factor. This indicates that this burden is solely from the burden due to heterologous protein
production.
Alongside this experiment we also tested how the cells behaved when initially grown in supple-
mented M9 with glucose (at 0.04%) and diluted into medium containing glycerol as the carbon
source (glucose runs out at approximately 2 hours when provided at 0.04%, at which time the
cells were diluted into supplemented M9 medium with 0.4% glycerol). In this situation, cells that
were induced at 0 hours showed no drop in GFP per cell until after the shift in carbon source
(see figure 4.7c). GFP production rates for these cells drop to approximately 20% relative to un-
transformed DH10G cells which is a greater decrease than for cells that have not experienced
this diauxic shift.
This shows that cells that have not required a shift in their proteome to cope with a shift in car-
bon source still display a drop in capacity monitor output when heterologous protein production
is induced, therefore the monitor is certainly able to detect the increase in burden on shared
resources required for this production. A shift in carbon sources requires the cell to produce
additional proteins to survive, and this experiment shows that our monitor is able to detect this
extra burden caused by a compounding of this increase in cellular protein production with the
burden from heterologous protein production.
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(a) Growth Curve - Glucose -> Glycerol (b) Growth Curve - Glycerol -> Glycerol
(c) GFP Production - Glucose -> Glycerol (d) GFP Production - Glycerol -> Glycerol
Figure 4.7: Growth and GFP production rates in supplemented M9 with arabinose induction at
t=0,2,4 and dilution at t=2 (but not 4 hours) for cells containing plasmids with AraBAD controlled
Lux operon. In (a) and (c) cells were initially grown in M9 + 0.04% glucose and diluted into M9
+ 0.4% glycerol at 2 hours and in (b) and (d) cells were initally grown in M9 + 0.4% glycerol and
then diluted into fresh M9 + 0.4% glycerol. (a), (b) OD readings with DH10B cells as a negative
control, and (c), (d) estimated GFP production rate, normalised against DH10G grown in same
conditions. ‘-’ suffix indicates no induction and numbers in brackets indicated time of induction.
DH10G are DH10B cells containing capacity monitor. Red lines indicate times of arabinose
induction. Green line indicates time of dilution.
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As we have seen, there is a difference between how the capacity monitor responds to the
expression of protein from a synthetic circuit in different carbon sources. In glucose we do not
observe a significant drop in monitor output upon the induction of the Lux device, however in
glycerol there is a significant drop in monitor output upon induction. In addition to the presence
of this ‘burden’ another difference we see between cells grown in the different carbon sources
is the rate of decline of GFP production from the capacity monitor in cells with no additional
synthetic circuit. Figure 4.8 shows that after having approximately the same GFP production
rate in the second half hour of growth, for cells grown in glycerol this declines to approximately
75% relative to cells grown in glucose at t=1.5-2 hours. After dilution into fresh medium both
sets of cells recover to the same GFP output levels at t=3-3.5 hours after which they appear
to decline again at approximately the same rate. Since dilution into new medium allows the
recovery of GFP output, we hypothesise that it is the depletion of resources which causes this
decrease. It may be that it is the carbon source itself which is running out, however it may also
be the case that cells using glycerol as their carbon source may use some nutrients at a higher
rate. In order to identify which resource this might be, rather than diluting into fresh medium we
could add different nutrients, such as carbon source or amino acids, to the cells to see which
induces recovery of GFP output. Additional experiments (not shown) indicated that fructose
was a carbon source that could be used without affecting the induction of the AraBAD promoter
unit.
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Figure 4.8: GFP production rates in supplemented M9 with dilution at t=2 (with carbon sources
before/after: glucose/glycerol and glycerol/glycerol) for cells containing only capacity monitor
and no additional synthetic circuits. Green line indicates time of dilution.
4.3 Conclusion
From the results shown in this chapter we can see that our monitor is able to fulfil all of the key
requirements outlined in Section 3.2. We are able to use the GFP production rate (as estimated
using GFP fluorescence and OD 600 time series readings) as a capacity monitor to estimate
the amount of shared resources available within the cell. These quantifications allow us to
make dynamic estimates of the capacity in the cell and observe a decrease in cellular capacity
within half an hour after the induction of a synthetic gene.
This has been achieved by placing a constitutively expressed, fully synthetic gene into the
genome of E. coli DH10B at the λ-site. By placing the monitor into the genome we have ensured
that it is compatible with any synthetic circuit that 1) does not express GFP and 2) does not use
kanamycin resistance for selection. The use of sfGFP as our monitor output means it is highly
portable and can be used by any researcher with access to GFP fluorescence quantification
equipment. We have also shown that by placing the monitor device into the genome we have
minimised the impact on the cell, specifically by not changing the growth rate relative to DH10B
cells without the monitor device.
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Through a series of experiments we have been able to establish that the phenomenon being
quantified by the monitor device is the use of shared resources by a synthetic circuit. We
have also been able to observe the additional resources being used by the chassis cell in
order to cope with a change in carbon source. Both timing and medium choice have been
important in these experiments as some of the carbon sources used have caused interactions
with the synthetic circuit that mean the induction does not occur at the correct time. In order to
avoid these interactions, in subsequent experiments fructose was used as the carbon source
in defined M9 medium.
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Chapter 5
Results: Effects of Gene Expression
Control Points on Cellular Burden
5.1 Introduction
After constructing our capacity monitor and confirming that we were able to detect the produc-
tion of heterologous protein using it we decided to use it to understand how different design
strategies could affect the amount of burden placed on a cell.
We designed a combinatorial library where we altered a number of gene expression control fea-
tures (plasmid backbone, promoter, RBS and codon usage) in order to gain an understanding
of how altering these impacted on circuit output and the burden it induces.
5.2 Protein Expression Control Points
There are a number of points in a genetic circuit that can be altered in order to change the




The number of copies of the circuit that exist in a cell. This can be altered by changing the
way the circuit is inserted into the cell. Generally a genomic insertion will have the lowest copy
number as it is inserted into a single point in the genome of the host cell. This copy number
can change dependent on the location on the genome and the growth rate of cells [70]. Different
plasmid-based insertion systems will have different copy numbers that will be dependent on the
origin of replication used [70] (or the amount of an inducer for inducible copy number plasmids)
as well as growth rate [70]. Changing the copy number can have a profound affect on the amount
of protein production as well as the level of impact the synthetic circuit has on a cell. The
Registry of Standard Parts advises:
“Oftentimes, it pays to use a different set of plasmid backbones for operating or
running your BioBrick device or system than you use for assembly. For example,
some BioBrick devices and systems consume too many resources when operated
on a high copy plasmid backbone and significantly impact cell growth. In those
cases, you might want to switch to a low or medium copy plasmid backbone.” [2]
This quote applies not only to copy number, but is also indicative of the precise problems this
project is looking to understand.
5.2.2 Promoter
The promoter used in expressing a gene has a number of important characteristics. All bacterial
promoters require a sigma factor to be present in order to initiate the transcription of RNA
molecules. Different sigma factors are present under different conditions, such as σ70 which is
present in exponential growth [72] or σ54 which controls nitrogen regulated genes [19]. In addition,
many promoters are either inducible or repressible under the presence of a protein, or protein-
substrate complex and are very useful in regulating the amount of transcription that occurs
from a promoter. Finally there is the maximal output of the promoter, which is a measure of
the amount of transcription that occurs from that promoter under maximal induction, minimal
repression or under constitutive expression (dependent on the nature of the promoter). Recent
techniques have allowed the creation of promoter libraries that have varying strengths [32], which
can be particularly useful if one wants to maintain the same regulatory characteristics of a
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promoter whilst varying its maximal output [32].
5.2.3 Ribosome Binding Site (RBS)
The strength of an RBS dictates the rate at which translation initiation on an mRNA occurs. The
strength is a function of the availability of the RBS to be bound by a ribosome, the binding affinity
between ribosomes and an mRNA, and the rate at which elongation is initialised. Numerous
tools exist for both the forward and reverse engineering of RBS sequences with respect to
strength [85,69].
5.2.4 Codon Usage
The selection of codons used to encode a protein can play an important part in the efficiency
and rate at which proteins are produced from mRNA transcripts. Of the 20 natural amino acids,
18 can be coded for by at least two different codons, and 10 of those have 3 or more potential
codons. The codon used to encode for a specific amino acid affects the rate at which amino
acids are added to a protein and therefore how rapidly ribosomes move along the transcript.
It has been shown that the choice of DNA sequence chosen to encode a given amino acid
sequence can greatly impact protein production rates [102] as well as cause other phenomena
such as ribosomal stalling [66].
5.3 Optimisation of Gene Expression
There exist a number of tools for ‘optimising’ gene expression. These tools include the DNA2.0
codon optimisation algorithm that designs the sequence of a coding region to maximise pro-
tein production, and the Salis RBS calculator which allows researchers to forward and reverse
engineer RBS sequences with respect to the rate at which translational initiation occurs. How-
ever, these are generally ‘maximising’ approaches whereby they are designed to maximise
the expression of a gene. For example, the DNA2.0 technique is designed to provide a DNA
sequence that maximises the amount of protein produced per transcript [44]. The Salis RBS
calculator allows users to select a specific desired RBS strength to have an RBS designed to,
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Figure 5.1: Control points for gene expression are shown, as well as how they affect different
processes in the central dogma (dashed lines) of protein production from DNA.
It is well known that overexpression of heterologous protein can have deleterious effects on a
host cell [30]. ‘Optimisation’ of the control points by simply by attempting to maximise protein
output can often lead to a slower growth rate, and subsequently a decreased rate of production
of the desired product. Usually the researcher must then use a trial and error approach to
change some other control points that have not been ‘optimised’ to improve the circuit so that
growth is less impacted and output is recovered.
In this project we are also addressing other types of optimisation, such as investigating how we
can minimise the impact a synthetic circuit has on shared resources for a given output. This is
important for a number of reasons. It is known that interactions between a synthetic circuit and
its host cell can have adverse effects on the circuit behaviour, causing it to ‘break’ in a number
of ways such as causing cell death [30] or circuit evolution so that function is diminished [94,93].
By minimising the burden placed on the cellular resources we can increase the likelihood of
circuits behaving as designed. In addition, if we design two parts of a circuit and characterise
them in isolation, we know that expression from one circuit can reduce the resources available
to the second and can affect its behaviour, again potentially ‘breaking’ the circuit. Minimising
the resource usage from both circuits will increase the likelihood that they both behave as
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predicted when used together and minimise the potential growth advantage to any cells that
mutate to remove the circuit function (and thus after a number of generations create populations
dominated by cells without the fully functional genetic circuit).
Since the shared resources we are talking about in this project are of many different types,
it is also important to understand how heterologous gene expression impacts these different
resources (or at least groups of resources). Optimising circuits to minimise the impact on
shared resources is a highly non-trivial problem since lowering the amount of one resource that
a circuit uses may cause the amount used of a second resource to increase. Understanding
the balance between different types of resources and how they affect the behaviour of the cell
and of additional synthetic circuits is crucial.
5.3.1 Key Metrics
In order to understand how changes in the control points we have mentioned impact upon these
different resources we need to make sure we clarify the key metrics we are both interested in
and able to measure. There are a number of quantities that we are interested in with regards
to the circuit behaviour, such as:
1. DNA copy number (DNA replication rate).
2. RNA per cell/RNA production rate (transcription rate).
3. Protein per cell/protein production rate (translation rate).
These metrics then have a knock-on effect on global cellular factors such as growth rate, con-
tents of the transcriptome or contents of the proteome, as well as many others. These inter-
actions with global cellular factors occur predominantly through the shared resource pool. This
section of the project takes a look at how altering these control points affects the cell and other
synthetic circuits by utilising the monitor we described in Chapter 3.
From the sort of biological scheme outlined in figure 5.1 we might simply assume that changing
copy number affects the amount of DNA polymerase usage, changing promoter strength affects
RNA polymerase usage and RBS and codon usage affect the amount of ribosomes being used
alone. The actual picture is much more complex and these additional complexities manifest
themselves in many forms, including relatively obvious phenomena such as copy number and
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promoter strength affecting the ribosomal usage, all the way to less intuitive interactions such
as certain different combinations of RBS and promoter giving the same protein production rate
whilst altering ribosomal usage.
In addition to these circuit metrics, we are interested in a number of cellular metrics. These
allow us to look at how the impact of a synthetic circuit on shared resources translates into
changes in native cellular functions and behaviours. The metrics we will be looking at in terms
of the cell are:
1. Growth Rate.
2. Total RNA amount per cell.
3. Total protein per cell.
5.4 Test Circuit Design - Specifications
In order to test the impact of the control points mentioned above on both protein output and the
impact on cellular resources we designed a combinatorial library of test circuits with a number
of different plasmid backbones, promoters, RBSs and codon usages.
As with our monitor we had a number of specifications which needed to be met for a useful
library of test constructs.
5.4.1 Compatiblity with Monitor
Clearly our test circuits need to be compatible with the monitor we have designed and imple-
mented. This requires taking into consideration a number of points such as:
• Monitor uses GFP as output, making this an inappropriate reporter from the test circuit.
• Monitor is integrated into the genome along with a kanamycin resistance marker, therefore
our test circuit cannot use the kanamycin resistance marker.
• Monitor is inserted into the λ-site of the genome meaning that the expression system for
the test devices cannot be a genomic integration into this site.
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Aside from these limitations, the design of our monitor system means we have a large amount
of freedom in terms of how we implement the circuits.
5.4.2 High Levels of Burden Caused at Maximal Expression
In order to understand how a synthetic circuit impacts a host cell across a wide range of expres-
sions we want to ensure that at the highest levels of expression our circuit is using large amount
of cellular resources. This can be done by ensuring that the ‘highest strength’ variants of each
of the control points we are investigating are ‘maximised’ using the techniques described in
Section 5.3. We will do this by implementing the following requirements:
• The highest copy number plasmid we use should be a ‘high copy number’ with a reported
abundance in the order of magnitude of hundreds of copies per cell.
• An inducible promoter should be used such that at its highest levels of induction induces
high rates of transcription. For example pBAD is known to have high levels of transcription
initiation at maximal induction levels [87].
• The Salis RBS calculator [85] will be used to design our strongest RBS to have a strength
of 100,000 au, which is close to the theoretical maximum.
• We will use a long gene (over 2kb) into which we can introduce both slow codons and
anti Shine-Dalgarno [58] sequences. Both of these motifs have been shown to reduce
translation rates [58,102] and it is not within the scope of this project to differentiate between
the effects of each (indeed, this is covered elsewhere in the literature), all we require is
the rate at which ribosomes move along the transcript to be decreased.
5.4.3 Easily Quantifiable Output
As with the monitor, we want to be able to easily and rapidly quantify the rate of protein output
from our test circuits. As mentioned above, fluorescent proteins are a commonly used method
for quantifying protein levels. As we see above, we require a circuit that will cause high levels
of burden at maximal expression levels and therefore want to use a large protein. In order to
quantify the amount of this large protein we can fuse a fluorescent protein to it using a small
peptide linker sequence.
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5.4.4 Minimal non-resource interaction with cell
We require the interaction with the cell and monitor to occur through the shared resource pool.
Therefore we must minimise the amount of non-resource-based interaction that occurs be-
tween the cell and test circuit. These undesirable interactions can be in the form of regulatory
mechanisms, metabolic mechanisms or toxic effects.
5.4.5 Simple Construction of Library
This investigation requires the creation of a large combinatorial library. In order to efficiently
create this library we must design our circuits in a way that allows us to simply and quickly
create all of the library members. There are a number of different construction techniques
currently available, ranging from restriction based ones to homology based recombination. We
must be pragmatic in our use of these techniques and ensure we are using the best techniques
for each part of the build process.
5.5 Test Circuit Design - Implementation
Taking the factors mentioned above into consideration we designed a test circuit that consisted
of a single fusion protein expressed from an arabinose inducible promoter unit.
5.5.1 Plasmid Backbones
We chose two plasmid backbones to use in this project that differed in copy number. In order
to be compatible with the monitor, we chose to use antibiotic resistance markers for Chloram-
phenicol and Ampicillin. The plasmid backbones used were:
• pSB1C3 - High copy number BioBrick plasmid backbone with chloramphenicol resistance
and pMB1 origin of replication.
• pSB3C5 - Medium copy number BioBrick plasmid backbone with chloramphenicol resis-
tance and p15A origin of replication.
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5.5.2 Promoter
We decided to use an arabinose inducible promoter unit AraBAD as in Chapter 3. More details
of this promoter can be found in Section 4.1.3.
In addition to being strong and inducible, another key advantage of using the AraBAD promoter
unit was that there exist a characterised library of variants of the PBAD promoter [5]. This allowed
a PBAD variant that had increased output to be quickly and easily identified. This meant it was
possible to use two versions of PBAD that had different activity levels. The promoter we used
from the library at DTU Denamark 2011 iGEM page was version 3 [5]. The sequence differences
between these two variants can be see in Figure 5.2.
It must be noted that whilst the wild-type version of PBAD is a strong promoter when compared
to other native E. coli promoters, it is weaker than the PBAD variant being used and therefore
will be referred to as the ‘weak promoter’ throughout the rest of this chapter.
-10 region
-35 region
Figure 5.2: Alignment of PBAD Versions - Red bases indicate differences between weak (wild-
type) PBAD sequence and strong PBAD sequence. The green and blue boxes indicate the -35
and -10 regions respectively. There is one base mutation in the -35 region and three in the -10
region with no mutations outside of these regions.
Characterising the variants
As mentioned at the end of the previous chapter, all experiments for this chapter are performed
in M9 medium supplemented with 0.4% fructose as this carbon source avoids any unintended
repression of the AraBAD promoter unit due to carbon source. The cell strains used were,
unless otherwise stated, DH10B (an industrially relevant E. coli strain and DH10G (DH10B
cells with the monitor device inserted into the λ-site in the genome).
Before using these promoters, their activity levels were characterised by using them to express
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mCherry and comparing the protein production rates. This was done by designing a RBS se-
quence using the Salis RBS calculator [85] (with predicted strength of 20,000au) in a pSB1C3
backbone transformed into DH10G. These two strains were grown for 6 hours in M9 medium
supplemented with 0.4% fructose along with DH10B and DH10G as controls. Measurements
of OD, GFP fluorescence and red fluorescence were taken at 30 minute intervals. These mea-
surements were used to estimate protein production rates and infer promoter strengths using
the methodology described in Section 2.15.
Relative activity rates were calculated by taking the relative RFP production rate for each time
interval between 2 hours and 8 hours and taking the mean of these relative strengths. The
low standard deviations seen in Figure 5.4 show that these relative promoter strengths are
maintained over the whole growth curve.
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(a) Monitor output as represented by GFP production rate
(b) Promoter activity as represented by mCherry production rate
Figure 5.3: PBAD Characterisation. Vertical red lines indicate dilution into fresh medium 2 hours
after induction a) monitor output as represented by GFP production rate b) promoter activity
as represented by mCherry production rate. ”-” denotes uninduced construct and ”+” denotes
arabinose induced construct. All mCherry constructs tested were transformed into DH10G.
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Figure 5.4: Relative promoter strengths of PBAD variants. Average of relative strengths across
all time points between 2 hour and 8 hour measurements as shown in Figure 5.3. Error bars
show standard deviations.
Name DTU iGEM Version ON Activity (relative) OFF Activity (relative)
Strong PBAD 3 2.42± 0.17 0.12± 0.02
Weak PBAD wt 1± 0.04 0.06± 0.01
Table 5.1: Characterisation data for PBAD variants, including activity in ON (full induction) and
OFF (no induction) states. ± indicates the standard deviation from the mean value.
Figure 5.4 shows the calculated relative mCherry production rates for the two promoter variants.
It can be seen that when induced, the activity of the strong version of PBAD is 2.42 times as
strong as the weak (wt) version (see Table 5.1 for details).
5.5.3 RBS
The Salis RBS calculator [85] was used to design RBS sequences with a range of strengths. The
strengths designed were as shown in table 5.2. Since the RBS calculator is not fully accurate
in its predictions, it is usually recommended that 2 sequence designs are ordered for each
strength. Since it was only necessary to create a library of RBSs with strengths from weak to
strong rather than with specific strengths, it was not required that the RBS sequences designed
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correlated directly to their predicted values. The primary requirement was that the RBSs used
had a range of strengths that include a very high RBS strength. In order to do this, 6 potential
RBSs were designed and run through preliminary screening to obtain a small library of 3 RBS
sequences with sufficiently different strengths.
We are not able to get accurate estimates for the relative RBS strengths since changing the
RBS strength has a number of additional affect on shared resources (which is exactly what this
project is looking to address). Therefore we chose the 3 RBS variants that gave a wide range of
outputs and behaviours. The results for the RBS characterisation can be seen in Section 5.7.7
where there is a full characterisation of the impact of RBS strength on circuit output, growth





Table 5.2: RBS strength as predicted by the Salis RBS calculator
5.5.4 Coding Region
The protein we chose to use is VioB, which is the second protein in the Violacein pathway and
catalyses a reaction that dimerises indole-3-pyruvic acid imine (IPA imine) into IPA imine dimer.
From a search of the E. coli Metabolome Database (ECMDB) and the Kyoto Encyclopedia of
Genes and Genomes (KEGG) we have ascertained that neither the substrate nor the product
of this reaction are naturally present in E. coli. This means that this enzyme should not interact
with the native metabolism of the host cell, i.e. it is orthogonal. VioB is a bacterial protein from
Chromobacterium violaceum, which along with E. coli is a gram-negative bacteria and VioB is
not known to cause any toxic effects on E. coli.
the vioB gene is 2994 bp long (VioB is a 998 amino acid protein) and has been codon opti-
mised by DNA2.0 for the 2009 Cambridge iGEM team (BioBrick number K274002). This codon
optimised version forms the ‘fast codon’ version of the coding region and the ‘slow codon’ ver-
sion has all of the argenine, isoleucine, leucine and proline genes between 2772 bp and 2952
bp replaced with ‘slow’ versions (AGG, ATA, CTA and CCC respectively) as well as anti Shine-
Dalgarno sequences [58] (see Figure 5.5).
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Anti Shine-Dalgarno sequence
Figure 5.5: Comparison of the sequence of slow and fast codon versions of vioB between 2721
bp and 2994 bp. Top sequence is codon optimised vioB and bottom sequence is vioB with slow
codons and anti Shine-Dalgarno sequence inserted. Blue highlighted region indicated anti
Shine-Dalgarno sequence and red bases indicate mismatches between the two sequences.
In order to easily quantify this protein, it has been tagged with a red fluorescent protein (BioBrick
E1010). This is a fluorescent protein that has an emission wavelength in the red spectrum and
does not overlap significantly with the GFP spectrum, meaning it can be accurately quantified
when in the same system as GFP proteins (the monitor). The amino acid sequence of the
linker is AEAAAKEAAAKEAAAKA and is suggested as a suitable linker for bifunctional fusion
proteins by Arai et al. [10].
5.6 Final Design
In total, the library of constructs included combinations of:
1. 2 plasmid backbones
2. 3 RBS sequences
3. 2 promoter sequences








































































































Figure 5.6: Library of constructs being used in this chapter consists of all combinations of
medium or high copy backbone (as indicated by text), RBS strength (dark red, medium red and
light red represent strong, medium and weak RBS respectively), promoter strength (dark and
light blue represent strong and weak promoter respectively) and codon speed (green arrow and
red arrow in CDS indicate fast and slow codons respectively).
This is a total of 24 constructs that were characterised both induced and uninduced, and the
results of these characterisations are shown through the remainder of this chapter. All the
combinations and construct names are shown in Figure 5.6.
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Figure 5.7: Plasmid map showing reference construct with pMB1 origin and CmR resistance
marker in the pSB1C3 backbone. AraC, Pst and Weak PBAD form the AraBAD promoter unit
and the VioB (Fast) is the codon optimised version of VioB tagged to mCherry.
In order to make reliable comparisons a reference construct was chosen that could be com-
pared against for changes in each of the control points. This construct is referred to throughout
this results chapter as the reference construct (see Figure 5.7 for the plasmid map) and has
the following properties:
1. Weak (wild-type) PBAD promoter.
2. Medium RBS
3. High-copy plasmid pSB1C3
4. Fast codon design
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5.7 Reference Construct Characterisation
The full characterisation of the reference construct is shown here, where the full data on the
following variables is shown over a time series:
1. Total OD
2. Growth Rate
3. Total monitor protein
4. Monitor protein per cell
5. Monitor protein production rate
6. Total circuit protein
7. Circuit protein per cell
8. Circuit protein production rate
Using this information we explain how we move towards a single time point of key metrics to
represent the circuit characterisation in the rest of this thesis.
5.7.1 OD and Growth Rate
Untransformed DH10G and both induced and uninduced DH10B cells transformed with refer-
ence construct H07 were grown over a period of 3 hours in M9 medium supplemented with 0.4
% fructose. OD readings were taken every 10 minutes and growth rates were estimated over a
1 hour moving window using Equation 3.1.
Figure 5.8a shows the growth curves for DH10G with no additional circuit as well as DH10G
cells with the H07 reference circuit both induced and uninduced. It can clearly be seen that
empty DH10G cells are at a higher OD at all time points, including the initial time point. The
induced and uninduced cells containing the circuit start at very similar ODs but diverge as the
cells grow, indicating that the induced cells grow at a slower rate compared than those that are
uninduced. At 160 minutes after induction there is a jump in the average OD of uninduced cells
that does not conform to the trajectory of the curve up until this point. There is also an increase
in the standard deviation and upon closer inspection of the underlying data it is apparent that
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this is due to a single sample having a high OD reading, most likely an error in the reading. Due
to the differences in starting OD this graph does not show clearly the difference in the growth
rate of empty DH10G cells compared to uninduced cells containing the reference construct.
Figure 5.8b shows the calculated growth rates over a 60 minute window (30 minutes either side
of the corresponding time point shown on the x-axis). It can be seen that DH10G cells without
a circuit grow at the highest rate, confirming what Figure 5.8a indicates. This means that the
maintenance of the plasmid containing the circuit as well as the expression of the antibiotic
resistance marker (chloramphenicol resistance) causes a slight decrease in the growth rate.
The increase in average growth rate for uninduced reference strain cells at 130 mins (average
growth rate between 100 and 160 mins) is an artefact of the erroneous measurement of the
sample at 160 mins mentioned above.
It can be clearly seen that upon induction the growth rate of induced reference strains cells
decreases relative to the uninduced ones. This means that the extra production of protein is
causing a decrease in the growth rate of the induced cells.
The dashed vertical green line in Figure 5.8b indicates the mid-point of the interval at which a
snapshot of growth rate is taken (between 100 and 160 minutes). This can be seen in Figure
5.11a, where growth rate is shown alongside a snapshot of the monitor output taken over the





Figure 5.8: OD and Growth Rate Comparison for Reference Construct. DH10G and both
induced and uninduced DH10G cells transformed with reference construct grown in M9 + 0.4%
fructose for 3 hours continually in 96-well plate with 200 µl volume per well. Readings taken
every 10 minutes and rates estimated over a 1 hour moving window. a) OD levels b) growth
rate calculated over 60 minute window, dashed green line indicates time of growth rate, monitor
output and circuit output snapshot. 115
5.7.2 Monitor Output
As in the previous section, DH10B, DH10G and both induced and uninduced DH10G cells
transformed with reference construct H07 were grown over a period of 3 hours in M9 medium
supplemented with 0.4 % fructose. OD and GFP fluorescence readings were taken every 10
minutes and GFP production rates were estimated over a 1 hour moving window using Equation
3.5.
Figure 5.9a shows the average total amount of GFP fluorescence per culture. Empty DH10G
cells clearly have the largest amount of total GFP and the distance between the DH10G curve
and that of the uninduced reference construct strain increases, meaning that the total amount
of GFP production is greatest for DH10G cells. Both the induced and uninduced reference
strains have the same initial total GFP as they are dilutions from the same starting culture and
have not had any time after being induced to develop distinct phenotypes. After approximately
one hour the curves start to noticeably diverge and it can be seen that the total amount of GFP
being produced by the uninduced reference strains is higher than the induced ones.
This graph does not contain enough information to understand the differences between the
monitor output for the different strains. This is because the effect of the number of cells pro-
ducing GFP (OD) is not taken into account. Figure 5.9b shows the calculated amount of GFP
per cell (GFP fluorescence divided by OD). At the start of the growth the amount of variance is
large, due to dividing by small ODs where small amounts of noise due to measurement errors
can have a large impact. After approximately 90 minutes a clear trend emerges in terms of the
amount of GFP per cell where DH10G cells have the most GFP per cell, uninduced cells con-
taining the reference construct have approximately 80% of the GFP per cell and induced cells
containing the reference construct have slightly greater than 50% of the GFP per cell compared
to empty DH10G cells.
Figure 5.9b also does not contain enough information to tell what the monitor output is for the
different strains as it does not take into account the dilution rate (cellular growth rate) of the GFP
protein. Figure 5.9c shows the calculated GFP production rate per cell for the three different
strains. These calculations were made using Equation 3.5. Again, only after approximately 90
minutes does a clear trend emerge.
The dashed vertical green line in Figure 5.8b indicates the mid-point of the interval at which
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a snapshot of monitor output is taken (between 100 and 160 minutes). This can be seen in
Figure 5.11a, where growth rate is shown alongside a snapshot of the growth rate taken over
the same time interval. A snapshot of circuit output from the same time interval is shown in
Figure 5.11b.
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(a) Total Monitor Protein (b) Monitor Protein per Cell
(c) Monitor Output
Figure 5.9: Monitor Protein Comparison for Reference Construct. DH10G and both induced
and uninduced DH10G cells transformed with reference construct grown in M9 + 0.4% fructose
for 3 hours continually in 96-well plate with 200 µl volume per well. Readings taken every 10
minutes and rates estimated over a 1 hour moving window. a) total culture GFP fluorescence
levels are indicative of the total amount of monitor protein (GFP) in all cells b) amount of monitor
protein per cell is calculated by dividing the GFP fluorescence levels by the OD c) monitor output
(GFP production rate per cell) calculated over 60 minute window, dashed green line indicates
time of growth rate, monitor output and circuit output snapshot time point (100 mins). Error bars
represent standard error of the mean.
118
5.7.3 Circuit Output
As in the previous sections, DH10B, DH10G and both induced and uninduced DH10G cells
transformed with reference construct H07 were grown over a period of 3 hours in M9 medium
supplemented with 0.4 % fructose. OD and mCherry fluorescence readings were taken every
10 minutes and mCherry production rates were estimated over a 1 hour moving window using
Equation 3.5.
Figure 5.10a shows the total mCherry fluorescence for cells containing the reference construct,
both induced and uninduced. Approximately an hour after induction the total amount of circuit
protein for induced cells becomes noticeably higher than in uninduced cells. This corresponds
with the time required for increased transcription and folding of mCherry to take place after
induction. The fact there is a slight increase in the total amount of circuit protein over time even
for uninduced cells indicates that there is leakiness from the PBAD promoter, which can also be
seen from the characterisation data for the promoter (see Figure 5.4).
The amount of circuit protein per cell (Figure 5.10b) follows very similar trajectories, though the
rate of increase is slower due to the mCherry fluorescence being divided by an increasing OD.
Calculated production rates for the circuit protein are shown in Figure 5.10c. This shows that, as
expected, there is no mCherry fluorescence produced in the DH10G cells. The uninduced cells
show a level of protein production, which corresponds with the data seen in the above figures
and implies a leakiness from the PBAD promoter. The circuit output (rate of production of circuit
protein) for induced cells is approximately 5x higher than for uninduced cells. This suggests
there is a greater level of leakage from the uninduced PBAD promoter than would be predicted
from the characterisation in Section 5.5.2. The reason for this is likely due to RBS-promoter
interaction and is discussed further in Section 5.7.7.
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(a) Total Circuit Protein (b) Circuit Protein per Cell
(c) Circuit Output
Figure 5.10: Circuit Protein Comparison for Reference Construct. DH10G and both induced
and uninduced DH10G cells transformed with reference construct grown in M9 + 0.4% fructose
for 3 hours continually in 96-well plate with 200 µl volume per well. Readings taken every 10
minutes and rates estimated over a 1 hour moving window. a) total culture mCherry fluores-
cence levels are indicative of the total amount of circuit protein (mCherry) in all cells b) amount
of circuit protein per cell is calculated by dividing the mCherry fluorescence levels by the OD
c) circuit output (mCherry production rate per cell) calculated over 60 minute window, dashed
green line indicates time of growth rate, monitor output and circuit output snapshot time point
(100 mins). Error bars represent standard error of the mean.
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5.7.4 Key Metrics
Figure 5.11 shows the growth rates, monitor outputs and circuit outputs for DH10G cells con-
taining the reference construct H08 (see Figure 5.6) both induced and uninduced. The data
shown in these graphs corresponds to the data in Figures 5.8b, 5.9c and 5.10c at the vertical
green lines. These data are calculated over a one hour window 30 minutes either side of the
mid-point denoted on the x-axis (between 70 and 130 minutes centred at 100 minutes). This
approach is used throughout the rest of the data shown in this results section where time-series
plots are not shown but the column graphs all indicate the calculated values between 70 and
130 minutes.
In order to represent these data, we chose to visualise snapshot metrics in column graphs
rather than show the entire time series as by doing this it is much easier to visualise the differ-
ences when different circuits are used. Previous characterisation has shown by the time these
metrics are taken that the metrics have approximately reached a steady state as the cells grow
through mid-log phase. Therefore, these metric snapshots can be said to be representative
across all time points after approximately an hour of growth. The key results from this data
have been discussed in more detail above. Throughout the remainder of this results section
only these key metrics will be shown for the characterisation of the constructs.
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(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.11: Growth rate, monitor output and circuit output comparison for reference construct
at 100 mins. Taken as snapshot during growth in M9 medium supplemented with 0.4% fructose.
a) OD levels b) growth rate calculated over 60 minute window, dashed green line indicates time
of growth rate, monitor output and circuit output snapshot.
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5.7.5 Identifying Causes of Burden in Plasmid Based System
It is highly informative to understand where in the system we have designed most of the burden
on the shared resources is coming from. In order to do this, a set of different plasmids were
constructed and tested. These plasmids were:
• Empty pSB1C3 backbone
• pSB1C3 containing AraBAD promoter unit
• pSB1C3 containing full reference construct
Figure 5.12 shows that DH10B (no monitor) and DH10G (DH10B with monitor) cells have very
similar growth rates. pSB1C3, pSB1C3 with AraBAD and the reference construct all have
very similar monitor output and growth rate. The monitor output rates are approximately 20%
lower than DH10G cells and the growth rates are approximately 6-12% lower. The fact these
constructs all have very similar behaviours shows that this decrease is due to the presence of
the backbone.
The reference construct plasmid contains twice as much DNA as the empty pSB1C3 plasmid
and since they both impose very similar burden levels and have similar decreases in growth rate
relative to DH10G, it can be argued that the extra DNA replication machinery required does not
impose an extra burden on the cell. The difference in monitor output and growth rate when the
pSB1C3 plasmid is inserted into the cell is most likely due to extra burden placed on cells from
the expression of the resistance marker protein and origin of replication machinery.
5.7.6 Comparison of Promoter Strengths
Figure 5.13 shows the differences between two constructs with weak promoters and strong
promoters. These two constructs are identical except for the promoter used and they are high-
copy (pSB1C3 backbone) with fast codons and medium strength RBS. The weak promoter
version is the reference construct H08 whereas the strong promoter is construct H11.
It can be clearly seen that when the circuits are uninduced the amount of monitor output is
less for the strong promoter than the weak promoter (as shown by comparing the columns with
green outline and white fill). This indicates that an extra burden is being placed on the shared
resources by this construct even when it is not induced. Looking at the amount of protein being
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Figure 5.12: Growth rate and monitor output of reference construct parts, showing empty (no
monitor) DH10B cells, DH10G cells, DH10G cells containing the pSB1C3 backbone, DH10G
cells containing pSB1C3 backbone with AraBAD promoter unit, reference construct uninduced
and reference construct induced.
produced by the two circuits when uninduced it can be seen that there is a larger amount of
leakage from the strong promoter, causing more protein to be produced, which corresponds
with the decrease in monitor output for this construct (as shown by the columns with red outline
and white fill). The growth rates of the two constructs are similar and within the range of
standard deviations of each other (see columns with orange outline and white fill). This is a
clear example of where our monitor is able to outperform simple growth rate measurements in
terms of being able to detect burden on shared resources.
When the circuits are induced the strong promoter construct produces approximately 2.4x as
much circuit protein than when uninduced (see solid red columns). This causes a slight de-
crease in growth rate (see solid orange columns), though standard deviations overlap, and
a larger (approximately 70%) decrease in the amount of monitor protein produced (see solid
green columns). When compared to the induced weak promoter construct, there is an approx-
imate 40% increase in circuit output. The monitor output is approximately 25% less for the
strong promoter construct.
124
(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.13: Promoter strength comparison for reference construct and strong promoter variant.
Strong Promoter construct is H11 and Weak Promoter construct is reference construct H08.
a) Growth rate and monitor output for both constructs induced and uninduced. b) Circuit output
for both constructs induced and uninduced.
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Figure 5.14 shows data for different constructs to those seen above in Figure 5.13. These con-
structs also have high-copy backbones and fast codons but have high strength RBS sequences
(constructs H07 and H10 for weak and strong promoter respectively). These versions show no
leakage when the promoters are uninduced, which may be due to interactions between the
RBS sequence and the promoter region. Both of the uninduced constructs grow at exactly
the same rate and have the same monitor output which corresponds to neither producing any
protein through leakage.
When the constructs are induced, the strong promoter construct produces protein at a rate that
is approximately 50% higher. The rate of protein production is lower, however, than for the
constructs where the RBS strength is lower (see Figure 5.13). This characteristic of diminished
output from very strong RBS sequences is discussed further in Section 5.7.7. The Growth
rates for the two constructs are very similar at an approximate decrease of 40%. The monitor
outputs are both very similar at a decrease of protein production of approximately 95%. This
represents a very catastrophic impact on the shared resource pool for both promoter strengths
with the strong RBS. This implies that the difference in the amount of transcripts (which we
expect to be a two-fold difference from promoter characterisation - see Section 5.5.2) does not
cause a large difference in the total amount of ribosomes recruited onto the circuit transcripts,
but does affect the amount of protein produced.
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(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.14: Promoter strength comparison for strong RBS constructs. Strong Promoter con-
struct is H10 and Weak Promoter construct is H07. a) Growth rate and monitor output for both
constructs induced and uninduced. b) Circuit output for both constructs induced and uninduced.
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5.7.7 Comparison of RBS Strengths
The relationship between RBS strength, the rate at which a protein expresses and the amount
of cellular resources used to do so is a complex one. Figure 5.15 shows the key metrics for
three different constructs with varying RBS strength. These constructs are all on high-copy
plasmids and have the weak promoter version and fast codon coding sequence. The strong,
medium and weak RBS constructs are constructs H07, H08 and H09 correspondingly.
When the constructs are not induced there is a 15-20% decrease in the growth rate for the
cells with the medium RBS construct as well as a similar decrease in the amount of output from
the capacity monitor relative to the cells with either the weak RBS construct or the strong RBS
construct. Cells containing the medium RBS construct are producing protein from the circuit
even when uninduced, whereas cells containing the other constructs are not. This fits with data
seen in previous graphs where there is leakage from circuits with the medium RBS but not
from circuits with other RBS versions (compare Figures 5.13b and 5.14b for examples). When
characterising the two versions of the PBAD promoter (Figure 5.4), there was very little leakage
from either promoter. This is most likely due to an interaction between the medium strength
RBS sequence and the promoter region or polymerases which cause there to be this leakage
from the promoter.
Induction causes all circuits to start producing protein. As would be predicted from only know-
ing the relative strengths of the RBS regions, the weak RBS construct causes less protein
production than the construct with the medium strength RBS. This corresponds to a decrease
in both the growth rate and monitor output of approximately 15% and 60% respectively for the
weak RBS construct and 15% and 75% respectively for the medium RBS construct. This is
due to the same number of transcripts (from the same promoter induced at the same level)
loading ribosomes and initiating translation at different rates, with a higher rate of initiation for
the medium RBS and thus more ribosomes being sequestered from the free ribosome pool
onto transcripts and a decrease in ribosomal availability, which is then reflected in the rate of
protein production from the capacity monitor.
The strong RBS construct causes the largest decrease in monitor output and growth rate when
induced (approximately 95% and 40% respectively). This does not, however, correspond to a
circuit production rate that is higher than the weak and medium strength RBS constructs. This
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is most likely due to a catastrophic decrease in ribosomes leading to cell death for a portion
of the population (which would explain a simultaneous decrease in growth rate, monitor output
and circuit output across the population).
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(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.15: RBS comparison for reference construct and RBS variants. Weak RBS construct
is H09, Medium RBS construct is the reference construct H08 and Strong RBS construct is
H07. a) Growth rate and monitor output for all constructs induced and uninduced. b) Circuit
output for all constructs induced and uninduced.
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5.7.8 Comparison of Copy Numbers
Changing the copy number is achieved by changing the plasmid backbone into which con-
structs are placed. In this comparison we have focussed on the difference between circuits
placed in high- and medium-copy backbones since we expect there to be an order of magni-
tude difference in the copy number of these plasmids (100-300 and 10-12 copies per cell for
high- and medium-copy plasmids respectively). Figure 5.14 shows the key metrics for the ref-
erence construct in high copy pSB1C3 backbone compared to the same construct in a medium
copy backbone. Changing the plasmid backbone does not only change the amount of circuit
DNA present in the cell, it also impacts on the number of copies of the antibiotic marker as well
as the type and amount of any regulatory mechanisms required for the origin of replication.
The constructs tested in this comparison are the reference construct H08 and the equivalent
construct in a medium copy plasmid M08.
Both constructs being tested contain the medium strength RBS and therefore show leakage
(see Section 5.7.7 for more details) when uninduced. When uninduced, the medium copy
plasmid shows a higher growth rate. This is likely due to a number of factors, including the
lower amount of DNA replication resources required to maintain a lower copy number as well
as the lower amount of chloramphenicol resistance protein produced from a lower copy number
backbone. These differences are also reflected in the monitor output, where the higher copy
number plasmid produces GFP at a rate that is 15-20% less than the medium copy.
When induced, both constructs show a very similar proportional increase in circuit output rel-
ative to when uninduced (approximately 4.3 fold and 4.7 fold for high and medium copy re-
spectively). The rate of protein production for the medium copy construct is approximately 10%
lower than that from the high copy and the standard deviations of the two overlap significantly.
This could be due to there being less competition for resources from elements in the plasmid
backbone, such as the origin of replication, chloramphenicol resistance marker and constitutive
AraC from the AraBAD promoter unit. This shows that a lower copy plasmid is able to use suf-
ficiently little of the cells resources for replication and maintenance (RNA and protein for origin
and resistance marker) that there is enough capacity for the main circuit to generate protein at
a rate that is comparable to that of a much higher copy plasmid.
When induced, the growth rate of the medium copy plasmid drops by a larger amount than
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the high copy construct (16% compared to 10%) though the absolute growth rate remains
higher. The drop in monitor output is greater for the high copy constructs with a decrease of
63% compared to 56%. Whilst these figures show that the lower copy plasmid has a higher
growth rate, higher monitor output and lower circuit output, the differences are relatively small
compared to those seen when altering other control points and do not correspond to expected
values for an order of magnitude difference in copy number as reported. It would be useful
in future work to obtain accurate quantifications of copy numbers for each of these plasmid
backbones.
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(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.16: Copy number comparison for reference construct and medium copy variant. High
copy construct is H08, Medium copy construct is the construct M08. a) Growth rate and monitor
output for all constructs induced and uninduced. b) Circuit output for all constructs induced and
uninduced.
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5.7.9 Comparison of Codon Usage
Figures 5.17 and 5.18 show the impact of introducing slow codons and anti Shine-Dalgarno
sequence into the end of vioB, before the mCherry fusion. Figure 5.17 shows the key metrics
for the reference construct H08 as well as another construct that is identical apart from having
slow codons in the coding region (H02). It can be seen that when the circuits are uninduced the
growth rates are very similar, as are the monitor outputs (though the slow codon version has
slightly lower monitor output). The leaking output from the circuit is also very similar for both
constructs.
When the circuits are induced a much larger difference is observed. It can be clearly seen that
the slow codon construct performs ’worse’ across all metrics. The amount of protein produced
by the circuit is 36% less for the slow codon construct than the fast codon construct. In addition,
the growth rate and monitor output are lower for the slow codon construct by 22% and 42%
respectively. This is likely due to the slow codons causing ribosomes to move less quickly
along the transcript, meaning that the flux of ribosomes along the mRNA is lower, and the
circuit output is lower. The slow codons also mean that the amount of time each ribosome that
is recruited onto the transcript spends in elongation is longer and so for an equivalent rate of
translational initiation (i.e. same RBS strength) more ribosomes will be used up at any point in
time, thus meaning more ribosomes are sequestered from the free pool and the monitor output
decreases.
When the RBS strength is increased and the medium RBS is replaced with the strong RBS,
the fast codon version shows a very large decrease in monitor output, as discussed in Section
5.7.7. Ass seen in Figure 5.18, the cells containing the slow codon construct show approx-
imately zero output and very low decreases in monitor output and growth rate (8% and 4%
respectively) with overlapping error bars. This behaviour is very similar to what would be ex-
pected from cells that do not have a circuit present. This is most likely due to the circuit having
mutated so that the circuit element of the plasmid has been removed or no longer produces
protein. This adaptation shows that high RBS strengths combined with slow codons can cause
levels of burden that render cells unviable, meaning they evolve to cope with this.
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(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.17: Codon usage comparison for reference construct and slow codon variant. Fast
codon construct is reference H08, Slow codon construct is H02. a) Growth rate and monitor
output for all constructs induced and uninduced. b) Circuit output for all constructs induced and
uninduced.
135
(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.18: Codon usage comparison for strong RBS constructs. Fast codon construct is H07,
Slow codon construct is H01. a) Growth rate and monitor output for all constructs induced and
uninduced. b) Circuit output for all constructs induced and uninduced.
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5.8 Obtaining Similar Circuit Output with Different Burden Levels
It is important to not only investigate what the impact of changes in single controls points are
on the cell, but to also look at how changing different control points together can provide im-
provements in the system. Figure 5.19 shows how the 4 combination of 2 promoters and 2
RBSs allows a range of outputs and burdens from a synthetic circuit. It can be clearly seen that
strong promoters cause a higher circuit output than the weak promoter variants with the same
RBS, as well as a lower monitor output (higher burden on resources). Similarly strong RBS
constructs give higher circuit output and lower monitor output than the weak RBS constructs
with the same promoter.
An interesting result is that the construct with weak promoter and strong RBS (H07) has ap-
proximately the same level of circuit output as the construct with strong promoter and medium
RBS (H08). While the outputs are very similar for these constructs, the level of monitor out-
put is approximately double for the construct with the weak RBS and strong promoter (see
Figure 5.19a). This suggests that the weaker RBS/stronger promoter construct uses less re-
sources per protein produced than the stronger RBS/weaker promoter construct. The medium
RBS/strong promoter combination is more efficient - a term we explore further below.
The reason for this difference is most likely related to the efficiency of transcripts in terms of the
ratio between the average rate of protein production per transcript and the number of ribosomes
per transcript:
Efficiency =
Rate of circuit protein production (proteins per second)
Ribosomes used (average number of ribosomes across transcripts)
(5.1)
In terms of measurable quantities that we can use to estimate this efficiency we argue that the
rate of protein production can be used to represent the circuit output rate and the number of
ribosomes used can be approximated as the decrease in output from the burden monitor. The
denominator in our formula is the difference between the output when the circuit is induced
(Ci) and the output when uninduced (Cu). Similarly, the denominator is the difference between
the monitor output when the circuit is uninduced (Mu) and when it is induced (Mi). Using this





Figure 5.19b shows the calculated efficiencies for the different constructs. We can see that
for the two constructs with similar circuit outputs the one with the higher monitor output has
greater efficiency than the one with lower output. However, we also see that the growth rate for
the most efficient construct is slightly lower (the relationship between growth rate and monitor
output, circuit output and efficiency are discussed further in Section 5.11).
This result is interesting as it shows that using principles outlined in this project we can improve
the way circuits are designed to provide the same output whilst decreasing resource usage,
thus reducing ‘inefficiency’. This is discussed further in Sections 5.12 and 7.1.2.
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(a) Monitor Output and Circuit Output
(b) Growth Rates and Efficiency
Figure 5.19: Obtaining similar circuit output with different burden levels. This figure shows cir-
cuit output and monitor output for all four combinations of medium (stronger) and weak (weaker)




Figure 5.20 shows a comparison between a number of constructs that have been shown above
in Figures 5.13, 5.16 and 5.17. This figure given an overview of the impact of changing different
control points relative to the reference construct. Slow codons give no benefit in terms of growth
rate, monitor output or circuit output and in the context of this project it appears that it is always
beneficial to use a codon optimised coding region without slow codons or anti Shine-Dalgarno
sequences. The stronger promoter causes a slight decrease in both monitor output and growth
rate, but also causes a 40% increase in circuit output, therefore being a good design strategy
if circuit output is the most important consideration. Using a lower copy plasmid gives the best
growth rate and monitor output, both of which are higher than the empty DH10G cells.
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(a) Growth Rate and Monitor Output
(b) Circuit Output and Efficiency
Figure 5.20: Overview of key metrics for reference construct and similar constructs shows how
changing the codon usage, promoter strength and copy number affect a) monitor output and
growth rate and b) circuit output and efficiency. Reference Construct H08, Slow Codons H02,
Strong Promoter H11, Medium Copy M08.
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5.9 MG1655 - Impact of the Stringent Response
So far all of the circuits tested have been characterised in DH10B cells. As mentioned previ-
ously, these cells do not have the stringent response phenotype (see Section 1.1.5 for more
details) and therefore would be expected to behave differently when experiencing ‘burden’. We
performed the same testing protocol used above for DH10B cells on MG1655 cells that had a
capacity monitor inserted into the genome. The circuits tested were all versions with high-copy
backbone and medium strength RBS.
Figure 5.21a shows the monitor output and growth rate for untransformed MG1655 cells as
well as ones transformed with the constructs detailed above. It can be clearly seen that when
uninduced the cells with fast codons have no drop in growth rate, whereas cells containing the
slow codon constructs have a decrease of approximately 5%. However, we see a large de-
crease in the rate of monitor output with cells containing the weak promoter/fast codons circuit
decreasing by approximately 50% and all others decreasing by approximately 90%. When we
consider the level of leakage of the circuit, as shown in Figure 5.21b, we see that the weak
promoter/fast codons circuit has very little leakage, whereas the others have a noticeable level
of leakage.
When looking at the induced circuits, the rate of circuit output for the fast codon constructs as
higher than for the corresponding slow codon circuits, which matches what we have observed
in DH10B cells. In addition, the growth rate of cells containing slow codon circuits is also
lower compared to those containing fast codon circuits. For the strong promoter circuits the
fast codon circuit has an output which is is an approximately 2.3x higher than the slow codon
circuit, whereas both the fast and slow codon versions have similar rates of circuit output for
the weak promoter.
These results indicate that MG1655 cells heavily down regulate the production of unneces-
sary protein when heterologous protein production is detected though the usage of shared
resources. However, when compared to DH10B cells, the level of circuit output is similar. This
indicates that the stringent response may be more effective at down regulating the production
of protein from genomic DNA compared to plasmid DNA since the monitor is present on the
genome while the circuit is plasmid based.
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(a) Growth Rate and Monitor Output
(b) Circuit Output
Figure 5.21: Snapshot of key metrics for MG1655G cells (MG1655 with capacity monitor) trans-
formed with all high copy/medium RBS constructs. Grown for 3 hours in M9 medium supple-
mented with 0.4% fructose in 200 µl volumes in 96-well plate. Snapshot taken at 100 minutes
after growth started. a) growth rate and monitor output, b) circuit output.
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5.10 Impact on RNA Levels
In order to separate the impact of expressing a synthetic DNA on the shared resource pool into
transcription and translation resources, RNA levels were quantified and compared to protein
levels. Total RNA levels per cell were calculated and are shown against growth rates in Figure
5.22 and are shown to be very proportional with an R-squared value of 92.7% when fitted with
a linear regression passing through the origin. This proportional relationship between cellular
RNA levels and growth rate is well known and was previously reported in [51].
Figure 5.22: Scatter diagram of cellular RNA levels (normalised against DH10G cells), as es-
timated by nano-drop of cellular RNA extraction, against growth rate for DH10G cells trans-
formed with reference construct H08 and strong promoter variant H11. RNA levels and growth
rate are taken after 3 hour growth in 96-well plate in 200 µl M9 medium supplemented with
0.4% fructose.
Relative cellular amounts of the capacity monitor mRNA were measured using qPCR relative to
the gapA housekeeping gene. A number of housekeeping genes were tested in an unreported
study and gapA was shown to be a stable housekeeping gene when looking at cells with dif-
ferent amount of burden placed on the shared resources pool (F. Ceroni, T. Ellis, unpublished
data). The proportion of monitor mRNA per cell was multiplied by the estimated total RNA per
cell to estimate the absolute amount of monitor mRNA per cell (see Figure 5.23). These fig-
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ures were then divided by protein production rates to give an estimate of the translational rates
within the cell.
Figure 5.23: Cellular RNA amounts, showing normalised total RNA per cell (from RNA extrac-
tion at 3 hours) and normalised GFP mRNA per cell (estimated by qPCR).
Figure 5.24 shows the monitor output and calculated translation rates within the reference con-
struct H08 and the equivalent construct with a strong promoter (H11). These are shown for
these constructs both induced and uninduced. This data clearly shows that the changes in
monitor output are highly correlated with the rate of translation and therefore that the main bot-
tleneck in resources that causes the ‘burden’ measured by our monitor is on the translational
resources. These findings reflect what has been reported elsewhere in the literature [90,24,104].
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Figure 5.24: Translation rates and monitor outputs shown for the reference construct (H08)
and the equivalent construct with the strong promoter version (H11). This clearly shows that
changes in monitor output are highly correlated to the translation rate within cells.
5.11 Relationship Between Growth Rate and Other Metrics
A key consideration in this project is understanding if and how the capacity monitor that has
been implemented is superior to the growth rate as an indicator of the burden placed on shared
resources by a synthetic circuit. The growth rate of cells is a complex function of many factors
such as proteome, growth medium, temperature etc. Figure 5.25a shows the relationship be-
tween growth rate and monitor output for all of the constructs shown so far in this section as well
other data so that all high-copy constructs are shown as well as medium copy constructs with
medium strength RBS. All of the data shown are for induced constructs and we have omitted
the data for cells containing the high copy/strong RBS with slow codons constructs that we have
previously shown are likely to have evolved so that the circuit is no longer functional. We can
clearly see that there is, at best, a weak correlation between growth rate and monitor output.
We see in Figure 5.25b that there is very little correlation between the circuit output and growth
rate. Figure 5.25c shows that growth rate and circuit efficiency also have very little correlation.
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(a) Growth Rate vs Monitor Output (b) Growth Rate vs Circuit Output
(c) Growth Rate vs Circuit Efficiency
Figure 5.25: Scatter plots showing the relationship between growth rate and a) monitor output,
b) circuit output and c) circuit efficiency for all high copy constructs and medium copy constructs
with medium RBS. Error bars indicate standard errors over 6 repeats.
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5.12 Conclusion
The results shown in this chapter show that we have been able to successfully build a library
of constructs that have been used in conjunction with the capacity monitor to shed light on
the impact of certain circuit design choices. We see a very complex interaction between gene
expression control points that point us towards some design principles and help us uncover
important considerations when designing genetic circuits.
The control points we have investigated are copy number, promoter strength, RBS strength and
codon usage. We have clearly seen that increasing promoter strength leads to an increase in
gene expression as well as a decrease in cellular capacity. RBS strength has a similar impact,
however when particularly strong RBS sequences were used we saw a decreased circuit output
with a decrease in capacity, most likely due to a cellular response to the burden being placed
on the cell. Codon usage was shown to be very important in both the gene expression levels
as well as the burden placed on the cell. Slow codons appear to be a poor design choice when
considering either the rate of protein production or the burden placed on the cell. Increasing
the copy number of the circuit increases the circuit output, however the additional resources
required to maintain a higher number of plasmids (because of origin of replication or antibiotic
resistance marker) means that this increase comes at a high burden ‘cost’.
We are able to uncover a design principle that allows two circuits to have the same rate of
protein production whilst causing different levels of burden. In this situation we saw that the
combination of a weak promoter with stronger RBS is less efficient (a term we define in this
chapter) than the equivalent construct with a strong promoter and weak RBS. We define the
efficiency of a circuit firstly at a theoretical level and then motivate a metric that we can calculate
from experimentally measurable quantities that may be used to represent efficiency.
Comparing the impact of circuits on DH10B cells and MG1655 cells we saw that MG1655 cells
had a much larger decrease in capacity. This may have been due to the stringent response
allowing the cells to detect the production of extra protein and adapt to cope with this by down
regulating the monitor promoter. However, we observed that slow codons are still shown to
be a poor design choice in MG1655 cells, indicating that this is a poor design choice across
different strains of E. coli.
Using RNA quantification with qPCR techniques we were able to estimate the relative total RNA
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levels in cells containing different constructs as well as estimate the translation rates within the
cells. The results showed that the growth rates and total RNA levels per cell are highly pro-
portional, as indicated by Klumpp et al. [51]. This is observed when growth rate is mediated
through changes in growth medium in Klumpp et al. and therefore is not indicative that com-
petition for transcriptional machinery is causing the decrease in total RNA. When these figures
are combined with monitor protein production rates we are able to estimate translation rates
for the monitor protein and we see that this is highly correlated with the rate of protein produc-
tion level, indicating that changes in the capacity monitor are predominantly due to changes in
translational resources.
We compared growth rate to circuit output, monitor output and circuit efficiency for the range
of constructs tested in this chapter and we observed very low correlation between growth rate
and each of these metrics. This indicates that growth rate is a poor indicator of cellular capacity
in terms of shared resources and that the system we have developed is a much more accurate
way of estimating this.
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Chapter 6
Results: Modelling Burden Caused by
Gene Expression
In this chapter we develop a model of gene expression. This model focuses on the translational
aspect of gene expression as this is where both the literature and the experimental data from
this project suggest the crucial interaction between gene expression and shared resources lies.
We aim to use this model to simulate similar conditions to those tested experimentally and
identify how closely in silico matches in vivo.
6.1 Basic Gene expression Model
We first propose a basic model of translation that only takes into account number of ribosomes
and transcripts. This does not take into account any features of the RNA such as codon usage,
RNA length etc. Therefore this model in isolation is not sufficient for our needs. We need to be












β2−→ Rib+ RNA+ P
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where Pol is an RNA polymerase, DNA is a strand of DNA, S is a transcriptional complex of
DNA and RNA polymerase, RNA is an mRNA transcript, Rib is a ribosome, L is a translational
complex of RNA and ribosomes and P is a protein.
6.2 Full Elongation Model
Both the literature and the wet-lab results from this project indicate that the bottleneck in re-
source availability in cells expressing heterologous protein is greatest at the ribosomal level [90,24,104].
Therefore we chose to build a model that focuses on ribosomal availability. In order to include
the ability for coding regions to have different codon profiles and for ribosomal traffic jams [66] to
be able to be modelled it was necessary to go beyond the ‘one step’ model shown above.
To create a model that could include these key features we had to look closely at the elongation
process in translation. This is a complex process that consists of multiple steps every time
the polypeptide is elongated and the ribosome moves along the transcript. Since obtaining
the values for the parameters associated with these individual processes was not possible
we collapsed them down in a way that each time the ribosome moved one codon along the
transcript it was a single process. It was not possible to obtain these rates for the constructs
used in this project either, however we were able to use the literature to estimate the rates and
roughly model how the differences in codon usage might be reflected in the elongation rates
used in the model.
We derived this model using a markovian process approach, though MacDonald et al. have
used mechanistic and deterministic approaches to obtain a similar model of the elongation
steps [60]. We tested the model by putting in parameters found in the literature and found that
the outputs reflected what would be expected in vivo. Subsequently we modelled what the
effects of changing the control points mentioned in above sections. This model does not include
growth rates as the complexity of the interaction between resource availability and growth rate
means it is not possible to model this interaction within the scope of this project.
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6.2.1 Derivation
A model of translation was built up where the movement of individual ribosomes is treated as a
random walk which occurs as follows:
Assumptions
Assumption 1. There are a fixed number of ribosomes R.
Assumption 2. There is a single species of transcripts of which there is a constant number M.
Assumption 3. Each transcript is identical and is of length L codons.
Assumption 4. Ribosomes can reversibly bind to the RBS of a transcript.
Assumption 5. Once elongation is initiated and a ribosome has moved to the first codon of the
transcript, it must continue unidirectionally along the transcript until it reaches the stop codon.
Assumption 6. When a ribosome reaches the stop codon it will release it and become a ‘free
ribosome’ again and a protein will be produced.
Assumption 7. We approximate the size of ribosomes to be such that they only occupy a single
codon (or RBS) along a transcript and neighbouring codons (and RBSes) can be occupied by
separate ribosomes.
Assumption 8. No two ribosomes can occupy the same codon or RBS.
Assumption 9. Ribosomes move along transcript one codon at a time and cannot move to the
next codon if it is occupied by another ribosome.
Assumption 10. Ribosomes move from one codon to the next at a fixed and constant rate if
the next codon is not occupied.
Assumption 11. There is a large number of total ribosomes, so R >> 1
Assumption 12. Time is modelled discretely with intervals of δt. A maximum of one state
transition for each ribosome may occur during this time (i.e. maximum one elongation step).
Transitions from one elongation state to the next are single steps and as time is modelled
discretely with intervals δt
Assumption 13. All transcripts are identical and so the probability of a ribosome r being in
elongation stage i ∈ {0, ..., L} at time t is the same for any mRNA:
P(Erm,i, t) = P(Ers,i, t) ∀ m, s ∈ {1, ...,M}
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Assumption 14. All ribosomes are identical and so have the same probability distribution:
P(Erm,i, t) = P(E
q
m,i, t) ∀ r, q ∈ {1, ..., R}
Assumption 15. The event of a new transcript creation is defined as the moment an mRNA
is finished being transcribed. Ribosomes move along mRNA closely following the RNA poly-
merase as it transcribes, and are already moving along the mRNA before it has finished being
fully transcribed [81]. Therefore upon the creation of a new mRNA we can approximate that it is
already covered in ribosomes and that we can make a steady-state approximation over these
equations.
Assumption 16. The process is Markovian and at any point in time the position of one ribo-
some is independent of the positions of others at that point in time.
While we acknowledge some of these assumptions do not accurately represent the reality of
the complex biological process of translation, we make them in order to simplify the model in
a way that we do not anticipate will affect the core behaviours of the translation dynamics. For
example, we know that a ribosome occupies space that covers more than one codon at a time,
however by approximating it as occupying the space of only one codon we simplify the model
significantly. What we lose in the accuracy of this specific detail we more than make up for in
the increased ease with which we can work with the model.
Events
1. Erm,i is the event of ribosome r being on transcript m in elongation state i (i.e. at the i
th
codon) for i ∈ {1, ..., L}.
2. Erm,0 is the event of ribosome r being on the RBS of transcript m.
3. Ribr is the event of ribosome r not being on any transcript (i.e. in the free ribosome pool).
For any ribosome ‘r’ from a pool of R ribosomes, if it is freely available (Ribr) it can bind to the
RBS of mRNA ‘m’ (Erm,0) and from this state it can either unbind and join the free ribosome pool
again, or translation can be initiated and it moves into the initial state of elongation (Erm,1). From
this the only path the ribosome can take is to go from the ith stage of elongation (Erm,i) to the
i+1th stage of elongation (Erm,i+1) and is not able to unbind from the mRNA until it reaches the
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final elongation stage which, without loss of generality, can be the Lth stage (Erm,L). From this,
translation finishes, a full protein is produced and the ribosome returns to the free ribosome
pool.
P(Erm,i, t) is the probability that event Erm,i occurs at time t. For the random walk we consider a
discrete time distribution with steps of length δt and define the following ‘rates’:



























for i ∈ {0, ..., L− 1}
βL = lim
δt→0
P(Ribr, t+ δt|Erm,L, t)
δt
where α+ is the binding rate of a ribosome to an RBS, α− is the unbinding rate of a ribosome
from an RBS and the βi values are the rates of elongation at which a ribosome moves to the
next codon (if it is not blocked). Overlines indicate an event no occurring (ie. A is the event
where A does not occur).
The Model
The system can be displayed mathematically as:








P(Ribr, t+ δt|Ers,L, t)P(Ers,L, t) (6.1a)
P(Erm,0, t+ δt) = P(Erm,0, t+ δt|Erm,0, t)P(Erm,0, t)
+ P(Erm,0, t+ δt|Ribr, t)P(Ribr, t) (6.1b)
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P(Erm,1, t+ δt) = P(Erm,1, t+ δt|Erm,1, t)P(Erm,1, t)
+ P(Erm,1, t+ δt|Erm,0, t)P(Erm,0, t) (6.1c)
...
P(Erm,i, t+ δt) = P(Erm,i, t+ δt|Erm,i, t)P(Erm,i, t)
+ P(Erm,i, t+ δt|Erm,i−1, t)P(Erm,i−1, t) ∀i ∈ {2, ..., L− 1} (6.1d)
...
P(Erm,L, t+ δt) = P(Erm,L, t+ δt|Erm,L, t)P(Erm,L, t)
+ P(Erm,L, t+ δt|Erm,L−1, t)P(Erm,L−1, t) (6.1e)
We next rewrite the probability of a ribosome staying in the same state as being equal to 1
minus the probability of it moving out of that state:















P(Ribr, t+ δt|Ers,L, t)P(Ers,L, t) (6.2a)
P(Erm,0, t+ δt) =
(
1− P(Ribr, t+ δt|Erm,0, t)− P(Erm,1, t+ δt|Erm,0, t)
)
P(Erm,0, t)
+ P(Erm,0, t+ δt|Ribr, t)P(Ribr, t) (6.2b)
P(Erm,1, t+ δt) =
(
1− P(Erm,2, t+ δt|Erm,1, t)
)
P(Erm,1, t)
+ P(Erm,1, t+ δt|Erm,0, t)P(Erm,0, t) (6.2c)
...
P(Erm,i, t+ δt) =
(
1− P(Erm,i+1, t+ δt|Erm,i, t)
)
P(Erm,i, t)
+ P(Erm,i, t+ δt|Erm,i−1, t)P(Erm,i−1, t) ∀i ∈ {2, ..., L− 1} (6.2d)
...
P(Erm,L, t+ δt) =
(
1− P(Ribr, t+ δt|Erm,L, t)
)
P(Erm,L, t)
+ P(Erm,L, t+ δt|Erm,L−1, t)P(Erm,L−1, t) (6.2e)
155
Rearranging gives:
P(Ribr, t+ δt)− P(Ribr, t) = −
M∑
s=1








P(Ribr, t+ δt|Ers,L, t)P(Ers,L, t) (6.3a)
P(Erm,0, t+ δt)− P(Erm,0, t) = −
(
P(Ribr, t+ δt|Erm,0, t)− P(Erm,1, t+ δt|Erm,0, t)
)
P(Erm,0, t)
+ P(Erm,0, t+ δt|Ribr, t)P(Ribr, t) (6.3b)
P(Erm,1, t+ δt)− P(Erm,1, t) = −P(Erm,2, t+ δt|Erm,1, t)P(Erm,1, t)
+ P(Erm,1, t+ δt|Erm,0, t)P(Erm,0, t) (6.3c)
...
P(Erm,i, t+ δt)− P(Erm,i, t) = −P(Erm,i+1, t+ δt|Erm,i, t)P(Erm,i, t) for i ∈ {2, ..., L− 1}
+ P(Erm,i, t+ δt|Erm,i−1, t)P(Erm,i−1, t) (6.3d)
...
P(Erm,L, t+ δt)− P(Erm,L, t) = −P(Ribr, t+ δt|Erm,L, t)P(Erm,L, t)
+ P(Erm,L, t+ δt|Erm,L−1, t)P(Erm,L−1, t) (6.3e)
For all events Erm,i at a time t + δt we have that the probability P(Erm,i, t + δt|X) for any event
X can be split into two subsets, one where there is a ribosome in elongation state i on mRNA
m at time t and one where there is not:
P(Erm,i, t|X)P(X) = P(Erm,i, t|X ∩ (
⋃
q 6=r




+P(Erm,i, t|X ∩ (
⋂
q 6=r




Since the probability of two ribosomes being in the same state on the same mRNA is zero we
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must have that:
P(Erm,i, t|X)P(X) = P(Erm,i, t|X ∩ (
⋂
q 6=r




which can be rewritten as:







Due to mutual exclusivity, we know that the probability of no other ribosomes being there is
equal to 1 minus the sum of the probabilities of each other ribosome being there:







Combining this with equations (6.3) gives:



























P(Ribr, t+ δt|Ers,L, t)P(Ers,L, t) (6.8a)


















































































































∀i ∈ {2, ..., L− 1} (6.8e)
...




















Dividing both sides by δt and taking limδt→0 as well as taking the definitions of the rates as


























































− βLP(Erm,L, t) (6.9e)
Using assumptions (4) and (5) we can take the sums and along with using assumption (6) and
saying R >> 1 =⇒ R − 1 ' R (the minimal number of ribosomes we have modelled this
system with is 1000, and often higher meaning this assumption holds) we get:
dP(Ribr, t)
dt
= M · α−P(Erm,0, t)
−M · α+P(Ribr, t)(1−R · P(Erm,0, t))




+ α+P(Ribr, t)(1−R · P(Erm,0, t))
− β0P(Erm,0, t))(1−R · P(Erm,1, t)) (6.10b)
dP(Erm,1, t)
dt
= β0P(Erm,0, t)(1−R · P(Erm,1, t))




= βi−1P(Erm,i−1, t)(1−R · P(Erm,i, t))




= βL−1P(Erm,L−1, t)(1−R · P(Erm,L, t))
− βLP(Erm,L, t) (6.10e)
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A set of random variables Xm,i (i ∈ {0...L}) is defined as follows:
Xm,i(t) =
 1 if there is a ribosome present in elongation stage ‘i’ on mRNA ‘m’ at time ‘t’0 if there is no ribosome present in elongation stage ‘i’ on mRNA ‘m’ at time ‘t’
The random variable F (t) represents the number of ribosomes not on a transcript at time t. At
any time ‘t’, using assumption (17) on independence of ribosome positions:









By the definition of expectation:






Using assumption (1) we get:
E(Xm,i(t)) = R · P(Erm,i, t) (6.11)
where R is the total number of ribosomes. We further define the random variable Xi(t) as
the sum of random variables Xm,i(t) across all mRNA, i.e. the total number of ribosomes in















R · P(Erm,i, t) (6.12)
Now, using assumption (2), we have:
E(Xi(t)) =MR · P(Erm,i, t) (6.13)
We define the variable Yi(t) to be the expectation of the random variable Xi(t)
Yi(t) = E(Xi(t)) (6.14)
Therefore,
Yi(t) =MR · P(Erm,i, t) ∀i ∈ {0, ..., L} (6.15)
We also investigate the variance of Xi(t) to be confident that the system will reliably behave as
the expectation dictates. The variance of each Xm,i(t) is equal to:




)− E (Xm,i(t))2 (6.16)
However, since Xm,i(t) can only take the values 0 or 1, it has a Bernoulli distribution and it so,
if we let µ = E(Xm,i(t)) it must be the case that:
V ar(Xm,i(t)) = µ− µ2 (6.17)
Xi(t) is a random variable that represents the sum of a population of independent, identically
distributed (IID) random variables Xm,i(t). From the variance of a population of independent,






This gives us an estimate of the cell to cell variance we would expect in these values from this
model, however there are many other factors not included in this model which cause both cell
to cell variations as well as population level variations in circuit output. This indicates that the
behaviour of the circuit becomes less noisy as the number of transcripts increases since the
variance per cell is inversely proportional to the number of transcripts. This is an interesting
result and suggests that a stronger promoter would cause lower cell to cell variation.
It is tempting to include a ‘deterministic’ variance for the simulation we perform to estimate
what the cell to cell variation would be. However, our simulations are performed to represent
populations of identical cells (similar to the in vivo results shown) and therefore expected cell
to cell variation cannot be compared to the population to population variance we see from in
vivo results. This is because in vivo populations contain very large numbers of cells in which
any variation as predicted by our model would be silenced, and the variation observed in vivo
is due to additional factors not included in our model.
The random variable F which is the number of free ribosomes can be calculated as the total
number of ribosomes minus the expected total number of ribosomes on transcripts:




and letting G(t) be the expectation of the random variable F (t)
G(t) = E(F (t)) (6.20)
by combining (6.15) and (6.19) with (6.10) and dropping the (t) from notation by letting Xi =
Xi(t) and F = F (t) we are left with:
dG
dt
= −Mα+G(1− Y0/M) + α−Y0 + βLYL (6.21a)
dY0
dt












= βL−1YL−1(1− YL/M)− βLYL (6.21e)
We assume that the system is in steady state in exponential growth where each transcript has
a steady state distribution of ribosomes on it (Assumption 15). The steady state equations are:
Mα+G(1− Y0/M) = α−Y0 + βLYL (6.22)








6.2.2 Solving the Steady State Model





we can define functions fRib, fL and fk ∀k ∈ {1, ...,m− 1}:
Rib = fRib(L,F1) (6.24a)
L = fL(F1, F2) (6.24b)
Fk = fk(Fk+1, Fk+2) ∀k ∈ {1, ...,m− 2} (6.24c)
Fm−1 = fm−1(Fm) (6.24d)
These functions can be rewritten as:
Rib = gRib(Fm) (6.25a)
L = gL(Fm) (6.25b)
Fk = gk(Fm) ∀k ∈ {1, ...,m− 2} (6.25c)
Fm−1 = gm−1(Fm) (6.25d)
6.2.3 Asserting monotonicity in the model
In order to assert that there is a unique solution to set of equations 6.25 we must ensure that
the total number of ribosomes can be expressed as a strictly monotonically increasing function
of ribosomes in the free pool. In order to do this we must use the inverse function theorem and
show that each variable is a strictly monotonically increasing function of free ribosomes.
Fm−1 = gm−1(Fm) (6.26a)
=
βmFm






(M − Fm)2 (6.27a)
> 0 (6.27b)
So Fm−1 is a strictly monotonically increasing function of Fm. For Fm−2:
Fm−2 = gm−2(Fm) (6.28a)
=
βmFm








M − (Fm−1 − FmdFm−1dFm )
(M − Fm−1)2 (6.29a)







(M − Fm) − Fm
M




FmM − F 2m − FmM










and Fm−2 is a strictly monotonically increasing function of Fm. Using inductive reasoning we




Fi = gi(Fm) (6.33a)
= (βm/βi)
Fm








M − (Fi+1 − FmdFi+1dFm )
(M − Fi+1)2 (6.34a)








(M − Fi+2) − Fm
M − Fi+2 + FmdFi+2dFm




MFm − FmFi+2 − FmM + FmFi+2 − F 2M dFi+2dFm






(M − Fi+2)2 (6.35c)
≤ 0 (6.35d)




Since dFmdFm > 0 and
dFm−1
dFm
> 0 we can use inductive reasoning to get that gRib, gL and gk for
∀k ∈ {1, ...,m} are all strictly monotonically increasing functions in Fm and therefore (by the
inverse function theorem) have inverse functions. This means we can rewrite all the variables
as strictly monotonically increasing functions of Rib:
Rib = hRib(Rib) (6.37a)
L = hL(Rib) (6.37b)
Fk = hk(Rib) ∀k ∈ {1, ...,m} (6.37c)






The left-hand-side of this equation is a sum of strictly monotonically increasing functions and
therefore is itself a strictly monotonically increasing function of Rib and tends to +∞ as Rib
tends to +∞. Therefore, for any RibT we have a unique solution for Rib, and from equations (h
functions) unique solutions in L and Fk for ∀k ∈ {1, ...,m}.
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6.3 Simulating Circuit and Monitor Behaviour
Equations 6.37 and 6.38 cannot be solved analytically for systems that are large enough to be
representative of real synthetic circuits. Therefore, the model must be simulated to understand
how changing the control points affects the circuit behaviour and free ribosome pool.
A python script was built that allowed this model to be simulated. It consists of two classes,
Circuit and Cell. The Circuit class describes individual circuits and allows a user to define
the number of transcripts, elongation rates, binding and unbinding affinities for RBS. This can
be done for any number of circuits. The Cell class allows user to define a model of a cell
including the total number of ribosomes available in the cell as well as which circuits it contains.
These classes have attributes and methods that allow simulations of the system to be run. The
method simulate on the Cell class allows the simulation of the cell to be run and gives a
dictionary output that describes the number of free ribosomes remaining in the cell as well as
the distribution of ribosomes for each circuit. This script uses functions provided by the scipy
python package, which thus must be installed a priori.
from scipy.optimize import fsolve
###############################




Object respresenting a cell.
free_ribosomes = integer number of ribosomes available in the cell
for synthetic circuits to use.
circuits = list of synthetic gene circuits in cell.
"""
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def __init__(self, free_ribosomes=1000, circuits=[]):
self.free_ribosomes = free_ribosomes
self.circuits = circuits
self.array = [0] #free ribosomes








for circuit in self.circuits:




for i, circuit in enumerate(self.circuits):




Function that simulates the steady state solution to the ribosomal
distribution based on the parameters entered. Returns a dictionary
with the following key, value pairs:
free_ribosomes: the number of free ribosomes in the cell.
circuits: a list of dictionaries where each one represents a
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separate circuit in the cell with the following key, value pairs:
name: name of circuit as defined in inputs.
ribosomes: total number of ribosomes on all transcripts for the
given circuit.
distribution: list of total number of ribosomes at each state along
all transcripts for given circuit.
efficiency: efficiency of circuit (circuit output/ribosomes used).
"""
initial_conditions = [self.free_ribosomes]
for circuit in self.circuits:
initial_conditions += circuit.initial_conditions
solution = fsolve(self.equation, initial_conditions)
result = {’free_ribosomes’: solution[0], ’circuits’: []}
shift_counter = 1
for circuit in self.circuits:
length = circuit.length+1






Object representing synthetic gene circuits that will be placed into
a cell.
total_transcripts = integer number of transcripts for this circuit
in the cell. Is a function of both copy number and promoter
strength.
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alpha_plus = rate at which free ribosomes bind to RBS. Units are
1/seconds.
alpha_minus = rate at which ribosomes unbind from RBS. Units are
1/seconds.
betas = list of rates for ribosomes moving along transcript. betas[0]
represents the rate at which ribosome moves from RBS to initial
elongation state. betas[i] represents rate at which ribosomes
moves from position i to position i+1 if unblocked (or into free
ribosome pool for i = length(betas)). Units are 1/seconds.
RBS_strength = single number that replaces alpha_plus, alpha_minus
and betas[0] if defined.
"""















self.initial_conditions = [0 for i in range(self.length+1)]]
def equation(self,q,index):
"""
Provides ODE equation set for this species solving fsolve
p is the equation input









eqns = ( a_p * x * (T - y[0])
- a_m * y[0]
- b[0] * y[0] * (1 - y[1]/T) ,)
for eqn in (( b[i] * y[i] * (1 - y[i+1]/T)
- b[i+1] * y[i+1] * (1 - y[i+2]/T) ,)
for i in range(L-1)):
eqns = eqns + eqn
eqns = eqns + (b[L-1] * y[L-1] * (1 - y[L]/T) - b[L] * y[L],)
return eqns
Units for each parameter are detailed within the code.
It is trivial to extend the model described in Section 6.2.2 to a system of two (or more) circuits. A
simulation was done of a two circuit system in a way where one circuit represented the monitor
and the other represented a synthetic circuit. Simulation of this model allows predictions to
be made about changes in the behaviour of a synthetic circuit when the key control points
discussed in Section 5.2 are altered as well as how the expected output from the monitor
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changes. These results can then be compared to the wet-lab data from Chapter 5 to verify their
validity.
6.3.1 Parameter and Unit Checking
In order to test this model, we start by performing a simulation with realistic values that are
observed in the actual system. Using parameters obtained from BioNumbers [63], we run a
simulation to test whether the output values observed are within realistic bounds. Table 6.1
shows the parameters. These roughly represent a medium copy plasmid (25-50 copies per cell)
with a medium promoter (2-4 transcripts per promoter in cell at any time) giving 100 transcripts,
1000 available ribosomes (5% of total cellular ribosomes at 20,000), a 900 bp CDS (300 amino
acids long) that has been codon optimised so elongation rate at each codon is 20 codons per
second for all codons.
Parameter Model Parameter Value Units
Codon speed (elongation rate) βi for all i 20 ribosomes-1 s-1
Transcripts M 100 mRNA cell-1
Available ribosomes RibT 1000 ribosomes cell-1
Transcript length m 300 codons
Ribosome-RBS binding rate α+ 0.0001 ribsome-1 RBS-1 s-1
Ribosome-RBS unbinding rate α− 200 ribsome-RBS-complex-1 s-1
Table 6.1: Model parameters used for testing model validity
Running a simulation of a single circuit with ribosomes gives a circuit that produces proteins at
an average rate of 35.04 proteins per second. This uses an average of 537.97 ribosomes at
any point in time which is 2.5% of all cellular ribosomes. This appears to be the correct order
of magnitude since there are approximately 4000 genes, of which perhaps half are active.
This gives 2000 active promoters with approximately 2-4 transcripts per promoter with a total
of 4000-8000 cellular transcripts per cell. The 100 transcripts from the synthetic construct
constitute 1.25-2.5% of the total cellular transcripts and therefore we would expect the same
proportion of the total cellular ribosomes to be on circuit transcripts.
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6.4 Modelling Control Points
We use a simple two circuit simulation to investigate the effect of changing the parameters as-
sociated with the different control points. Since we do not know the exact biological parameters
for the systems we are investigating we cannot expect an accurate quantitative prediction of the
impacts of specific changes. However, we can do a comparative investigation where we look
at the qualitative and relative changes in system behaviour when we change the control point
parameters.
6.4.1 Promoter Strength and Copy Number
The model being considered in this project only models ribosomal availability and therefore
when considering the number of circuit transcripts it is independent of the mechanisms that
cause changes in the amount of mRNA. Plasmid backbones cause different levels of ‘back-
ground’ burden on the cell and are not considered as part of this model due the the higher
levels of complexity of different origins of replication and resistance markers.
A suitable approach would be to characterise the behaviour of the backbone as demonstrated
in Section 5.7.5 and use this modelling approach to predict how to best optimise the design of
the circuit contained in the plasmid given a set of constraints.
In this modelling approach the plasmid copy number and promoter strength are compounded
into a single variable - the number of transcripts. Figure 6.1 shows the amount of circuit output
and monitor output for the model system for a range of transcript numbers. At low levels of
transcripts (< 400 per cell) the relationship between transcript number and circuit output is
approximately proportional. Similarly, the relationship between the number of transcripts and
monitor output is approximately linear in this region. This indicates that for a given number
of ribosomes and for transcript numbers in this range, all transcripts use a similar number of
ribosomes to produce protein at a similar rate.
As the number of transcripts increases, the system becomes saturated with respect to tran-
scripts and large increases in the number of transcripts cause relatively small increases and
decreases in circuit output and monitor output respectively.
The vertical yellow lines in Figure 6.1 show where the data shown in Figure 6.2 lies on this
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Figure 6.1: Modelled impact of transcript number on circuit and monitor outputs. This figure
shows both both monitor output and circuit output for a range of circuit transcript numbers.
Lines represent best fit of Hill curves using GraphPad Prism with no parameter constraints.
Figure 6.2: Modelled impact of transcript number on circuit and monitor output. This figure
shows that a higher number of transcripts causes higher circuit output and lower monitor output.
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6.4.2 RBS Strength and Codon Usage
We modelled the system with a range of different RBS strengths as well as two different codon
usages. The fast codon version has uniform elongation rates of 1 along a 100 codon transcript
and the slow codon version has uniform elongation rates of 1 along a 100 codon transcript with
the exception of elongation rates of 0.5 for codons 85 to 95.
Both codon usage and RBS have a large impact on the behaviour of the circuit. Figure 6.3
shows how both codon usage and RBS strength affect the monitor output and circuit output. For
both codon usages, as the RBS strength strength increases at low levels (< 0.4) the relationship
between circuit output and RBS strength is approximately linear. As the RBS strength continues
to increase, the circuit output reaches a saturation level. Slower codons heavily impact the
maximum output of the circuit. This is due to slower codons imposing a lower maximum flux of
ribosomes through the system. Also, for slower codons this saturation is reached at lower RBS
strength. This intuitively makes sense since slower codons will cause a lower maximum flux
through the system and a higher rate of recruitment of ribosomes onto the transcript will cause
this maximum to be reached.
In terms of monitor output, for RBS strengths < 1, the relationship between RBS strength and
monitor output is approximately linear. For higher RBS strengths, the monitor output tends to a
lower asymptote. The slower codon circuit causes a decrease in monitor output.
The yellow lines represent the time point at which the data represented in Figure 6.4 are con-
sidered, while the dashed blue line represents the time point at which the data represented in
Figure 6.5 are considered. We can see that this data qualitatively matches the results seen
in the wet-lab in Figures 5.15 and 5.17. However, we are unable to capture the phenomenon
of reduced circuit output at the highest RBS strengths. This is because we are not including
cellular response and adaptation in this model, though it would be a very interesting thing to
include into the model, which we plan to do in future work.
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Figure 6.3: Modelled impact of RBS strength and codon usage on circuit and monitor outputs.
Shows both monitor output and circuit output for a range of RBS strengths for two different
codon usages. Lines represent best fit of Hill curves using GraphPad Prism with no parameter
constraints.
Figure 6.4: Modelled impact of RBS strength on circuit and monitor output shows that a stronger
RBS causes higher circuit output and lower monitor output.
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Figure 6.5: Modelled impact of codon usage on circuit and monitor output shows that slower
codons in the circuit cause lower circuit output as well as lower monitor output.
6.5 Obtaining Similar Circuit Output with Different Burden Levels
A particularly interesting result from the wet-lab data was to see that it was possible to design
two circuits with similar circuit output but different monitor output (resource usage). This was
done by changing both the RBS and promoter together so that in one case a stronger promoter
was used with a weaker RBS and in the other case a weaker promoter was used with a stronger
RBS.
We simulated this using RBS strengths and transcript numbers that were above the regions
where we saw a proportional behaviour between the variables and circuit output. The weak
RBS had strength 0.4 and the strong RBS had strength of 2, a 5-fold difference (approximately
the same difference as predicted by the Salis RBS calculator for the two RBS strengths used
in the wet-lab experiment). The number of transcripts used was 300 for the weak promoter
and 500 for the strong promoter. This is approximately the same difference in output that we
saw when the two PBAD promoters were characterised and the values correspond to relatively
strong promoters on high-copy plasmids.
177
Figure 6.6a shows the data obtained from the modelling and shows that the circuit output for the
strong promoter/weak RBS and weak promoter/strong RBS is approximately the same, how-
ever the output from the capacity monitor is higher for the strong promoter/weak RBS version.
The weak promoter/weak RBS construct has the lowest circuit output and highest monitor out-
put whilst the strong promoter/weak RBS construct has the highest circuit output and lowest
monitor output.
Comparing these results to the wet-lab data shown in Figure 6.6b we can see that whilst there
is not an exact quantitative match between the simulation and the experimental data, there is
definitely a qualitative match. This shows that our model is able to predict some of the more
unexpected and interesting behaviours that arise from changing control points together. It also




Figure 6.6: A comparison of the results of both a) modelling simulation and b) experimental
results when attempting to obtain the same circuit output levels while causing different amounts
of burden by changing RBS and promoter strengths.
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6.6 Optimising the Monitor
Since our monitor was designed before any of the modelling and simulation of control point
experimental testing is it likely that it is itself not the optimal design. We wanted to investigate
how we might be able to obtain better performance by changing the design. Our results show
that the faster the codons in the coding region, the less burden and the higher the output will
be for a circuit. The capacity monitor sfGFP has already been codon optimised so it is unlikely
that the codon usage can be improved upon.
The RBS we chose for the circuit was designed by maximising the predicted strength on the
Salis RBS calculator. Figure 6.7 shows how the RBS strength affects the sensitivity of the
monitor to changes in ribosomal availability. It is clear that the higher the RBS strength, the
less sensitive the monitor will be to changes in ribosomal availability, especially at higher levels.
It is also important to take into consideration the slope of the curve, since for a shallower slope
the noise in the monitor output may make it difficult to accurately calculate the amount of free
ribosomes available in the cell.
From the experiment data shown above we are confident that our monitor is certainly sufficient
for the type of investigation that we have performed in this project, however if it were to be
used in specific industrial and biotechnological contexts, these are important considerations
that should be taken into account when improving the monitor.
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Figure 6.7: Effect of RBS strength on monitor sensitivity shows the monitor output levels for
different free ribosome numbers for different monitor RBS strengths. Lines represent best fit of
hill curves using GraphPad Prism with no parameter constraints.
6.7 Conclusion
In this chapter we have shown the development of a model of translation. This has been
designed so that it is able to incorporate the effect of codon usage on gene expression as well
as ribosomal usage. This model assumes that the competition for transcriptional resources is
less important than the competition for translational resources and can be neglected.
We used a markovian approach to model the behaviour of ribosomes within a cell moving
from a free pool and reversibly binding to a transcript before moving unidirectionally along the
transcript. This approach was then developed into a deterministic steady-state model using
expectations. We then proved that there was a unique solution to these equations. However,
unfortunately for any realistic circuit we might want to model these equations are not analytically
solvable and therefore we must use numerical methods to simulate their behaviour.
We provide a python script that is able to simulate a cell with an arbitrary number of mRNA
species where the length, codon speed, RBS strength and number of transcripts call all be de-
fined. We then ran a simulation of this with biologically realistic numbers and obtained outputs
that were within realistic bounds.
This model was subsequently used to predict the impact of changing the number of transcripts
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(to reflect a change in copy number or promoter strength). These results showed that there
are diminishing returns for protein production levels as transcript numbers are increased and
that both monitor output and circuit output tend towards asymptotes. The simulations also
qualitatively reflected the results observed in the experimental data.
The model also predicted that increases in RBS strength would lead to saturating increases in
circuit output as well as decreases in monitor output. Unfortunately, since the model did not
include any cellular feedback we were not able to observe a decreased circuit output for par-
ticularly high RBS strengths. We also observed that introducing slow codons into the transcript
caused a decrease in both monitor output and circuit output, reflecting the experimental results.
Crucially, the model was also able to reflect the ability for two circuits to have the same circuit
output whilst causing different levels of burden. A construct with low transcript numbers and
high RBS strength (weak promoter, strong RBS) was shown to cause a higher level of burden
than a circuit with a higher number of transcripts (stronger promoter) and weaker RBS that
gave the same circuit output. This shows that our model may be used to uncover additional
non-intuitive circuit behaviours.
We also modelled the impact of different RBS strengths for the circuit monitor to test what the
impact of this might be on the sensitivity of the circuit to changes in ribosomal availability. We
see that increased RBS strengths are predicted to make the circuit less sensitive to changes in
ribosomal availability. However, the slope of the curve and the ability to accurately identify differ-
ences in monitor output when noise is considered should be thought about in the experimental





The overarching aim of this project was to gain a greater understanding of the interactions be-
tween a synthetic cell and its host chassis cell. The work done has focused on the interactions
through shared resources. Here we defined shared resources as the cellular machinery and
building blocks such as ribosomes, polymerases, amino acids etc. Looking back on the objec-
tives of this project (Section 1.2) we note that there were three core modules to this project.
7.1.1 Module 1: Capacity Monitor
We were able to successfully design and implement a device that monitored the cell to detect
the production of heterologous protein as well as cellular adaptation to medium shifts. A key
question arising from this is whether it is actually the capacity for the cell to produce additional
proteins that we are quantifying.
Detecting Capacity
The device expresses codon-optimised superfolder GFP from a fully-synthetic constitutive pro-
moter controlled by a synthetically designed RBS. Since our device is constitutively expressed,
we expect that any changes in the expression rate are due to changes in the global shared
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resources rather than any specific regulatory factor. Therefore we argue that the monitor is
detecting the burden that additional protein is putting on the shared resources of the cell.
We do not expect that there is a direct proportionality between the output of the monitor and
any particular resource (though we do believe that a key factor impacting the monitor output
is ribosome availability). However, a greater output from the monitor would indicate that there
are more resources available within the cell and therefore if genes were added to the synthetic
circuit, a higher monitor output would indicate that these genes would be expressed at a higher
level.
Compatibility with Synthetic Circuits
The monitor device we built was integrated into the genome of E. coli DH10B and MG1655
at the λ-site. This genomic integration means that there are no compatibility issues with any
other (non-λ) integrations or any plasmid origins of replication. However, the CRIM integration
methodology used to integrate into the genome leaves the resistance marker of the CRIM
plasmid within the genome [46]. In the case of the λ-site CRIM plasmid (pAH63) the resistance
marker is kanamycin. This means that our capacity monitor is not compatible with synthetic
circuits that use kanamycin as either part of the circuit or as part of the DNA used to introduce
them to the cell.
The use of GFP as the reporter protein means that the device is incompatible with synthetic
circuits that use GFP. This is potentially quite a large issue, due to the prevalence of GFP as a
reporter protein in synthetic biology. However, the functionality of the monitor device does not
depend on the excitation/emission of the protein used as a reporter and therefore implementing
a similar device (or range of devices) with different fluorescent proteins (that fulfil requirements
such as long half-life etc) would allow a larger range of synthetic circuits to be characterised
using capacity monitors. This is potential further work that could be done for this project and is
discussed in more detail later.
Copy Number and Degradation Tags
We investigated a range of 12 potential monitor devices and characterised the production rates
and degradation rates of GFP across them as well as their impact on the growth rates of the
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cells. It was decided that the optimal design was the device with no degradation tag integrated
into the genome.
By integrating the monitor onto the genome and having it at a single-copy, we have shown
that we are able to avoid any large impact on the cell (as indicated by growth rate). This
has been done whilst maintaining the ability to detect GFP at levels that allow us to estimate
the production rate. GFP production rates are most reliably estimated for proteins without
degradation tags (due to the widely varying half-lives of proteins with the same degradation
tag). We have shown that tagging GFP with SsrA degradation proteins leads to unpredictable
and unreliable protein degradation rates and we therefore chose to avoid using them in our
device. These results are due to competition for the native cellular degradation machinery and
have been shown in the literature [27]. It is also possible, however that some of the samples
were incorrectly labelled and that some of what we though were AAV tagged proteins were
actually tagged with the LVA degradation tag.
Testing the Monitor
We performed a number of tests to confirm that changes in the rate of protein output from
our monitor were due to changes in the amount of shared protein expression resources. By
inducing the expression of protein from a synthetic circuit we confirm that the production of
heterologous protein is causing the reduction in rate of protein output from the monitor device.
By controlling the time of induction and the carbon source in the medium we are able to identify
that the monitor device is able to detect the usage of shared resources due to a number of
factors.
The capacity monitor is able to detect decreases in shared resources from both the production
of additional heterologous protein from a synthetic circuit and increased native use of resources
in the host cell. When the cells underwent a diauxic shift we observed an additional decrease
in capacity monitor output when the cells adapt to a new carbon source.
A key result from this module is that we were able to develop both a device for monitoring the
capacity in the shared resource pool and a protocol for characterising circuits in terms of their
impact on shared resources, as well as the cell’s response to additional stresses.
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7.1.2 Module 2: Investigating the Impact of Various Control Points
The aim of this module was to gain a greater understanding of how changing key genetic
control points affects both the protein output and resource usage of a synthetic circuit. The
control points we investigated were the copy number, promoter strength, RBS strength and
codon usage. By successfully creating a combinatorial library of constructs with all of these
control points varied we were able to gain an insight into the impact of changing these control
points both in isolation, and in tandem.
Characterising this library of constructs in DH10B E. coli cells was done by estimating the
GFP production rates from the capacity monitor using regular (every 10 minutes) readings of
both OD 600 and GFP fluorescence. The results have shown there is a complex relationship
between changes in the genetic control points for a circuit and its behaviour in terms of both
output and the burden it places on shared resources.
Promoter Strength
We used two strength PBAD variants - a wild-type ‘weak’ promoter (this is weak relative to
the modified variant, though PBAD is a strong promoter when compared to most native E. coli
promoters) and a modified ‘strong’ version. Changing the promoter strength alters the amount
of mRNA that are transcribed from each promoter. As would be expected, an increase in
promoter strength causes an increase in the output of the circuit as well as a corresponding
decrease in capacity in the cell.
RBS Strength
Increases in RBS strength cause increases in the amount of burden a circuit places on the
shared resource pool. At lower RBS strengths, these increases also correspond to an increase
in the protein production rate from a circuit. However, above a certain point increases in the
RBS strength start to cause decreases in the protein production rate. This is a result that has
been reported elsewhere in the literature and is likely due to cells adapting to the depleted
resources. The continued decrease in capacity is likely due to the fact the cell is using more
ribosomes to produce proteins to change its proteome to adapt to the burden caused by the
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synthetic circuit.
When characterising the different constructs in our library we observed that there was signifi-
cantly higher leakage for constructs with the medium strength RBS when the promoters were
uninduced. The fact this occurs with the medium strength RBS but not the strong or weak RBS
suggests that it is not a function of the RBS strength. The reason for this is that if it was a func-
tion of the strength we would also expect the same (or more) leakage from either the strong or
weak promoter as well as the fact that the RBS strength only matters post-transcription when
translation is being initiated. Therefore this behaviour is most likely due to sequence-specific
interactions whereby the sequence of the medium strength RBS helps recruit additional poly-
merases to the promoter. Such context-dependency has been discussed by Cardinale et al. [22].
This could be tested by designing RBS sequences with similar strength to this RBS but with
different sequences. If the leakage is due to interaction between the RBS sequence and the
promoter we would expect to see similar levels of induced output but significantly lower leakage.
Copy Number
The copy number of a circuit is the average number of copies of the circuit DNA per cell. For
genomic integrations this number will depend on the rate at which the cell is growing and the
location on the genome with slower growth meaning there are less copies per cell and the
closer to the 50’ genome location, the lower the copy number. For larger copy numbers in
E. coli, plasmid systems are often used where the copy number is controlled by the origin of
replication used. In order to maintain the plasmid in cells a selection marker is used, often an
antibiotic resistance gene. Since there is a copy of the resistance marker on every plasmid,
the amount of protein produced increases with the copy number as does the amount of shared
resources required to maintain the plasmid. Our results show that the output from a circuit on a
high-copy plasmid (100-300 copies per cell) is only marginally higher than the same circuit on
a medium-copy plasmid (10-12 copies per cell). The growth rate is also higher for the medium
copy plasmid. This is also the case when the circuit is uninduced, indicating that the resources
required to maintain the plasmid are significantly higher for the higher copy plasmid.
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Codon Usage
Another crucial control point is the codon usage in a protein coding region. The sequence of
a coding region is important for a number of factors. The sequence of the 5’ region is impor-
tant because of two main reasons. Firstly, the sequence impacts the formation of secondary
structures with the RBS that might cause it to be blocked and therefore affects the rate at which
translation initiates and this is something that is taken into account in the RBS ‘strength’. The
second main reason is that slower codons at the start of a transcript mediate the rate at which
ribosomes start moving along the mRNA in the elongation stage. This ‘on ramp’ helps minimise
traffic jams caused by slow codons further along the transcript.
In addition to the 5’ region, the sequence of the transcript is important as it dictates the rate at
which ribosomes move along it. There are two reasons for this given in the literature. Firstly
the codons used to encode the amino acid sequence of the protein affect which transfer RNAs
(tRNAs) are used to recruit amino acids into the elongating peptide chain. Different tRNAs
occur at different concentrations within the cell and their relative abundances mean their amino
acids are incorporated into the elongating peptide at different rates. Certain codons in E. coli
are considered to be ‘slow codons’ and are translated at a slower rate relative to other codons.
Secondly, certain sequences known as anti Shine-Dalgarno sequences have a high affinity for
the 16S ribosomal RNA of the translating ribosome which causes a decrease in the rate at
which the ribosome is able to elongate past this sequence [58]. The locations of slow codons
and anti Shine-Dalgarno sequences are highly correlated as the anti Shine-Dalgarno sequence
contains the same sequence as a number of slow codons [58].
In this study we have not made the distinction between the two factors when trying to introduce a
delay in the translation rate towards the end of the vioB sequence. We introduced slow codons
as well as anti Shine-Dalgarno sequences. Our experimental results show that the introduction
of these sequence motifs towards the end of the vioB causes both decreased capacity as well
as decreased circuit output. This is because the slow codons (a term we use to describe a
sequence that contains both slow codons and anti Shine-Dalgarno sequences) are causing a
decrease in the flux of ribosomes through a certain point (or set of points) along the mRNA.
Each protein produced corresponds to a ribosome moving fully along the mRNA and translating
an entire peptide chain and therefore, decreasing flux of proteins along the mRNA decreases
the rate at which proteins are produced. Also, if ribosomes are being recruited onto the mRNA
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at a higher rate than they are moving past the slow codons then this will lead to ribosomes
being in ‘traffic jams’ at the slow codons due to a bottleneck in the flux.
The relationship between the strength of the RBS and the minimal translational rate across the
mRNA (due to codon usage/anti Shine-Dalgarno sequences) impacts heavily on the efficiency
of the transcript. When the RBS strength is low, the rate at which transcription is initiated is
the limiting factor in protein production. This also means that traffic jams occur with much
lower frequency. We hypothesise that for a given coding sequence (in a given set of growth
conditions) there is a threshold for RBS strength above which, the codon usage and presence
of anti Shine-Dalgarno sequences become the limiting factor in protein production rate and
‘traffic jams’ increasingly occur, thus decreasing the efficiency of the circuit.
Whilst slow codons appear to be a poor choice in circuit design, they can be useful in ensuring
the correct folding of multi-domain proteins [100]. Therefore, in some circumstances their use
may be required. In this case we suggest that the circuit should be designed so that the
RBS strength is at, or just below, the threshold mentioned above (see Section 7.3.10 for more
details) and the correct level of expression should be controlled via the promoter strength and
copy number. This threshold can be obtained by creating a library of constructs with different
RBS strengths and using the methodology outlined in this project to identify where increases in
RBS strength start causing non-linear decreases in capacity.
The DH10B cells used in most of this project do not have the stringent response phenotype,
but by performing some of the same experiments in MG1655 cells we were able to observe
the behaviour of wild-type cells in response to burden. We saw that MG1655 cells had a much
larger decrease in capacity when heterologous protein production was induced. This may have
been due to the stringent response allowing the cells to detect the production of extra protein
and adapt to cope with this by down regulating the monitor promoter. We observed that slow
codons are also a poor design choice in MG1655 cells, indicating that they should be avoided
(where possible) across different strains of E. coli.
Growth rate is frequently used as a proxy for the ‘health’ of the cell, however our results have
shown there is weak correlation between this and metrics such as cellular capacity or circuit
efficiency. Given that we are using a more direct system for observing resource availability we
argue that our system is a better method for observing the ‘health’ of a cell in the context of
cellular capacity and resource availability.
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7.1.3 Module 3: Modelling the Interactions
Both the literature and wet-lab results indicate that the key factor in cell-circuit interactions
through shared resources is ribosomal availability [90,24,104]. Therefore we develop a model of
gene expression that focuses on the translational process and includes elongation stages. The
model was derived as a Markovian random walk process and developed into a determinis-
tic steady-state model using expectations. This model enables us to simulate the ribosomal
density across transcripts and in the free ribosome pool.
The parameters in the model allow us to control the number of transcripts (to represent a
change in the copy number or promoter strength), the length of transcripts, elongation rates
at each codon, RBS strength (RBS-ribosome binding and unbinding rates) and total number
of ribosomes. For systems with transcripts of non-trivial length (>2 elongation stages) the
equations cannot be solved analytically. Therefore, we use numerical analysis to solve them.
We tested the model using parameter values that are approximately what we would expect in
vivo. The results of these simulations give system variables that correspond to what we would
expect to be the case in vivo.
We simulate a system with a burden monitor device and a synthetic circuit and change the pa-
rameters to reflect the experiments performed in vivo. The simulation results closely resemble
the experimental data. Some of the areas where there were differences were at higher RBS
strengths. The experimental data shows that at high RBS strengths there is a decrease in the
protein output, most likely due to the host cell adapting to cope with the depleted resources.
The cellular behaviour is not modelled in our system and therefore the adaptation of the cell to
the stress and its feedback to the circuit output would not be expected to be observed in the
simulations of the model.
The model is able to not only predict the impact of changes of single parameters at a time,
but is also able to capture more complex interactions across multiple control points. We were
able to experimentally show that by balancing promoter strength and RBS strength we are able
to construct two circuits that have the same output but place different levels of burden on the
resource pool. By simulating this experiment in the model we obtained the same conclusion
whereby a strong promoter and weak RBS combination is more efficient than a strong RBS and
weak promoter combination. Due to a lack of knowledge about the exact parameter values we
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did not get a fully quantitative match, however we were able to get a strong qualitative match
in terms of both monitor output and circuit output across all four RBS/promoter combinations.
This may also be partially due to the lack of burden due to DNA replication or RNA production
in our model.
This model is clearly a very simplified way of representing gene expression and the interaction
with shared resources. A number of assumptions are made in the derivation of the model and
may impact on our ability to accurately model the cellular system. One assumption that we
know to be incorrect is that each ribosome occupies a single codon on the mRNA. In reality
a ribosome occludes a space of approximately 13 codons [89]. However the core dynamics of
the process are unaltered by this assumption and we are able to much more easily simulate
behaviour to a qualitatively accurate level.
We know that occasionally ribosomes can terminate translation early and exit the mRNA be-
fore reaching the stop codon. This is not allowed in our model, and indeed it may be the
case that ribosomal traffic jams encourage early termination and therefore less ribosomes are
sequestered in these situations than predicted by our model.
Another assumption we make is that the position of a ribosome at a given point in time is
independent of the position of all other ribosomes. This is an important assumption in the
derivation of our model as it allows us to simplify many of the probability functions of ribosomal
movement. The implication of the removal of this assumption is that the equations obtained
are a lot more complex and asserting the existence and uniqueness of solutions may not be
possible. The full model is of a similar form to one derived elsewhere in the literature using
different techniques [60].
This model was implemented in a python script which allows users to simulate the behaviour
of cells with any number of circuits. Users are able to define all of the key metrics for both
the circuits and the cell and simulate the behaviour using a simple piece of code. This could




In this project we have investigated how synthetic genetic circuits and host chassis E. coli cells
interact through shared resources. By inserting a constitutively expressed GFP into the genome
we have created a device which is able to monitor the cell’s capacity for gene expression. The
device was tested and we showed that it can detect the burden placed on a cell’s shared
resource pool both from heterologous gene expression as well as the cell producing additional
protein to adapt to a change in growth medium.
We created a library of sequences in order to test the impact of changing the key control points
of synthetic circuits. We established how changes in these control points affected the circuit
output and the burden it placed on the cell. An important finding was that slow codons are
detrimental in terms of both of these factors. We established certain design principles that
allow circuits to be designed to have the same output but place different burdens on the cell by
using a combination of weak and strong RBS and promoter parts. Our results confirmed that
translation was the limiting step in gene expression for the circuits we investigated. We also
showed the relationship between growth rate and cellular capacity has only a weak correlation.
By building a model of translational processes we have been able to reproduce almost all of the
experimental data. In addition we have been able to predict the impact of mRNA levels and RBS
strength are ’saturating’, whereby as the strengths tend to infinity the circuit output and monitor
output tend to predictable, finite values. This means that both burden levels and circuit output
tend towards asymptotes as these variables are increased. We have built a programmable
implementation of the model (using python) that could easily be used as a package in biological
CAD/modelling software. The model has also been used to identify how future versions of the
monitor might be designed by changing the RBS strength to affect the ’sensitivity’ of the monitor.
7.3 Future Work and Implications
There is a range of further work that could be done to expand and complement the results of
this project. This ranges from performing some additional characterisation experiments to the
inclusion of additional considerations such as noise.
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7.3.1 Improving the Capacity Monitor
The final monitor device design was decided upon after a number of versions were considered
with different degradation tags and copy numbers. The core design such as promoter, RBS
sequence and coding sequence were decided upon by simply trying to maximise the rate of
protein output from the device and no variations of these were tested. This project has shown
clearly that this approach is not optimal for maximising the efficiency of the circuit. It would
be interesting to look at how the core monitor device could be redesigned by considering the
results of this project. We have seen that our model may be able to help guide this design
taking into account factors such as sensitivity to changes in free ribosome numbers.
The capacity monitor has been introduced into the cell via a genomic integration into the λ-
site where a pit-dependent origin of replication and a kanamycin resistance marker are also
present from the CRIM system [46]. The kanamycin resistance marker causes constitutive ex-
pression of a kanamycin resistance protein, which has two main effects. Firstly the production
of any protein requires shared resources and since the capacity monitor should have as lit-
tle impact on the cell’s shared resources, the presence of any unnecessary gene is not ideal.
Also, by having a kanamycin resistance gene on the genome cells are incompatible with any
synthetic circuits that use kanamycin to maintain their presence (i.e. plasmids with kanamycin
resistance). Genomic insertion of the core monitor device without the origin of replication and
resistance marker would be an important piece of work when improving the monitor.
The choice of sfGFP as the reporter protein in the monitor device gives a number of important
advantages such as having a well characterised protein that can be used in many synthetic
biology labs. However, this means the monitor is incompatible with any synthetic circuit that
uses GFP. Compatibility could be increased by implementing a library of monitor versions with
a range of alternative fluorescent proteins with different emission and excitation wavelengths.
If these monitors could be compared and calibrated against each other it may be possible to
characterise and compare any selection of genetic circuits.
The capacity monitor was inserted into the λ-site on the E. coli genome. Genomic insertions
were attempted at both the λ- and Φ80-sites, however the Φ80-site integration was unsuccess-
ful on the first attempt. For this project we did not consider the exact location of the integra-
tion within the genome to be important, however it would be interesting to investigate different
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integration locations for two reasons. Firstly, the local genetic context might affect the moni-
tor expression levels depending on the expression of neighbouring genes which may change
when the cell is growing in different conditions or under different stresses. Secondly, different
locations on the genome exist at different copy numbers at different growth rates to ensure that
genome replication happens at the same rate as cell division and therefore the monitor may
exist at different copy numbers in different conditions depending on its location on the genome.
7.3.2 Additional Growth Conditions and Stresses
The characterisation of the library of constructs was performed under the same growth con-
ditions, i.e., growing in volumes of 200 µl in a 96-well plate with M9 medium supplemented
with 0.4% fructose at 37°C. These conditions are very specific and it would be interesting to
test how circuits behave under different conditions. Interesting conditions to test would be with
different medium such as a different carbon source or amino acid composition. By changing
the amino acid availability, the rate at which elongation occurs may change, though the rate of
initiation might stay the same. This would impact the balance between RBS strength and codon
usage (something our modelling has shown is key) and may change whether the RBS strength
or elongation speed is the rate limiting factor in protein production rate.
Additional experiments could also be done to test how the capacity of cells is affected when
they undergo stress. This stress may come in different forms such as temperature stress,
oxidative stress, nitrogen starvation etc. It would be interesting to look at ‘steady-state’ growth
in these conditions as well as observing how the capacity of the cell behaves when a stress
is put on the cell (such as a shift in the carbon source as shown in Chapter 4). It would be
interesting to observe how well cells containing different versions of the test circuit are able to
adapt to cope with these stresses and see if we can predict the nature of these adaptations.
In this context, an interesting question would be whether circuits that cause higher levels of
burden cause cells to take longer to adapt to stressful conditions. This would hint that the role
of capacity in exponential growth is to allow for quick adaptation.
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7.3.3 Testing in Additional Strains and Organisms
All of the experiments performed were in E. coli DH10B, with the exception of a comparison
with MG1655 for a selection of circuits. Cardinale et al. [23] have investigated cell-circuit interac-
tions by investigating how a synthetic circuit behaves in different cellular contexts. Testing the
construct in different strains of E. coli would enable us to understand the relative differences
in native capacity, i.e. how much of the shared resources can we use before adversely affect-
ing the cell? Different strains may also affect how different control points relate to each other,
for example a cell with a higher native abundance of charged tRNAs may cause a different
interaction between the RBS strength and codon usage in a synthetic circuit.
In addition to working with E. coli it would be interesting to implement a similar burden moni-
tor in other bacteria such as Bacillus subtilis to investigate the different capacities and cellular
responses to the addition of genetic circuits. This should be a relatively simple expansion, as
long as the species the monitor is implemented in have reasonably simple ways of introducing
a circuit into the genome. Attempting to implement a capacity monitor in eukaryotes such as
Saccharomyces cerevisiae would pose additional challenges, however it would be very inter-
esting to observe the implications of doing so. It would be interesting to investigate whether the
native capacity of different species is different and whether there is any relationship with the
range of environments the natural species exist in and need to adapt between.
It may be possible to build a controllable burden-inducing device which can be used to impose
a range of different definable burden levels on the shared resource pool. This would allow
cells to be characterised in terms of how much native capacity they have as well as how they
respond to a range of burdens. This information can be used with circuit characterisation data
in an extended model of cell-circuit interaction to predict how separately characterised cells and
circuits might behave together. This device could be a simple inducible promoter driving the
production of RNA that sequesters a defined number of ribosomes.
7.3.4 Expanding the Test Construct Library
The library of constructs we produced contained 2 promoter variants, 2 plasmid backbone
variants, 3 RBS variants and 2 codon usage variants. This gave a total of 24 constructs in
our library with which we were able to gain an understanding into the impact of changes in
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these control points. From the data obtained in characterising these circuits with the capacity
monitor we were able to get a good insight into the way in which synthetic circuits interact
with the shared resource pool. However, obtaining data for a broader range of variants of
these control points could give us a finer, and more detailed, insight into how these control
points affect circuit behaviour. We are able to use our model to get curves of circuit output
and monitor output across a range of RBS and promoters strengths and it would be useful
to get the corresponding in vivo data to make a more informed comparison. Different codon
usages could be investigated by introducing ‘on ramps’ of slow codons towards the start of
the transcript as well as changing the location and length of the slow codon regions. Using
different plasmid backbones would allow us to investigate the implications of different origins of
replications and selection markers on cellular capacity and might help us develop plasmids that
are better optimised for minimising the impact of a circuit on shared resources.
All of the constructs we built used the VioB protein. This is a limiting factor in the sense that
the decrease in monitor output may be a function of the fact we are using VioB. This is unlikely
as we selected this protein for its orthogonality to the cellular metabolome and the fact it is
non-toxic. Constructing alternative test circuits with different proteins would allow us to confirm
that the behaviour we see is not due to the VioB protein (we see evidence of this from the
circuits used in Chapter 4, though it is not directly comparable). However, VioB-specific effects
are unlikely since we have shown that the luciferase constructs we initially tested the monitor
with cause burden. Use of alternative proteins would also allow greater potential genetic space
for testing different codon usage profiles.
7.3.5 Using the Capacity Monitor to Predict Additional Circuit Behaviour
In this project we used the capacity monitor to provide a proof of principle that we can observe
differences in resource availability within E. coli cells and to gain a greater understanding of
the impact of different design choices on circuit output and resource usage. The monitor may
also be used to predict how additional circuits or genes would be expressed when introduced
in combination with a characterised circuit. For example take synthetic circuits X and Y that
have been characterised with the capacity monitor and an additional gene (or circuit) Z. If cells
containing construct X show a greater output from the monitor than cells containing Y, would
gene Z be expressed at higher levels in the former when compared to the latter. Such a utility
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for the monitor would be very useful when designing larger and more complex circuits.
7.3.6 Expanding the Concept of Optimisation
As mentioned in the introduction, until recently the concept of optimising gene expression was
largely considered in the context of maximising protein output. We have seen in our results that
another important consideration is the amount of resources a circuit uses. By comparing the
amount of resources a circuit uses and its output we have developed a metric which we call
‘efficiency’ and gives an insight into how much resources a circuit is using to provide a given
rate of protein production.
Whilst this is a crucial consideration, we acknowledge that there are other factors we have not
considered that might need to be taken into account. For example, the noise in the output of
a circuit and the cell to cell variation in its behaviour might be important factors. These are
factors we have not investigated in this project and when we compared two circuits with the
same protein production rate but different burden levels we claimed that the one with the lower
burden was more optimal. This is only the case if the aim is to reduce resource usage and it
may be the case that the circuit that caused higher burden had less cell-cell variation, which
might be a more important consideration in some situations. Investigating how these additional
metrics can be obtained and implemented into our system could broaden the scope of how
people are able to optimise circuits.
We have proposed a metric for efficiency which is based on the rate of protein production
divided by the number of ribosomes used by the circuit in producing that protein at any one
point in time. Since we cannot directly measure the number of ribosomes being used we use
the drop in the output of the capacity monitor as a proxy for this number. However, we do
not expect the relationship between used ribosomes and drop in monitor output to be a linear
function, indeed our modelling agrees with this hypothesis. This lack of linear relationship
means that we cannot say a doubling in the drop in monitor output corresponds to a doubling in
the amount of ribosomes sequestered by the synthetic circuit. This in turn makes it difficult to
reliably compare the efficiency of two circuits with different protein production rates using this
metric. A possible way to get past this would be to perform additional experiments that would
allow transfer functions to be uncovered that could allow us to estimate the actual number of
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ribosomes sequestered that correspond to different monitor outputs.
7.3.7 Using Growth Rate Decreases in Circuit Design
Tan et al. show that it is possible to create novel functionality in a circuit by exploiting inter-
actions between the circuit and the cell through growth rate [99]. It may be possible to use this
principle to design circuits that have burden causing aspects that will feed back on their own
behaviour through a link with growth rate. Biotechnology applications often want to maximise
the yield of protein produced from a given amount of input. By slowing the growth rate of cells
it is possible to cause a greater ‘per cell’ accumulation of protein, even if it is being produced
at a lower rate. Balancing these factors may mean circuits can be designed to induce a certain
level of growth retardation that causes the most amount of protein per cell. This may mean the
batch takes longer to grow to the final density, but by diverting more resources to the production
of the protein of interest, and away from growth, the total protein yield per unit of input may be
greater.
7.3.8 Expanding the Model
The model developed in this project allows us to capture most of the behaviours observed in
vivo, however there are a number of ways in which this model could be extended or adapted
to improve it. We have focused on modelling the translational process as this is what both the
literature and our own results indicated was the main factor in cell-circuit interactions through
shared resources. In addition we have not included any cellular behaviour such as growth rate
or any feedback through cellular adaptation.
Extending the model to include important cellular metrics such as growth rate is non-trivial due
to the complex relationships between the shared resource pool and growth rate. A deeper
study of the literature combined with more experimental work may allow a reliable model of this
link to be developed. In addition it may be possible to predict how the cell will adapt to burden
being placed on shared resources through the stringent response or other mechanisms. It is
unlikely that this will be possible from a first principles approach given current understanding of
the cellular processes. However, it may be possible to build a framework whereby cells can be
individually characterised and this data fed into a model as mentioned in Section 7.3.3.
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As well as modelling the cell’s behaviour it is possible to increase the level of detail to which
we describe the gene expression process. Including the impact of different growth rates on
mRNA levels (as shown in Klumpp et al. [51]) would be a sensible way of extending the gene
expression model to include direct relationships with the growth rate. In addition, we can include
the processes of transcription and DNA replication into the model to include competition for the
resources involved in them. Whilst we have seen that they are not as important as competition
for translational resources, their inclusion may allow us to more accurately predict how a circuit
behaves.
Further analysis of the model may enable us to uncover more design principles that allow
the design of more optimal circuits. We have seen that we are able to accurately reproduce
how a strong promoter/weak RBS construct causes lower burden than a weak promoter/strong
RBS construct when the constructs have the same output. It is likely that there are additional
unexpected interactions between different control point selections we can utilise to build more
optimal circuits.
We have made a number of assumptions in the development of the model, some of which we
know to be untrue. These were made in order to simplify the model and make simulation easier.
One important consideration is the size of the ribosome as this will impact how many ribosomes
can fit on a transcript and how many are sequestered in traffic jams. Whilst we have shown
that our current model is able to qualitatively reproduce in vivo results, a model with a more
accurate representation of ribosome sizes may allow more quantitative reliability in predictions.
7.3.9 Other Future Work
We have shown a limited amount of data from quantitative PCR and RNA quantification. We
have collected a few of these data, which have been very useful to identify what the main cause
of reduced capacity was. The laborious nature of RNA extraction and qPCR means that it is
very challenging to get all of the data on mRNA levels for the capacity monitor at the same
level of quality as protein levels. Finding a better way of quantifying mRNA levels in cells that
can be done at the same frequency and integrated into the current protocol would be highly
advantageous. One potential method would be to use Spinach RNA aptamers to quantify RNA
levels [76]. However, the fact it uses green fluorescence causes a slight issue as well as the low
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levels of fluorescence it provides, which may mean getting accurate quantifications is difficult.
A factor we have briefly touched upon in the introduction and Section 5.7.9 is the evolution
and stability of constructs. Recent papers by Sleight and Sauro indicate that burden from
gene expression as the key driver of deleterious mutation and construct instability over multiple
generations [94,93]. Our project could be used to predict the evolutionary stability and outcomes
of synthetic systems based on the burden they cause. There is certainly a large amount of
work to be done in solving this problem, however it is an exciting prospect.
It would also be an interesting study to extend both this work and the work of Li et al. [58] by
trying to decouple the slow codons from anti Shine-Dalgarno sequences and investigating their
separate effects on shared resource usage. This could be done by changing the 16S sequence
and investigating whether similar decreases in cellular capacity could be achieved using only a
modified anti Shine-Dalgarno sequence without slow codons and vice versa.
7.3.10 Design Principles
Through both in vivo and in silico work we have been able to uncover some key relationships
between the circuit design and the amount of shared resources it uses. These allow us to
hypothesise a methodology for optimally designing a synthetic circuit.
The initial stage in the process is to codon optimise the gene of interest. This should be done
by using an algorithm such as the one developed by DNA2.0 [44] whilst taking into account the
potential requirement for slow codons at certain locations for multi-domain proteins if they are
required for the correct folding of the protein. Any anti Shine-Dalgarno sequences should also
be removed. The impact of slow codons has been shown both in vivo and in silico in this
project.
Once this has been done, an appropriate RBS sequence should be selected. This should be
designed so that the RBS strength is such that translational initiation is the limiting factor. This
means that traffic jams are avoided and any necessary slow codons do not cause adverse
effects by being the limiting factor in translation rate. Depending on loaded tRNA abundances
and the growth conditions (which affect translational elongation rate) the choice of RBS strength
may be different, and a weaker RBS may be selected to increase the robustness of the circuit’s
efficiency when experiencing changes in growth conditions.
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The next stage is to select the plasmid backbone and promoter. We have seen that a lower copy
number causes less burden and impacts less on the circuit protein production rate. Therefore
a plasmid backbone should be chosen with the lowest copy number so that it places the lowest
burden on shared resources. The optimal origin of replication for each copy number and the
best selection marker should be investigated in future work. Finally the promoter should be
chosen at a strength that gives the desired rate of protein production. If this is not possible then
it may be necessary to increase the copy number of the circuit.
We believe this simple approach to circuit design will allow researchers to easily improve their
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